ConceptCode:308.3,ConceptCodeName:Acute Stress Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.9,ConceptCodeName:Adjustment Disorder Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.24,ConceptCodeName:Adjustment Disorder with Anxiety,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309,ConceptCodeName:Adjustment Disorder with Depressed Mood,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.3,ConceptCodeName:Adjustment Disorder with Disturbance of Conduct,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.28,ConceptCodeName:Adjustment Disorder with Mixed Anxiety and Depressed Mood,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.4,ConceptCodeName:Adjustment Disorder with Mixed Disturbance of Emotions and Conduct,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.22,ConceptCodeName:Agoraphobia without History of Panic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.1,ConceptCodeName:Anorexia Nervosa,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.7,ConceptCodeName:Antisocial Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.89,ConceptCodeName:Anxiety Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300,ConceptCodeName:Anxiety Disorder; NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.82,ConceptCodeName:Avoidant Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.8,ConceptCodeName:Bipolar Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.56,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.55,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.51,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.52,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.54,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.53,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.5,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.46,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.45,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.41,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.42,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.44,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.43,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.4,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.66,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.65,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.61,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.62,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.64,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.63,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.6,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.7,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.4,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Hypomanic,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.06,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.05,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.01,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.02,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.04,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.03,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.89,ConceptCodeName:Bipolar II Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.7,ConceptCodeName:Body Dysmorphic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.83,ConceptCodeName:Borderline Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Breathing-Related Sleep Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:298.8,ConceptCodeName:Brief Psychotic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.51,ConceptCodeName:Bulimia Nervosa,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.45,ConceptCodeName:Circadian Rhythm Sleep Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.11,ConceptCodeName:Conversion Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.13,ConceptCodeName:Cyclothymic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:297.1,ConceptCodeName:Delusional Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.6,ConceptCodeName:Dependent Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.6,ConceptCodeName:Depersonalization Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:311,ConceptCodeName:Depressive Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.12,ConceptCodeName:Dissociative Amnesia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.15,ConceptCodeName:Dissociative Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.13,ConceptCodeName:Dissociative Fugue,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.14,ConceptCodeName:Dissociative Identity Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.76,ConceptCodeName:Dyspareunia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Dyssomnia NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.44,ConceptCodeName:Dyssomnia Related to (Another Disorder),CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.4,ConceptCodeName:Dysthymic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.5,ConceptCodeName:Eating Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.4,ConceptCodeName:Exhibitionism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625,ConceptCodeName:Female Dyspareunia Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625.8,ConceptCodeName:Female Hypoactive Sexual Desire Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.73,ConceptCodeName:Female Orgasmic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.72,ConceptCodeName:Female Sexual Arousal Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.81,ConceptCodeName:Fetishism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.89,ConceptCodeName:Frotteurism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.85,ConceptCodeName:Gender Identity Disorder in Adolescents or Adults,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.6,ConceptCodeName:Gender Identity Disorder in Children,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.6,ConceptCodeName:Gender Identity Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.02,ConceptCodeName:Generalized Anxiety Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.5,ConceptCodeName:Histrionic Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.71,ConceptCodeName:Hypoactive Sexual Desire Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.7,ConceptCodeName:Hypochondriasis,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.3,ConceptCodeName:Impulse -Control Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.42,ConceptCodeName:Insomnia Related to (Another Disorder),CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.34,ConceptCodeName:Intermittent Explosive Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.32,ConceptCodeName:Kleptomania,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.36,ConceptCodeName:Major Depressive Disorder; Recurrent; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.35,ConceptCodeName:Major Depressive Disorder; Recurrent; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.31,ConceptCodeName:Major Depressive Disorder; Recurrent; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.32,ConceptCodeName:Major Depressive Disorder; Recurrent; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.34,ConceptCodeName:Major Depressive Disorder; Recurrent; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.33,ConceptCodeName:Major Depressive Disorder; Recurrent; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.3,ConceptCodeName:Major Depressive Disorder; Recurrent; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.26,ConceptCodeName:Major Depressive Disorder; Single Episode; In Full Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.25,ConceptCodeName:Major Depressive Disorder; Single Episode; In Partial Remission,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.21,ConceptCodeName:Major Depressive Disorder; Single Episode; Mild,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.22,ConceptCodeName:Major Depressive Disorder; Single Episode; Moderate,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.24,ConceptCodeName:Major Depressive Disorder; Single Episode; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.23,ConceptCodeName:Major Depressive Disorder; Single Episode; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.2,ConceptCodeName:Major Depressive Disorder; Single Episode; Unspecified,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Male Dyspareunia Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.72,ConceptCodeName:Male Erectile Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:607.84,ConceptCodeName:Male Erectile Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Male Hypoactive Sexual Desire Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.74,ConceptCodeName:Male Orgasmic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.83,ConceptCodeName:Mood Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.81,ConceptCodeName:Narcissistic Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:347,ConceptCodeName:Narcolepsy,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Nightmare Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.3,ConceptCodeName:Obsessive Compulsive Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.4,ConceptCodeName:Obsessive-Compulsive Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625.8,ConceptCodeName:Other Female Sexual Dysfunction Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Other Male Sexual Dysfunction Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.89,ConceptCodeName:Pain Disorder Associated with both Psychological Factors and Medical Conditions,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.8,ConceptCodeName:Pain Disorder Associated with Psychological Features,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.21,ConceptCodeName:Panic Disorder with Agoraphobia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.01,ConceptCodeName:Panic Disorder without Agoraphobia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301,ConceptCodeName:Paranoid Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.9,ConceptCodeName:Paraphilia; NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Parasomnia NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.31,ConceptCodeName:Pathological Gambling,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.2,ConceptCodeName:Pedophilia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.9,ConceptCodeName:Personality Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.81,ConceptCodeName:Posttraumatic Stress Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.75,ConceptCodeName:Premature Ejaculation,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.44,ConceptCodeName:Primary Hypersomnia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.42,ConceptCodeName:Primary Insomnia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.81,ConceptCodeName:Psychotic Disorder Due to Medical Condition; with Delusions,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.82,ConceptCodeName:Psychotic Disorder Due to Medical Condition; with Hallucinations,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:298.9,ConceptCodeName:Psychotic Disorder; NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.33,ConceptCodeName:Pyromania,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.7,ConceptCodeName:Schizoaffective Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.2,ConceptCodeName:Schizoid Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.2,ConceptCodeName:Schizophrenia; Catatonic Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.1,ConceptCodeName:Schizophrenia; Disorganized Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.3,ConceptCodeName:Schizophrenia; Paranoid Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.6,ConceptCodeName:Schizophrenia; Residual Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.9,ConceptCodeName:Schizophrenia; Undifferentiated Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.4,ConceptCodeName:Schizophreniform Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.22,ConceptCodeName:Schizotypal Personality Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.79,ConceptCodeName:Sexual Aversion Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.9,ConceptCodeName:Sexual Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.7,ConceptCodeName:Sexual Dysfunction NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.83,ConceptCodeName:Sexual Masochism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.84,ConceptCodeName:Sexual Sadism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:297.3,ConceptCodeName:Shared Psychotic Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.54,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Hypersomnia Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.52,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Insomnia Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Mixed Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Parasomnia Type,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.46,ConceptCodeName:Sleep Terror Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.46,ConceptCodeName:Sleepwalking Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.23,ConceptCodeName:Social Phobia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.81,ConceptCodeName:Somatization Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.81,ConceptCodeName:Somatoform Disorder NOS,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.29,ConceptCodeName:Specific Phobia,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.3,ConceptCodeName:Transvestic Fetishism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.39,ConceptCodeName:Trichotillomania,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.81,ConceptCodeName:Undifferentiated Somatoform Disorder,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:306.51,ConceptCodeName:Vaginismus,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.82,ConceptCodeName:Voyeurism,CodeSystemName:ICD-9,ValueSet:Psychiatric Disorders Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.81,ConceptCodeName:Psychotic Disorder Due to Medical Condition; with Delusions,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.82,ConceptCodeName:Psychotic Disorder Due to Medical Condition; with Hallucinations,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.83,ConceptCodeName:Mood Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:293.89,ConceptCodeName:Anxiety Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.1,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.10,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.11,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.12,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.13,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.14,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.15,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.2,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.20,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.21,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.22,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.23,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.24,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.25,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.3,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.30,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.31,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.32,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.33,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.34,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.35,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.4,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.40,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.41,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.42,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.43,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.44,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.45,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.6,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.60,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.61,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.62,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.63,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.64,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.65,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.7,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.70,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.71,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.72,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.73,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.74,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.75,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.9,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.90,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:295.91,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.01,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.02,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.03,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Severe Without mention of Psychotic behavior,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.04,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; Severe specified as with Psychotic behavior,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.05,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; In Partial or unspecified Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.06,ConceptCodeName:Bipolar I Disorder; Single Manic Episode; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.2,ConceptCodeName:Major Depressive Disorder; Single Episode; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.21,ConceptCodeName:Major Depressive Disorder; Single Episode; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.22,ConceptCodeName:Major Depressive Disorder; Single Episode; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.23,ConceptCodeName:Major Depressive Disorder; Single Episode; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.24,ConceptCodeName:Major Depressive Disorder; Single Episode; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.25,ConceptCodeName:Major Depressive Disorder; Single Episode; In Partial Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.26,ConceptCodeName:Major Depressive Disorder; Single Episode; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.3,ConceptCodeName:Major Depressive Disorder; Recurrent; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.31,ConceptCodeName:Major Depressive Disorder; Recurrent; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.32,ConceptCodeName:Major Depressive Disorder; Recurrent; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.33,ConceptCodeName:Major Depressive Disorder; Recurrent; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.34,ConceptCodeName:Major Depressive Disorder; Recurrent; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.35,ConceptCodeName:Major Depressive Disorder; Recurrent; In Partial Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.36,ConceptCodeName:Major Depressive Disorder; Recurrent; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.4,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Hypomanic,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.4,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.41,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.42,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.43,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.44,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.45,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; In Partial Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.46,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Manic; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.5,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.51,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.52,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.53,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.54,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.55,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; In Partial Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.56,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Depressed; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.6,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.61,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Mild,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.62,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Moderate,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.63,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Severe Without Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.64,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; Severe With Psychotic Features,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.65,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; In Partial Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.66,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Mixed; In Full Remission,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.7,ConceptCodeName:Bipolar I Disorder; Most Recent Episode Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.8,ConceptCodeName:Bipolar Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:296.89,ConceptCodeName:Bipolar II Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:297.1,ConceptCodeName:Delusional Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:297.3,ConceptCodeName:Shared Psychotic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:298.8,ConceptCodeName:Brief Psychotic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:298.9,ConceptCodeName:Psychotic Disorder; NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300,ConceptCodeName:Anxiety Disorder; NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.01,ConceptCodeName:Panic Disorder without Agoraphobia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.02,ConceptCodeName:Generalized Anxiety Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.4,ConceptCodeName:Dysthymic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.11,ConceptCodeName:Conversion Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.12,ConceptCodeName:Dissociative Amnesia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.13,ConceptCodeName:Dissociative Fugue,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.14,ConceptCodeName:Dissociative Identity Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.15,ConceptCodeName:Dissociative Disorders NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.21,ConceptCodeName:Panic Disorder with Agoraphobia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.22,ConceptCodeName:Agoraphobia without History of Panic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.23,ConceptCodeName:Social Phobia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.29,ConceptCodeName:Specific Phobia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.3,ConceptCodeName:Obsessive Compulsive Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.6,ConceptCodeName:Depersonalization Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.7,ConceptCodeName:Body Dysmorphic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.7,ConceptCodeName:Hypochondriasis,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.81,ConceptCodeName:Somatoform Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:300.81,ConceptCodeName:Undifferentiated Somatoform Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301,ConceptCodeName:Paranoid Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.13,ConceptCodeName:Cyclothymic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.2,ConceptCodeName:Schizoid Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.22,ConceptCodeName:Schizotypal Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.4,ConceptCodeName:Obsessive-Compulsive Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.5,ConceptCodeName:Histrionic Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.6,ConceptCodeName:Dependent Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.7,ConceptCodeName:Antisocial Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.81,ConceptCodeName:Narcissistic Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.82,ConceptCodeName:Avoidant Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.83,ConceptCodeName:Borderline Personality Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:301.9,ConceptCodeName:Personality Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.2,ConceptCodeName:Pedophilia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.3,ConceptCodeName:Transvestic Fetishism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.4,ConceptCodeName:Exhibitionism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.6,ConceptCodeName:Gender Identity Disorder in children,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.6,ConceptCodeName:Gender Identity Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.7,ConceptCodeName:Psychosexual Dysfunction;unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.71,ConceptCodeName:Hypoactive Sexual Desire Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.72,ConceptCodeName:Psychosexual dysfunction with inhibited sexual excitement,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.73,ConceptCodeName:Female Orgasmic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.74,ConceptCodeName:Male Orgasmic Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.75,ConceptCodeName:Premature Ejaculation,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.76,ConceptCodeName:Dyspareunia,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.79,ConceptCodeName:Sexual Aversion Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.81,ConceptCodeName:Fetishism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.82,ConceptCodeName:Voyeurism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.83,ConceptCodeName:Sexual Masochism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.84,ConceptCodeName:Sexual Sadism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.85,ConceptCodeName:Gender Identity Disorder in Adolescents or Adults,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.89,ConceptCodeName:Frotteurism,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:302.9,ConceptCodeName:Unspecified psychosexual disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:306.51,ConceptCodeName:Vaginismus,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.1,ConceptCodeName:Anorexia Nervosa,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.42,ConceptCodeName:Persistent disorder of initiating or maintaining sleep,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.44,ConceptCodeName:Persistent disorder of initiating or maintaining wakefulness,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.45,ConceptCodeName:Circadian Rhythm Sleep Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.46,ConceptCodeName:Sleep arousal disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Dyssomnia NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Nightmare Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.47,ConceptCodeName:Parasomnia NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.5,ConceptCodeName:Eating Disorder; unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.51,ConceptCodeName:Bulimia Nervosa,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.8,ConceptCodeName:Psychogenic pain; site unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:307.89,ConceptCodeName:Other pain disorder related to psychological factors,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:308.3,ConceptCodeName:Acute Stress Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309,ConceptCodeName:Adjustment Disorder with Depressed Mood,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.24,ConceptCodeName:Adjustment Disorder with Anxiety,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.28,ConceptCodeName:Adjustment Disorder with Mixed Anxiety and Depressed Mood,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.3,ConceptCodeName:Adjustment Disorder with Disturbance of Conduct,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.4,ConceptCodeName:Adjustment Disorder with Mixed Disturbance of Emotions and Conduct,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.81,ConceptCodeName:Posttraumatic Stress Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:309.9,ConceptCodeName:Adjustment Disorder Unspecified,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:311,ConceptCodeName:Depressive Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.3,ConceptCodeName:Impulse -Control Disorder NOS,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.31,ConceptCodeName:Pathological Gambling,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.32,ConceptCodeName:Kleptomania,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.33,ConceptCodeName:Pyromania,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.34,ConceptCodeName:Intermittent Explosive Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:312.39,ConceptCodeName:Trichotillomania,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:347,ConceptCodeName:Narcolepsy; without cataplexy,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:607.84,ConceptCodeName:Male Erectile Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Unspecified disorder of male genital organs,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Male Hypoactive Sexual Desire Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:608.89,ConceptCodeName:Other Male Sexual Dysfunction Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625,ConceptCodeName:Female Dyspareunia Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625.8,ConceptCodeName:Other specified symptoms associated with female genital organs,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625.8,ConceptCodeName:Female Hypoactive Sexual Desire Disorder Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:625.8,ConceptCodeName:Other Female Sexual Dysfunction Due to Medical Condition,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.52,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Insomnia Type,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.54,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Hypersomnia Type,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Breathing-Related Sleep Disorder,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Mixed Type,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:780.59,ConceptCodeName:Sleep Disorder Due to A Medical Condition; Parasomnia Type,CodeSystemName:ICD-9,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F06.2,ConceptCodeName:Psychotic disorder with delusions due to known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F06.0,ConceptCodeName:Psychotic disorder with hallucinations due to known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F06.30,ConceptCodeName:Mood disorder due to known physiological condition; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F06.01,ConceptCodeName:Catatonic disorder due to known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F53,ConceptCodeName:Puerperal psychosis,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.1,ConceptCodeName:Disorganized schizophrenia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.2,ConceptCodeName:Catatonic schizophrenia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.0,ConceptCodeName:Paranoid schizophrenia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.81,ConceptCodeName:Schizophreniform disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.5,ConceptCodeName:Residual schizophrenia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F25.9,ConceptCodeName:Schizoaffective disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F20.9,ConceptCodeName:Schizophrenia; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.10,ConceptCodeName:Manic episode without psychotic symptoms; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.11,ConceptCodeName:Manic episode without psychotic symptoms; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.12,ConceptCodeName:Manic episode without psychotic symptoms; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.13,ConceptCodeName:Manic episode; severe; without psychotic symptoms,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.2,ConceptCodeName:Manic episode; severe with psychotic symptoms,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.3,ConceptCodeName:Manic episode in partial remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F30.4,ConceptCodeName:Manic episode in full remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.9,ConceptCodeName:Major depressive disorder; single episode; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.0,ConceptCodeName:Major depressive disorder; single episode; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.1,ConceptCodeName:Major depressive disorder; single episode; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.2,ConceptCodeName:Major depressive disorder; single episode; severe without psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.3,ConceptCodeName:Major depressive disorder; single episode; severe with psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.4,ConceptCodeName:Major depressive disorder; single episode; in partial remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.5,ConceptCodeName:Major depressive disorder; single episode; in full remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.9,ConceptCodeName:Major depressive disorder; recurrent; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.0,ConceptCodeName:Major depressive disorder; recurrent; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.1,ConceptCodeName:Major depressive disorder; recurrent; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.2,ConceptCodeName:Major depressive disorder; recurrent severe without psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.3,ConceptCodeName:Major depressive disorder; recurrent; severe with psychotic symptoms,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.41,ConceptCodeName:Major depressive disorder; recurrent; in partial remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F33.42,ConceptCodeName:Major depressive disorder; recurrent; in full remission,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.10,ConceptCodeName:Bipolar disorder; current episode manic without psychotic features; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.10,ConceptCodeName:Bipolar disorder; current episode manic without psychotic features; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.11,ConceptCodeName:Bipolar disorder; current episode manic without psychotic features; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.12,ConceptCodeName:Bipolar disorder; current episode manic without psychotic features; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.13,ConceptCodeName:Bipolar disorder; current episode manic without psychotic features; severe,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.2,ConceptCodeName:Bipolar disorder; current episode manic severe with psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.73,ConceptCodeName:Bipolar disorder; in partial remission; most recent episode manic,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.74,ConceptCodeName:Bipolar disorder; in full remission; most recent episode manic,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.30,ConceptCodeName:Bipolar disorder; current episode depressed; mild or moderate severity; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.31,ConceptCodeName:Bipolar disorder; current episode depressed; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.32,ConceptCodeName:Bipolar disorder; current episode depressed; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.4,ConceptCodeName:Bipolar disorder; current episode depressed; severe; without psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.5,ConceptCodeName:Bipolar disorder; current episode depressed; severe; with psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.75,ConceptCodeName:Bipolar disorder; in partial remission; most recent episode depressed,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.76,ConceptCodeName:Bipolar disorder; in full remission; most recent episode depressed,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.60,ConceptCodeName:Bipolar disorder; current episode mixed; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.61,ConceptCodeName:Bipolar disorder; current episode mixed; mild,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.62,ConceptCodeName:Bipolar disorder; current episode mixed; moderate,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.63,ConceptCodeName:Bipolar disorder; current episode mixed; severe; without psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.64,ConceptCodeName:Bipolar disorder; current episode mixed; severe; with psychotic features,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.77,ConceptCodeName:Bipolar disorder; in partial remission; most recent episode mixed,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.78,ConceptCodeName:Bipolar disorder; in full remission; most recent episode mixed,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.9,ConceptCodeName:Bipolar disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.9,ConceptCodeName:Bipolar disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F31.81,ConceptCodeName:Bipolar II disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F22,ConceptCodeName:Delusional disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F24,ConceptCodeName:Shared psychotic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F23,ConceptCodeName:Brief psychotic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F29,ConceptCodeName:Unspecified psychosis not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F41.9,ConceptCodeName:Anxiety disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F41.0,ConceptCodeName:Panic disorder [episodic paroxysmal anxiety] without agoraphobia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F41.1,ConceptCodeName:Generalized anxiety disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F34.1,ConceptCodeName:Dysthymic Disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.4,ConceptCodeName:F44.4 Conversion disorder with motor symptom or deficit,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.6,ConceptCodeName:F44.6 Conversion disorder with sensory symptom or deficit,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.0,ConceptCodeName:Dissociative amnesia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.1,ConceptCodeName:Dissociative fugue,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.81,ConceptCodeName:Dissociative identity disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F44.9,ConceptCodeName:Dissociative and conversion disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.01,ConceptCodeName:Agoraphobia with panic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.02,ConceptCodeName:Agoraphobia without panic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.10,ConceptCodeName:Social phobia; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.218,ConceptCodeName:F40.218 Other animal type phobia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.240,ConceptCodeName:F40.240 Claustrophobia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.241,ConceptCodeName:F40.241 Acrophobia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F40.8,ConceptCodeName:F40.8 Other phobic anxiety disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F42,ConceptCodeName:Obsessive-compulsive disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F48.1,ConceptCodeName:Depersonalization-derealization syndrome,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.22,ConceptCodeName:Body dysmorphic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.21,ConceptCodeName:Hypochondriasis,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.0,ConceptCodeName:Somatization disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.0,ConceptCodeName:Somatization disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.0,ConceptCodeName:Paranoid personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F34.0,ConceptCodeName:Cyclothymic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.1,ConceptCodeName:Schizoid personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F21,ConceptCodeName:Schizotypal disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.5,ConceptCodeName:Obsessive-compulsive personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.4,ConceptCodeName:Histrionic personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.7,ConceptCodeName:Dependent personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.2,ConceptCodeName:Antisocial personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.81,ConceptCodeName:Narcissistic personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.6,ConceptCodeName:Avoidant personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.3,ConceptCodeName:Borderline personality disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F60.9,ConceptCodeName:Personality disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.4,ConceptCodeName:Pedophilia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.1,ConceptCodeName:Transvestic fetishism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.2,ConceptCodeName:Exhibitionism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F64.2,ConceptCodeName:Gender identity disorder of childhood,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F64.9,ConceptCodeName:Gender identity disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:R37,ConceptCodeName:Sexual dysfunction; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.0,ConceptCodeName:Hypoactive sexual desire disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.21,ConceptCodeName:Male erectile disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.8,ConceptCodeName:Other sexual dysfunction not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.31,ConceptCodeName:Female orgasmic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.32,ConceptCodeName:Male orgasmic disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.4,ConceptCodeName:Premature ejaculation,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.6,ConceptCodeName:Dyspareunia not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.1,ConceptCodeName:Sexual aversion disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.8,ConceptCodeName:Other sexual dysfunction not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.0,ConceptCodeName:Fetishism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.3,ConceptCodeName:Voyeurism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.51,ConceptCodeName:Sexual masochism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.52,ConceptCodeName:Sexual sadism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F64.1,ConceptCodeName:Gender identity disorder in adolescence and adulthood,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.81,ConceptCodeName:Frotteurism,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.89,ConceptCodeName:Other paraphilias,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F66,ConceptCodeName:Other sexual disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F65.9,ConceptCodeName:Paraphilia; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.5,ConceptCodeName:Vaginismus not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F50.00,ConceptCodeName:Anorexia nervosa; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.01,ConceptCodeName:Primary insomnia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.03,ConceptCodeName:Paradoxical insomnia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.09,ConceptCodeName:Other insomnia not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.11,ConceptCodeName:Primary hypersomnia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.19,ConceptCodeName:Other hypersomnia not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.12,ConceptCodeName:Insufficient sleep syndrome,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.8,ConceptCodeName:Other sleep disorders not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.3,ConceptCodeName:Sleepwalking [somnambulism],CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.8,ConceptCodeName:Other sleep disorders not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.8,ConceptCodeName:Other sleep disorders not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F51.8,ConceptCodeName:Other sleep disorders not due to a substance or known physiological condition,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F50.9,ConceptCodeName:Eating disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F50.2,ConceptCodeName:Bulimia nervosa,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.41,ConceptCodeName:Pain disorder exclusively related to psychological factors,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F45.42,ConceptCodeName:Pain disorder with related psychological factors,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.0,ConceptCodeName:Acute stress reaction,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.21,ConceptCodeName:Adjustment disorder with depressed mood,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.22,ConceptCodeName:Adjustment disorder with anxiety,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.23,ConceptCodeName:Adjustment disorder with mixed anxiety and depressed mood,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.24,ConceptCodeName:Adjustment disorder with disturbance of conduct,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.25,ConceptCodeName:Adjustment disorder with mixed disturbance of emotions and conduct,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.10,ConceptCodeName:Post-traumatic stress disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.12,ConceptCodeName:Post-traumatic stress disorder; chronic,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F43.20,ConceptCodeName:Adjustment disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F32.9,ConceptCodeName:Major depressive disorder; single episode; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.9,ConceptCodeName:Impulse disorder; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.0,ConceptCodeName:Pathological gambling,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.2,ConceptCodeName:Kleptomania,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.1,ConceptCodeName:Pyromania,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.81,ConceptCodeName:Intermittent explosive disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.3,ConceptCodeName:Trichotillomania,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F63.89,ConceptCodeName:Other impulse disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.419,ConceptCodeName:Narcolepsy without cataplexy,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N52.9,ConceptCodeName:Male erectile dysfunction; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N44.2,ConceptCodeName:N44.2 Benign cyst of testis,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N44.8,ConceptCodeName:N44.8 Other noninflammatory disorders of the testis,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N50.3,ConceptCodeName:N50.3 Cyst of epididymis,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N50.8,ConceptCodeName:N50.8 Other specified disorders of male genital organs,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N53.12,ConceptCodeName:N53.12 Painful ejaculation,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F52.0,ConceptCodeName:Hypoactive sexual desire disorder,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N52.1,ConceptCodeName:Erectile dysfunction due to diseases classified elsewhere,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N94.1,ConceptCodeName:Dyspareunia,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N94.89,ConceptCodeName:Other specified conditions associated with female genital organs and menstrual cycle,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N94.89,ConceptCodeName:Other specified conditions associated with female genital organs and menstrual cycle,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:N94.89,ConceptCodeName:Other specified conditions associated with female genital organs and menstrual cycle,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.00,ConceptCodeName:Insomnia; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.10,ConceptCodeName:Hypersomnia; unspecified,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.8,ConceptCodeName:Other sleep disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.8,ConceptCodeName:Other sleep disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:G47.8,ConceptCodeName:Other sleep disorders,CodeSystemName:ICD-10,ValueSet:ICD-9 to ICD-10 Walk through for Psychiatric Disorders,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305.0,ConceptCodeName:Nondependent alcohol abuse,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.00,ConceptCodeName:Alcohol Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.01,ConceptCodeName:Alcohol abuse-continuous,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.02,ConceptCodeName:Alcohol abuse-episodic,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.03,ConceptCodeName:Alcohol abuse-in remiss.,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303,ConceptCodeName:Alcohol dependence syndrome,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.0,ConceptCodeName:Acute alcoholic intoxication,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.00,ConceptCodeName:Acute alcoholic intoxication in alcoholism; uspecified,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.01,ConceptCodeName:Acute alcoholic intoxication in alcoholism; continuous,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.02,ConceptCodeName:Acute alcoholic intoxication in alcoholism; episodic,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.03,ConceptCodeName:Acute alcoholic intoxication in alcoholism; in remission,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.9,ConceptCodeName:Other and unspecified alcohol dependence,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.90,ConceptCodeName:Other and unspecified alcohol dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.91,ConceptCodeName:Other and unspecified alcohol dependence; continuous,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.92,ConceptCodeName:Other and unspecified alcohol dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:303.93,ConceptCodeName:Other and unspecified alcohol dependence; in remission,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.0,ConceptCodeName:Alcohol withdrawal delirium,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.1,ConceptCodeName:Alcohol-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.2,ConceptCodeName:Alcohol-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.3,ConceptCodeName:Alcohol-induced psychotic disorder with hallucinations,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.4,ConceptCodeName:Idiosyncratic alcohol intoxication,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.5,ConceptCodeName:Alcohol-induced psychotic disorder with delusions,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.8,ConceptCodeName:,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.81,ConceptCodeName:Alcohol withdrawal,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.82,ConceptCodeName:Alcohol induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.89,ConceptCodeName:Other specified alcohol-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:291.9,ConceptCodeName:Unspecified alcohol-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F10.10,ConceptCodeName:Alcohol abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.10,ConceptCodeName:Alcohol abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.10,ConceptCodeName:Alcohol abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.10,ConceptCodeName:Alcohol abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.229,ConceptCodeName:Alcohol dependence with intoxication; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.229,ConceptCodeName:Alcohol dependence with intoxication; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.229,ConceptCodeName:Alcohol dependence with intoxication; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.229,ConceptCodeName:Alcohol dependence with intoxication; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.20,ConceptCodeName:Alcohol dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.20,ConceptCodeName:Alcohol dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.20,ConceptCodeName:Alcohol dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.21,ConceptCodeName:Alcohol dependence; in remission,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.231,ConceptCodeName:Alcohol dependence with withdrawal delirium,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.96,ConceptCodeName:Alcohol use; unspecified with alcohol-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.27,ConceptCodeName:Alcohol dependence with alcohol-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.951,ConceptCodeName:Alcohol use; unspecified with alcohol-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.929,ConceptCodeName:Alcohol use; unspecified with intoxication; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.950,ConceptCodeName:Alcohol use; unspecified with alcohol-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.239,ConceptCodeName:Alcohol dependence with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.182,ConceptCodeName:Alcohol abuse with alcoho-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.282,ConceptCodeName:Alcohol dependence with alcoho-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.982,ConceptCodeName:Alcohol use; unspecified with alcoho-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.159,ConceptCodeName:F10.159 Alcohol abuse with alcohol-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.189,ConceptCodeName:F10.180 Alcohol abuse with alcohol-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.181,ConceptCodeName:F10.181 Alcohol abuse with alcohol-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.188,ConceptCodeName:F10.188 Alcohol abuse with other alcohol-induced disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.259,ConceptCodeName:F10.259 Alcohol dependence with alcohol-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.280,ConceptCodeName:F10.280 Alcohol dependence with alcohol-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.281,ConceptCodeName:F10.281 Alcohol dependence with alcohol-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.288,ConceptCodeName:F10.288 Alcohol dependence with other alcohol-induced disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.959,ConceptCodeName:F10.959 Alcohol use; unspecified with alcohol-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.980,ConceptCodeName:F10.980 Alcohol use; unspecified with alcohol-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F10.99,ConceptCodeName:Alcohol use; unspecified with unspecified alcohol-induced disorder,CodeSystemName:ICD-10,ValueSet:Alcohol  Value Sets  Abuse; Dependence; Induced Disorders,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.7,ConceptCodeName:Nondependent amphetamine abuse,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.70,ConceptCodeName:Amphetamine or related acting sympathomimetic abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.71,ConceptCodeName:Amphetamine or related acting sympathomimetic abuse; continuous,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.72,ConceptCodeName:Amphetamine or related acting sympathomimetic abuse; episodic,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.73,ConceptCodeName:Amphetamine or related acting sympathomimetic abuse; in remission,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.4,ConceptCodeName:Amphetamine and other psychostimulant dependence,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.40,ConceptCodeName:Amphetamine and other psychostimulant dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.41,ConceptCodeName:Amphetamine and other psychostimulant dependence; continuous,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.42,ConceptCodeName:Amphetamine and other psychostimulant dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.43,ConceptCodeName:Amphetamine and other psychostimulant dependence; in remission,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F15.10,ConceptCodeName:Other stimulant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.10,ConceptCodeName:Other stimulant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.10,ConceptCodeName:Other stimulant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.10,ConceptCodeName:Other stimulant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.20,ConceptCodeName:Other stimulant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.20,ConceptCodeName:Other stimulant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.20,ConceptCodeName:Other stimulant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.21,ConceptCodeName:Other stimulant dependence; in remission,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.182,ConceptCodeName:F15.182 Other stimulant abuse with stimulant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.282,ConceptCodeName:F15.282 Other stimulant dependence with stimulant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.982,ConceptCodeName:F15.982 Other stimulant use; unspecified with stimulant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.122,ConceptCodeName:F15.122 Other stimulant abuse with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.159,ConceptCodeName:F15.159 Other stimulant abuse with stimulant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.180,ConceptCodeName:F15.180 Other stimulant abuse with stimulant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.181,ConceptCodeName:F15.181 Other stimulant abuse with stimulant-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.188,ConceptCodeName:F15.188 Other stimulant abuse with other stimulant-induced disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.222,ConceptCodeName:F15.222 Other stimulant dependence with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.259,ConceptCodeName:F15.259 Other stimulant dependence with stimulant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.280,ConceptCodeName:F15.280 Other stimulant dependence with stimulant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.281,ConceptCodeName:F15.281 Other stimulant dependence with stimulant-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.288,ConceptCodeName:F15.288 Other stimulant dependence with other stimulant-induced disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.922,ConceptCodeName:F15.922 Other stimulant use; unspecified with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.959,ConceptCodeName:F15.959 Other stimulant use; unspecified with stimulant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.980,ConceptCodeName:F15.980 Other stimulant use; unspecified with stimulant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.981,ConceptCodeName:F15.981 Other stimulant use; unspecified with stimulant-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F15.988,ConceptCodeName:F15.988 Other stimulant use; unspecified with other stimulant-induced disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Amphetamine  Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.8,ConceptCodeName:Nondependent antidepressant type abuse,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.80,ConceptCodeName:Nondependent antidepressant type abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.81,ConceptCodeName:Nondependent antidepressant type abuse; continuous,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.82,ConceptCodeName:Nondependent antidepressant type abuse; episodic,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.83,ConceptCodeName:Nondependent antidepressant type abuse; in remission,CodeSystemName:ICD-9,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Antidepressant Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.2,ConceptCodeName:Nondependent Cannabis abuse,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.20,ConceptCodeName:Cannabis Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.21,ConceptCodeName:Cannabis abuse-continuous,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.22,ConceptCodeName:Cannabis abuse-episodic,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.23,ConceptCodeName:Cannabis abuse-in remission,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.3,ConceptCodeName:Cannabis t dependence,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.30,ConceptCodeName:Cannabis  dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.31,ConceptCodeName:Cannabis  dependence; continuousa,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.32,ConceptCodeName:Cannabis  dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.33,ConceptCodeName:Cannabis  dependence; in remission,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with halucinations,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F12.10,ConceptCodeName:Cannabis abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.90,ConceptCodeName:Cannabis use; unspecified; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.10,ConceptCodeName:Cannabis abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.90,ConceptCodeName:Cannabis use; unspecified; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.10,ConceptCodeName:Cannabis abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.90,ConceptCodeName:Cannabis use. unspecified; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.10,ConceptCodeName:Cannabis abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.90,ConceptCodeName:Cannabis use. unspecified; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.20,ConceptCodeName:Cannabis dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.20,ConceptCodeName:Cannabis dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.20,ConceptCodeName:Cannabis dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.21,ConceptCodeName:Cannabis dependence; in remission,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.122,ConceptCodeName:F12.122 Cannabis abuse with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.159,ConceptCodeName:F12.159 Cannabis abuse with psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.180,ConceptCodeName:F12.180 Cannabis abuse with Cannabis-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.188,ConceptCodeName:F12.188 Cannabis abuse with other Cannabis-induced disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.222,ConceptCodeName:F12.222 Cannabis dependence with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.259,ConceptCodeName:F12.259 Cannabis dependence with psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.280,ConceptCodeName:F12.280 Cannabis dependence with Cannabis-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.288,ConceptCodeName:F12.288 Cannabis dependence with other Cannabis-induced disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.922,ConceptCodeName:F12.922 Cannabis use; unspecified with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.959,ConceptCodeName:F12.959 Cannabis use; unspecified with psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.980,ConceptCodeName:F12.980 Cannabis use; unspecified with anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F12.988,ConceptCodeName:F12.988 Cannabis use; unspecified with other Cannabis-induced disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Cannabis Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.6,ConceptCodeName:Nondependent cocaine abuse,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.60,ConceptCodeName:Cocaine Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.61,ConceptCodeName:Cocaine abuse-continuous,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.62,ConceptCodeName:Cocaine abuse-episodic,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.63,ConceptCodeName:Cocaine abuse-in remission,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.2,ConceptCodeName:Cocaine dependence,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.20,ConceptCodeName:Cocaine dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.21,ConceptCodeName:Cocaine dependence; continuous,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.22,ConceptCodeName:Cocaine dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.23,ConceptCodeName:Cocaine dependence; in remission,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F14.10,ConceptCodeName:Cocaine abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.10,ConceptCodeName:Cocaine abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.10,ConceptCodeName:Cocaine abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.10,ConceptCodeName:Cocaine abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.20,ConceptCodeName:Cocaine dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.20,ConceptCodeName:Cocaine dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.20,ConceptCodeName:Cocaine dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.21,ConceptCodeName:Cocaine dependence; in remission,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.182,ConceptCodeName:F14.182 Cocaine abuse with cocaine-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.282,ConceptCodeName:F14.282 Cocaine dependence with cocaine-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.982,ConceptCodeName:F14.982 Cocaine use; unspecified with cocaine-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.122,ConceptCodeName:F14.122 Cocaine abuse with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.159,ConceptCodeName:F14.159 Cocaine abuse with cocaine-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.180,ConceptCodeName:F14.180 Cocaine abuse with cocaine-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.181,ConceptCodeName:F14.181 Cocaine abuse with cocaine-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.188,ConceptCodeName:F14.188 Cocaine abuse with other cocaine-induced disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.222,ConceptCodeName:F14.222 Cocaine dependence with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.259,ConceptCodeName:F14.259 Cocaine dependence with cocaine-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.280,ConceptCodeName:F14.280 Cocaine dependence with cocaine-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.281,ConceptCodeName:F14.281 Cocaine dependence with cocaine-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.288,ConceptCodeName:F14.288 Cocaine dependence with other cocaine-induced disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.922,ConceptCodeName:F14.922 Cocaine use; unspecified with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.959,ConceptCodeName:F14.959 Cocaine use; unspecified with cocaine-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.980,ConceptCodeName:F14.980 Cocaine use; unspecified with cocaine-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.981,ConceptCodeName:F14.981 Cocaine use; unspecified with cocaine-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F14.988,ConceptCodeName:F14.988 Cocaine use; unspecified with other cocaine-induced disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Cocaine Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.3,ConceptCodeName:Nondependent hallucinogen abuse,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.30,ConceptCodeName:Hallucinogen Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.31,ConceptCodeName:Hallucinogen abuse-continuous,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.32,ConceptCodeName:Hallucinogen abuse-episodic,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.33,ConceptCodeName:Hallucinogen abuse-in remission,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.5,ConceptCodeName:Hallucinogen and other psychostimulantt dependence,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.50,ConceptCodeName:Hallucinogen dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.51,ConceptCodeName:Hallucinogen dependence; continuous,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.52,ConceptCodeName:Hallucinogen dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.53,ConceptCodeName:Hallucinogen dependence; in remission,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F16.10,ConceptCodeName:Hallucinogen abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.10,ConceptCodeName:Hallucinogen abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.10,ConceptCodeName:Hallucinogen abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.10,ConceptCodeName:Hallucinogen abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.20,ConceptCodeName:Hallucinogen dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.20,ConceptCodeName:Hallucinogen dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.20,ConceptCodeName:Hallucinogen dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.21,ConceptCodeName:Hallucinogen dependence; in remission,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.182,ConceptCodeName:F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.282,ConceptCodeName:F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.982,ConceptCodeName:F19.982 Other psychoactive substance use; unspecified with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.122,ConceptCodeName:F16.122 Hallucinogen abuse with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.159,ConceptCodeName:F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.180,ConceptCodeName:F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.183,ConceptCodeName:F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks),CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.188,ConceptCodeName:F16.188 Hallucinogen abuse with other hallucinogen-induced disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.259,ConceptCodeName:F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.280,ConceptCodeName:F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.283,ConceptCodeName:F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks),CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.288,ConceptCodeName:F16.288 Hallucinogen dependence with other hallucinogen-induced disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.959,ConceptCodeName:F16.959 Hallucinogen use; unspecified with hallucinogen-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.980,ConceptCodeName:F16.980 Hallucinogen use; unspecified with hallucinogen-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.983,ConceptCodeName:F16.983 Hallucinogen use; unspecified with hallucinogen persisting perception disorder (flashbacks),CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F16.988,ConceptCodeName:F16.988 Hallucinogen use; unspecified with other hallucinogen-induced disorder,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorde,CodeSystemName:ICD-10,ValueSet:Hallucinogen Abuse; Dependence; Induced Disorders Abuse  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.9,ConceptCodeName:Nondependent other mixed or unspecified drug abuse,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.90,ConceptCodeName:Other; mixed; or unspecified drug abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.91,ConceptCodeName:Other; mixed; or unspecified drug abuse; continuous,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.92,ConceptCodeName:Other; mixed; or unspecified drug abuse; episodic,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.93,ConceptCodeName:Other; mixed; or unspecified drug abuse; in remission,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.6,ConceptCodeName:Other specified drug dependence,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.60,ConceptCodeName:Other specified drug dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.61,ConceptCodeName:Other specified drug dependence; continuous,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.62,ConceptCodeName:Other specified drug dependence; episodic,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.63,ConceptCodeName:Other specified drug dependence; in remission,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F18.10,ConceptCodeName:Inhalant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.10,ConceptCodeName:Inhalant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.10,ConceptCodeName:Inhalant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.10,ConceptCodeName:Inhalant abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.20,ConceptCodeName:Inhalant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.20,ConceptCodeName:Inhalant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.20,ConceptCodeName:Inhalant dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.21,ConceptCodeName:Inhalant dependence; in remission,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.182,ConceptCodeName:F18.182 Inhalant abuse with inhalant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.282,ConceptCodeName:F18.282 Inhalant dependence with inhalant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.982,ConceptCodeName:F18.982 Inhalant use; unspecified with inhalant-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.159,ConceptCodeName:F18.159 Inhalant abuse with inhalant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.180,ConceptCodeName:F18.180 Inhalant abuse with inhalant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.188,ConceptCodeName:F18.188 Inhalant abuse with other inhalant-induced disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.259,ConceptCodeName:F18.259 Inhalant dependence with inhalant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.280,ConceptCodeName:F18.280 Inhalant dependence with inhalant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.288,ConceptCodeName:F18.288 Inhalant dependence with other inhalant-induced disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.959,ConceptCodeName:F18.959 Inhalant use; unspecified with inhalant-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.980,ConceptCodeName:F18.980 Inhalant use; unspecified with inhalant-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F18.988,ConceptCodeName:F18.988 Inhalant use; unspecified with other inhalant-induced disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Inhalant Abuse; Dependence; Induced DisordersValue Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.5,ConceptCodeName:Nondependent opiod abuse,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.50,ConceptCodeName:Opiod Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.51,ConceptCodeName:Opiod abuse-continuous,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.52,ConceptCodeName:Opiod abuse-episodic,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.53,ConceptCodeName:Opiod abuse-in remission,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.0,ConceptCodeName:Opiod dependence,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.00,ConceptCodeName:Opiod dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.01,ConceptCodeName:Opiod dependence; continuous,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.02,ConceptCodeName:Opiod dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.03,ConceptCodeName:Opiod dependence; in remission,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.70,ConceptCodeName:Combinations of opioid type drug with any other drug dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.71,ConceptCodeName:Combinations of opioid type drug with any other drug dependence; continuous,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.72,ConceptCodeName:Combinations of opioid type drug with any other drug dependence; episodic,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.73,ConceptCodeName:Combinations of opioid type drug with any other drug dependence; in remission,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F11.10,ConceptCodeName:Opiod abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.10,ConceptCodeName:Opiod abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.10,ConceptCodeName:Opiod abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.10,ConceptCodeName:Opiod abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.20,ConceptCodeName:Opiod dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.20,ConceptCodeName:Opiod dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.20,ConceptCodeName:Opiod dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.21,ConceptCodeName:Opiod dependence; in remission,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.21,ConceptCodeName:Other psychoactive substance dependence; in remission,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.182,ConceptCodeName:F11.182 Opioid abuse with opioid-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.282,ConceptCodeName:F11.282 Opioid dependence with opioid-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.982,ConceptCodeName:F11.982 Opioid use; unspecified with opioid-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.159,ConceptCodeName:F11.159 Opioid abuse with opioid-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.181,ConceptCodeName:F11.181 Opioid abuse with opioid-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.188,ConceptCodeName:F11.188 Opioid abuse with other opioid-induced disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.222,ConceptCodeName:F11.222 Opioid dependence with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.259,ConceptCodeName:F11.259 Opioid dependence with opioid-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.281,ConceptCodeName:F11.281 Opioid dependence with opioid-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.288,ConceptCodeName:F11.288 Opioid dependence with other opioid-induced disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.922,ConceptCodeName:F11.922 Opioid use; unspecified with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.959,ConceptCodeName:F11.959 Opioid use; unspecified with opioid-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.981,ConceptCodeName:F11.981 Opioid use; unspecified with opioid-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F11.988,ConceptCodeName:F11.988 Opioid use; unspecified with other opioid-induced disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Opioid Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.4,ConceptCodeName:Nondependent Sedative; hypnotic; or anxiolytic abuse,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.40,ConceptCodeName:Sedative; hypnotic; or anxiolytic Abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.41,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse-continuous,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.42,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse-episodic,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.43,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse-in remission,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.1,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.10,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.11,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; continuous,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.12,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence ; episodic,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.13,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; in remission,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with hallucinations,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F13.10,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.10,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.10,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.10,ConceptCodeName:Sedative; hypnotic; or anxiolytic abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.20,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.20,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.20,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.21,ConceptCodeName:Sedative; hypnotic; or anxiolytic dependence; in remission,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.182,ConceptCodeName:F13.182 Sedative; hypnotic or anxiolytic abuse with sedative; hypnotic or anxiolytic-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.282,ConceptCodeName:F13.282 Sedative; hypnotic or anxiolytic dependence with sedative; hypnotic or anxiolytic-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.982,ConceptCodeName:F13.982 Sedative; hypnotic or anxiolytic use; unspecified with sedative; hypnotic or anxiolytic-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.159,ConceptCodeName:F13.159 Sedative; hypnotic or anxiolytic abuse with sedative; hypnotic or anxiolytic-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.180,ConceptCodeName:F13.180 Sedative; hypnotic or anxiolytic abuse with sedative; hypnotic or anxiolytic-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.181,ConceptCodeName:F13.181 Sedative; hypnotic or anxiolytic abuse with sedative; hypnotic or anxiolytic-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.188,ConceptCodeName:F13.259 Sedative; hypnotic or anxiolytic dependence with sedative; hypnotic or anxiolytic-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.259,ConceptCodeName:F13.259 Sedative; hypnotic or anxiolytic dependence with sedative; hypnotic or anxiolytic-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.280,ConceptCodeName:F13.280 Sedative; hypnotic or anxiolytic dependence with sedative; hypnotic or anxiolytic-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.281,ConceptCodeName:F13.281 Sedative; hypnotic or anxiolytic dependence with sedative; hypnotic or anxiolytic-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.288,ConceptCodeName:F13.288 Sedative; hypnotic or anxiolytic dependence with other sedative; hypnotic or anxiolytic-induced disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.959,ConceptCodeName:F13.959 Sedative; hypnotic or anxiolytic use; unspecified with sedative; hypnotic or anxiolytic-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.980,ConceptCodeName:F13.980 Sedative; hypnotic or anxiolytic use; unspecified with sedative; hypnotic or anxiolytic-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.981,ConceptCodeName:F13.981 Sedative; hypnotic or anxiolytic use; unspecified with sedative; hypnotic or anxiolytic-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F13.988,ConceptCodeName:F13.988 Sedative; hypnotic or anxiolytic use; unspecified with other sedative; hypnotic or anxiolytic-induced disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Sedative; hypnotic; anxiolytic Abuse; Dependence; Induced Disorders Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:305,ConceptCodeName:Nondependent abuse of drugs,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.9,ConceptCodeName:Nondependent other mixed or unspecified drug abuse,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.90,ConceptCodeName:Other; mixed; or unspecified drug abuse; unspecified,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.91,ConceptCodeName:Other; mixed; or unspecified drug abuse; continuous,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.92,ConceptCodeName:Other; mixed; or unspecified drug abuse; episodic,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:305.93,ConceptCodeName:Other; mixed; or unspecified drug abuse; in remission,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.2,ConceptCodeName:Pathological drug intoxication,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.6,ConceptCodeName:Phencyclidine dependence,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.60,ConceptCodeName:Other specified drug dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.61,ConceptCodeName:Other specified drug dependence; continuous,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.62,ConceptCodeName:Other specified drug dependence; episodic,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.63,ConceptCodeName:Other specified drug dependence; in remission,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.80,ConceptCodeName:Combinations of drug dependence excluding opioid type drug; unspecified,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.81,ConceptCodeName:Combinations of drug dependence excluding opioid type drug; continuous,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.82,ConceptCodeName:Combinations of drug dependence excluding opioid type drug; episodic,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.83,ConceptCodeName:Combinations of drug dependence excluding opioid type drug; in remission,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.90,ConceptCodeName:Unspecified drug dependence; unspecified,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.91,ConceptCodeName:Unspecified drug dependence; continuous,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.92,ConceptCodeName:Unspecified drug dependence; episodic,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:304.93,ConceptCodeName:Unspecified drug dependence; in remission,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292,ConceptCodeName:Drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.0,ConceptCodeName:Drug withdrawal,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.1,ConceptCodeName:Drug-induced psychotic disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.11,ConceptCodeName:Drug-induced psychotic disorders with delusions,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.12,ConceptCodeName:Drug-induced psychotic disorders with halucinations,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.8,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.81,ConceptCodeName:Drug-induced delirium,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.82,ConceptCodeName:Drug-induced persisting dementia,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.83,ConceptCodeName:Drug-induced persisting amnestic disorder,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.84,ConceptCodeName:Drug-induced mood disorder,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.85,ConceptCodeName:Drug induced sleep disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.89,ConceptCodeName:Other specified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:292.9,ConceptCodeName:Unspecified drug-induced mental disorders,CodeSystemName:ICD-9,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.42
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.10,ConceptCodeName:Other psychoactive substance abuse; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.21,ConceptCodeName:Other psychoactive substance dependence; in remission,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.21,ConceptCodeName:Other psychoactive substance dependence; in remission,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.20,ConceptCodeName:Other psychoactive substance dependence; uncomplicated,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.21,ConceptCodeName:Other psychoactive substance dependence; in remission,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.939,ConceptCodeName:Other psychoactive substance use; unspecified with withdrawal; unspecified,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.950,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with delusions,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.951,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder with hallucinations,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.921,ConceptCodeName:Other psychoactive substance use; unspecified with intoxication with delirium,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.97,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting dementia,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.96,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced persisting amnestic disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.94,ConceptCodeName:Other psychoactive substance use; unspecified with psychoactive substance-induced mood disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.182,ConceptCodeName:F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.282,ConceptCodeName:F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.982,ConceptCodeName:F19.982 Other psychoactive substance use; unspecified with psychoactive substance-induced sleep disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.122,ConceptCodeName:F19.122 Other psychoactive substance abuse with intoxication with perceptual disturbances,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.159,ConceptCodeName:F19.159 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.180,ConceptCodeName:F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.181,ConceptCodeName:F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.188,ConceptCodeName:F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.222,ConceptCodeName:F19.222 Other psychoactive substance dependence with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.259,ConceptCodeName:F19.259 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.280,ConceptCodeName:F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.281,ConceptCodeName:F19.281 Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.288,ConceptCodeName:F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.922,ConceptCodeName:F19.922 Other psychoactive substance use; unspecified with intoxication with perceptual disturbance,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.959,ConceptCodeName:F19.959 Other psychoactive substance use; unspecified with psychoactive substance-induced psychotic disorder; unspecified,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.980,ConceptCodeName:F19.980 Other psychoactive substance use; unspecified with psychoactive substance-induced anxiety disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.981,ConceptCodeName:F19.981 Other psychoactive substance use; unspecified with psychoactive substance-induced sexual dysfunction,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.988,ConceptCodeName:F19.988 Other psychoactive substance use; unspecified with other psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:F19.99,ConceptCodeName:Other psychoactive substance use; unspecified with unspecified psychoactive substance-induced disorder,CodeSystemName:ICD-10,ValueSet:Other Substances of Abuse ; Dependence; Induced Disorders  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.3
ConceptCode:7243,ConceptCodeName:Naltrexone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863847,ConceptCodeName:MS 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863849,ConceptCodeName:MS 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863851,ConceptCodeName:MS 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863853,ConceptCodeName:MS 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863855,ConceptCodeName:MS 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863857,ConceptCodeName:MS 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule [Embeda],CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:207028,ConceptCodeName:ReVia 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:637216,ConceptCodeName:Vivitrol 112 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863845,ConceptCodeName:Morphine Sulfate 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863848,ConceptCodeName:Morphine Sulfate 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863850,ConceptCodeName:Morphine Sulfate 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863852,ConceptCodeName:Morphine Sulfate 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863854,ConceptCodeName:Morphine Sulfate 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:863856,ConceptCodeName:Morphine Sulfate 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:637213,ConceptCodeName:Naltrexone 112 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198011,ConceptCodeName:Naltrexone 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542207,ConceptCodeName:Depade,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542214,ConceptCodeName:Depade 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859959,ConceptCodeName:Embeda,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152092,ConceptCodeName:ReVia,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:636556,ConceptCodeName:Vivitrol,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:105069,ConceptCodeName:Naltrexone hydrochloride,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:866331,ConceptCodeName:Morphine / Naltrexone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3554,ConceptCodeName:Disulfiram,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:151358,ConceptCodeName:Antabuse,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199731,ConceptCodeName:Disulfiram 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197623,ConceptCodeName:Disulfiram 250 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197624,ConceptCodeName:Disulfiram 500 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:210628,ConceptCodeName:Antabuse 250 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:210716,ConceptCodeName:Antabuse 500 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:82819,ConceptCodeName:acamprosate,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:602959,ConceptCodeName:Campral,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835726,ConceptCodeName:Acamprosate calcium 333 MG Enteric Coated Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:967896,ConceptCodeName:{180 (Acamprosate calcium 333 MG Enteric Coated Tablet) } Pack,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835728,ConceptCodeName:Campral 333 MG (equivalent to acamprosate 300 MG) Enteric Coated Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:967897,ConceptCodeName:Campral Dose Pak,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1819,ConceptCodeName:Buprenorphine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352364,ConceptCodeName:Buprenorphine / Naloxone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:203840,ConceptCodeName:Buprenex,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904871,ConceptCodeName:BuTrans,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352990,ConceptCodeName:Suboxone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1818,ConceptCodeName:Subutex,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1431077,ConceptCodeName:Zubsolv,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:246474,ConceptCodeName:Buprenorphine 0.2 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1431076,ConceptCodeName:Buprenorphine 1.4 MG / Naloxone 0.36 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1431102,ConceptCodeName:Buprenorphine 5.7 MG / Naloxone 1.4 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:238129,ConceptCodeName:Buprenorphine 0.3 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904870,ConceptCodeName:168 HR Buprenorphine 0.01 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1307061,ConceptCodeName:Buprenorphine 12 MG / Naloxone 3 MG Oral Strip,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1432969,ConceptCodeName:168 HR Buprenorphine 0.015 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351264,ConceptCodeName:Buprenorphine 2 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010600,ConceptCodeName:Buprenorphine 2 MG / Naloxone 0.5 MG Oral Strip,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351266,ConceptCodeName:Buprenorphine 2 MG / Naloxone 0.5 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904876,ConceptCodeName:168 HR Buprenorphine 0.02 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1307056,ConceptCodeName:Buprenorphine 4 MG / Naloxone 1 MG Oral Strip,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904880,ConceptCodeName:168 HR Buprenorphine 0.005 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351265,ConceptCodeName:Buprenorphine 8 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010604,ConceptCodeName:Buprenorphine 8 MG / Naloxone 2 MG Oral Strip,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351267,ConceptCodeName:Buprenorphine 8 MG / Naloxone 2 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:205533,ConceptCodeName:Buprenex 0.3 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904874,ConceptCodeName:BuTrans 10 MCG/HR Weekly Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1432971,ConceptCodeName:BuTrans 15 MCG/HR Weekly Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904878,ConceptCodeName:BuTrans 20 MCG/HR Weekly Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:904882,ConceptCodeName:BuTrans 5 MCG/HR Weekly Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1307063,ConceptCodeName:Suboxone 12/3 Sublingual Film,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010603,ConceptCodeName:Suboxone 2/0.5 Sublingual Film,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010608,ConceptCodeName:Suboxone 2/0.5 Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1307058,ConceptCodeName:Suboxone 4/1 Sublingual Film,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010606,ConceptCodeName:Suboxone 8/2 Sublingual Film,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1010609,ConceptCodeName:Suboxone 8/2 Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404413,ConceptCodeName:Subutex 2 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404414,ConceptCodeName:Subutex 8 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1431083,ConceptCodeName:Zubsolv 1.4/0.36 Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1431104,ConceptCodeName:Zubsolv 5.7/1.4 Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:6813,ConceptCodeName:Methadone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:202370,ConceptCodeName:Dolophine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152751,ConceptCodeName:Methadose,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:991147,ConceptCodeName:Methadone Hydrochloride 0.333 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1361710,ConceptCodeName:1 ML Methadone Hydrochloride 1 MG/ML Prefilled Syringe,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864706,ConceptCodeName:Methadone Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864769,ConceptCodeName:Methadone Hydrochloride 2 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864714,ConceptCodeName:Methadone Hydrochloride 10 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864978,ConceptCodeName:Methadone Hydrochloride 0.333 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864718,ConceptCodeName:Methadone Hydrochloride 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864761,ConceptCodeName:Methadone Hydrochloride 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864708,ConceptCodeName:Dolophine 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864720,ConceptCodeName:Dolophine 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:991149,ConceptCodeName:Methadose 0.333 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864980,ConceptCodeName:Methadose 0.333 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864712,ConceptCodeName:Methadose 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:864737,ConceptCodeName:Methadose 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2626,ConceptCodeName:cloZAPine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:216102,ConceptCodeName:Clozaril,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542974,ConceptCodeName:Fazaclo,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369826,ConceptCodeName:Versacloz,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476177,ConceptCodeName:cloZAPine 100 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197535,ConceptCodeName:cloZAPine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721773,ConceptCodeName:cloZAPine 12.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1006801,ConceptCodeName:cloZAPine 150 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:996921,ConceptCodeName:cloZAPine 200 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309374,ConceptCodeName:cloZAPine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476179,ConceptCodeName:cloZAPine 25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197536,ConceptCodeName:cloZAPine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:429212,ConceptCodeName:cloZAPine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369825,ConceptCodeName:cloZAPine 50 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104776,ConceptCodeName:Clozaril 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104775,ConceptCodeName:Clozaril 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542977,ConceptCodeName:Fazaclo 100 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721775,ConceptCodeName:Fazaclo 12.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1006803,ConceptCodeName:Fazaclo 150 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:996923,ConceptCodeName:Fazaclo 200 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:543013,ConceptCodeName:Fazaclo 25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369831,ConceptCodeName:Versacloz 50 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:35636,ConceptCodeName:risperiDONE,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152318,ConceptCodeName:RisperDAL,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:645037,ConceptCodeName:risperiDONE 0.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312828,ConceptCodeName:risperiDONE 0.25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403825,ConceptCodeName:risperiDONE 0.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312829,ConceptCodeName:risperiDONE 0.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:401953,ConceptCodeName:risperiDONE 1 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312830,ConceptCodeName:risperiDONE 1 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199387,ConceptCodeName:risperiDONE 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706822,ConceptCodeName:risperiDONE 6.25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:401954,ConceptCodeName:risperiDONE 2 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312831,ConceptCodeName:risperiDONE 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402010,ConceptCodeName:risperiDONE 12.5 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616698,ConceptCodeName:risperiDONE 3 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312832,ConceptCodeName:risperiDONE 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402011,ConceptCodeName:risperiDONE 18.8 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616705,ConceptCodeName:risperiDONE 4 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314211,ConceptCodeName:risperiDONE 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:249289,ConceptCodeName:risperiDONE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402012,ConceptCodeName:risperiDONE 25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:262077,ConceptCodeName:RisperDAL 0.25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806297,ConceptCodeName:RisperDAL 0.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:262222,ConceptCodeName:RisperDAL 0.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806298,ConceptCodeName:RisperDAL 1 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104781,ConceptCodeName:RisperDAL 1 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211489,ConceptCodeName:RisperDAL 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706831,ConceptCodeName:RisperDAL 12.5 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706827,ConceptCodeName:RisperDAL 18.8 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806299,ConceptCodeName:RisperDAL 2 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104782,ConceptCodeName:RisperDAL 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706829,ConceptCodeName:RisperDAL 25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:630890,ConceptCodeName:RisperDAL 3 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104783,ConceptCodeName:RisperDAL 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:630974,ConceptCodeName:RisperDAL 4 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104784,ConceptCodeName:RisperDAL 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706825,ConceptCodeName:RisperDAL 6.25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:89013,ConceptCodeName:ARIPiprazole,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352393,ConceptCodeName:Abilify,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:485496,ConceptCodeName:ARIPiprazole 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643019,ConceptCodeName:ARIPiprazole 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349545,ConceptCodeName:ARIPiprazole 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643022,ConceptCodeName:ARIPiprazole 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349490,ConceptCodeName:ARIPiprazole 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:602964,ConceptCodeName:ARIPiprazole 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643027,ConceptCodeName:ARIPiprazole 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349553,ConceptCodeName:ARIPiprazole 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643058,ConceptCodeName:ARIPiprazole 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349547,ConceptCodeName:ARIPiprazole 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1371191,ConceptCodeName:ARIPiprazole 200 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402131,ConceptCodeName:ARIPiprazole 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:672356,ConceptCodeName:ARIPiprazole 7.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:544412,ConceptCodeName:Abilify 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352307,ConceptCodeName:Abilify 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352308,ConceptCodeName:Abilify 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:615172,ConceptCodeName:Abilify 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352309,ConceptCodeName:Abilify 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1371194,ConceptCodeName:Abilify 200 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352310,ConceptCodeName:Abilify 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404602,ConceptCodeName:Abilify 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:672540,ConceptCodeName:Abilify 7.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643021,ConceptCodeName:Abilify Discmelt 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643023,ConceptCodeName:Abilify Discmelt 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:61381,ConceptCodeName:OLANZapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611247,ConceptCodeName:FLUoxetine / OLANZapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:405343,ConceptCodeName:Symbyax,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:135423,ConceptCodeName:ZyPREXA,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403970,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721787,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 3 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403969,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403971,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403972,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312076,ConceptCodeName:OLANZapine 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314154,ConceptCodeName:OLANZapine 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351107,ConceptCodeName:OLANZapine 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312077,ConceptCodeName:OLANZapine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:885865,ConceptCodeName:OLANZapine 150 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:200034,ConceptCodeName:OLANZapine 2.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351108,ConceptCodeName:OLANZapine 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283639,ConceptCodeName:OLANZapine 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314155,ConceptCodeName:OLANZapine 5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312078,ConceptCodeName:OLANZapine 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:485968,ConceptCodeName:OLANZapine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312079,ConceptCodeName:OLANZapine 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725076,ConceptCodeName:Symbyax 12/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725068,ConceptCodeName:Symbyax 12/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725080,ConceptCodeName:Symbyax 3/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725064,ConceptCodeName:Symbyax 6/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725072,ConceptCodeName:Symbyax 6/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153048,ConceptCodeName:ZyPREXA 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261337,ConceptCodeName:ZyPREXA 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:885867,ConceptCodeName:ZyPREXA 150 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:212405,ConceptCodeName:ZyPREXA 2.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284514,ConceptCodeName:ZyPREXA 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754506,ConceptCodeName:ZyPREXA 5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153046,ConceptCodeName:ZyPREXA 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:545353,ConceptCodeName:ZyPREXA 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153047,ConceptCodeName:ZyPREXA 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754503,ConceptCodeName:ZyPREXA Zydis 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754504,ConceptCodeName:ZyPREXA Zydis 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754505,ConceptCodeName:ZyPREXA Zydis 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:51272,ConceptCodeName:QUEtiapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:83553,ConceptCodeName:SEROquel,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312743,ConceptCodeName:QUEtiapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:389201,ConceptCodeName:QUEtiapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317174,ConceptCodeName:QUEtiapine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312744,ConceptCodeName:QUEtiapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312745,ConceptCodeName:QUEtiapine 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616483,ConceptCodeName:QUEtiapine 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616487,ConceptCodeName:QUEtiapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895670,ConceptCodeName:24 HR QUEtiapine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721791,ConceptCodeName:24 HR QUEtiapine 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721794,ConceptCodeName:24 HR QUEtiapine 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721796,ConceptCodeName:24 HR QUEtiapine 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853201,ConceptCodeName:24 HR QUEtiapine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895671,ConceptCodeName:24 HR SEROquel 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721793,ConceptCodeName:24 HR SEROquel 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721795,ConceptCodeName:24 HR SEROquel 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721797,ConceptCodeName:24 HR SEROquel 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853202,ConceptCodeName:24 HR SEROquel 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153639,ConceptCodeName:SEROquel 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153640,ConceptCodeName:SEROquel 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153638,ConceptCodeName:SEROquel 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284509,ConceptCodeName:SEROquel 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616485,ConceptCodeName:SEROquel 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616489,ConceptCodeName:SEROquel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:115698,ConceptCodeName:ziprasidone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:285064,ConceptCodeName:Geodon,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314286,ConceptCodeName:ziprasidone 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313776,ConceptCodeName:ziprasidone 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313777,ConceptCodeName:ziprasidone 60 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313778,ConceptCodeName:ziprasidone 80 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351223,ConceptCodeName:ziprasidone 20 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:285127,ConceptCodeName:Geodon 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352228,ConceptCodeName:Geodon 20 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284548,ConceptCodeName:Geodon 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284549,ConceptCodeName:Geodon 60 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284550,ConceptCodeName:Geodon 80 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3638,ConceptCodeName:Doxepin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261625,ConceptCodeName:Prudoxin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966788,ConceptCodeName:Silenor,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9801,ConceptCodeName:Zonalon,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966787,ConceptCodeName:Doxepin 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966793,ConceptCodeName:Doxepin 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000048,ConceptCodeName:Doxepin Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000054,ConceptCodeName:Doxepin Hydrochloride 10 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000058,ConceptCodeName:Doxepin Hydrochloride 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000064,ConceptCodeName:Doxepin Hydrochloride 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000070,ConceptCodeName:Doxepin Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000091,ConceptCodeName:Doxepin Hydrochloride 50 MG/ML Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000076,ConceptCodeName:Doxepin Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000097,ConceptCodeName:Doxepin Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000093,ConceptCodeName:Prudoxin 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966791,ConceptCodeName:Silenor 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966795,ConceptCodeName:Silenor 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000095,ConceptCodeName:Zonalon 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2597,ConceptCodeName:clomiPRAMINE,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:756,ConceptCodeName:Anafranil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857291,ConceptCodeName:clomiPRAMINE Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857297,ConceptCodeName:clomiPRAMINE Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857296,ConceptCodeName:clomiPRAMINE Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857301,ConceptCodeName:clomiPRAMINE Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857315,ConceptCodeName:clomiPRAMINE Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857305,ConceptCodeName:clomiPRAMINE Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857299,ConceptCodeName:Anafranil 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857303,ConceptCodeName:Anafranil 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857307,ConceptCodeName:Anafranil 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42347,ConceptCodeName:buPROPion,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835486,ConceptCodeName:Aplenzin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:581646,ConceptCodeName:Budeprion,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:581650,ConceptCodeName:Buproban,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232586,ConceptCodeName:Forfivo,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42568,ConceptCodeName:Wellbutrin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:227948,ConceptCodeName:Zyban,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993550,ConceptCodeName:24 HR buPROPion hydrobromide 174 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993567,ConceptCodeName:24 HR buPROPion hydrobromide 348 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993681,ConceptCodeName:24 HR buPROPion hydrobromide 522 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993503,ConceptCodeName:12 HR buPROPion Hydrochloride 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993687,ConceptCodeName:buPROPion Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993518,ConceptCodeName:12 HR buPROPion Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993536,ConceptCodeName:12 HR buPROPion Hydrochloride 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232585,ConceptCodeName:24 HR buPROPion Hydrochloride 450 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993691,ConceptCodeName:buPROPion Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993541,ConceptCodeName:24 HR buPROPion Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993557,ConceptCodeName:24 HR buPROPion Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993505,ConceptCodeName:12 HR Budeprion 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993520,ConceptCodeName:12 HR Budeprion 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993524,ConceptCodeName:12 HR Buproban 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993511,ConceptCodeName:12 HR Wellbutrin 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993528,ConceptCodeName:12 HR Wellbutrin 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993537,ConceptCodeName:12 HR Wellbutrin 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993954,ConceptCodeName:12 HR Zyban 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993552,ConceptCodeName:24 HR Aplenzin 174 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993569,ConceptCodeName:24 HR Aplenzin 348 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993683,ConceptCodeName:24 HR Aplenzin 522 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993542,ConceptCodeName:24 HR Budeprion 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993559,ConceptCodeName:24 HR Budeprion 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232591,ConceptCodeName:24 HR Forfivo 450 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993545,ConceptCodeName:24 HR Wellbutrin 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993564,ConceptCodeName:24 HR Wellbutrin 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993688,ConceptCodeName:Wellbutrin 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993693,ConceptCodeName:Wellbutrin 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:722,ConceptCodeName:Amoxapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:784649,ConceptCodeName:Asenapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197363,ConceptCodeName:Amoxapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197364,ConceptCodeName:Amoxapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197365,ConceptCodeName:Amoxapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197366,ConceptCodeName:Amoxapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859975,ConceptCodeName:Asenapine 10 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859981,ConceptCodeName:Asenapine 5 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859976,ConceptCodeName:Saphris,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859979,ConceptCodeName:Saphris 10 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859983,ConceptCodeName:Saphris 5 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:7531,ConceptCodeName:Nortriptyline,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:7866,ConceptCodeName:Pamelor,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198045,ConceptCodeName:Nortriptyline 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199283,ConceptCodeName:Nortriptyline 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312036,ConceptCodeName:Nortriptyline 2 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317136,ConceptCodeName:Nortriptyline 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198046,ConceptCodeName:Nortriptyline 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198047,ConceptCodeName:Nortriptyline 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209329,ConceptCodeName:Pamelor 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209339,ConceptCodeName:Pamelor 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209350,ConceptCodeName:Pamelor 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209391,ConceptCodeName:Pamelor 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2556,ConceptCodeName:Citalopram,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:215928,ConceptCodeName:CeleXA,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283672,ConceptCodeName:Citalopram 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730440,ConceptCodeName:Citalopram 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309313,ConceptCodeName:Citalopram 2 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:200371,ConceptCodeName:Citalopram 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730441,ConceptCodeName:Citalopram 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309314,ConceptCodeName:Citalopram 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730442,ConceptCodeName:Citalopram 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284591,ConceptCodeName:CeleXA 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:213344,ConceptCodeName:CeleXA 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:213345,ConceptCodeName:CeleXA 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:72625,ConceptCodeName:DULoxetine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:482574,ConceptCodeName:Cymbalta,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596926,ConceptCodeName:DULoxetine 20 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596930,ConceptCodeName:DULoxetine 30 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596934,ConceptCodeName:DULoxetine 60 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596928,ConceptCodeName:Cymbalta 20 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596932,ConceptCodeName:Cymbalta 30 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:615186,ConceptCodeName:Cymbalta 60 MG (DULoxetine hydrochloride 67.3 MG) Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10737,ConceptCodeName:traZODone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:204192,ConceptCodeName:Desyrel,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898698,ConceptCodeName:Oleptro,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856373,ConceptCodeName:traZODone Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898697,ConceptCodeName:24 HR traZODone Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856364,ConceptCodeName:traZODone Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898704,ConceptCodeName:24 HR traZODone Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856369,ConceptCodeName:traZODone Hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856377,ConceptCodeName:traZODone Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856379,ConceptCodeName:Desyrel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856366,ConceptCodeName:Desyrel Dividose 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898701,ConceptCodeName:Oleptro 150 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898706,ConceptCodeName:Oleptro 300 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:39786,ConceptCodeName:venlafaxine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:151692,ConceptCodeName:Effexor,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313581,ConceptCodeName:24 HR venlafaxine 150 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313583,ConceptCodeName:24 HR venlafaxine 37.5 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313585,ConceptCodeName:24 HR venlafaxine 75 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313580,ConceptCodeName:venlafaxine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808744,ConceptCodeName:24 HR venlafaxine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808748,ConceptCodeName:24 HR venlafaxine 225 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313582,ConceptCodeName:venlafaxine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313584,ConceptCodeName:venlafaxine 37.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808751,ConceptCodeName:24 HR venlafaxine 37.5 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314277,ConceptCodeName:venlafaxine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313586,ConceptCodeName:venlafaxine 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808753,ConceptCodeName:24 HR venlafaxine 75 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729931,ConceptCodeName:24 HR Effexor 150 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729932,ConceptCodeName:24 HR Effexor 37.5 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729929,ConceptCodeName:24 HR Effexor 75 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208848,ConceptCodeName:Effexor 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208849,ConceptCodeName:Effexor 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208850,ConceptCodeName:Effexor 37.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208851,ConceptCodeName:Effexor 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208853,ConceptCodeName:Effexor 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9639,ConceptCodeName:Selegiline,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:92571,ConceptCodeName:Eldepryl,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:617716,ConceptCodeName:Emsam,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643054,ConceptCodeName:Zelapar,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865214,ConceptCodeName:24 HR selegiline hydrochloride 0.5 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859190,ConceptCodeName:selegiline hydrochloride 1.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859186,ConceptCodeName:selegiline hydrochloride 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859193,ConceptCodeName:selegiline hydrochloride 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865206,ConceptCodeName:24 HR selegiline hydrochloride 0.25 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865210,ConceptCodeName:24 HR selegiline hydrochloride 0.375 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865216,ConceptCodeName:24 HR Emsam 0.5 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859188,ConceptCodeName:Eldepryl 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865217,ConceptCodeName:Eldepryl 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865208,ConceptCodeName:Emsam 6 MG per 24 HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865212,ConceptCodeName:Emsam 9 MG per 24 HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859192,ConceptCodeName:Zelapar 1.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8076,ConceptCodeName:Perphenazine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198075,ConceptCodeName:Perphenazine 16 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198076,ConceptCodeName:Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198077,ConceptCodeName:Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:238104,ConceptCodeName:Perphenazine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312325,ConceptCodeName:Perphenazine 8 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198078,ConceptCodeName:Perphenazine 8 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:704,ConceptCodeName:Amitriptyline,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:214220,ConceptCodeName:Amitriptyline / chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42940,ConceptCodeName:Elavil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28727,ConceptCodeName:Limbitrol,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856783,ConceptCodeName:Amitriptyline Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856762,ConceptCodeName:Amitriptyline Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856769,ConceptCodeName:Amitriptyline Hydrochloride 12.5 MG / chlordiazePOXIDE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856773,ConceptCodeName:Amitriptyline Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856792,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / chlordiazePOXIDE 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856834,ConceptCodeName:Amitriptyline Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856845,ConceptCodeName:Amitriptyline Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856853,ConceptCodeName:Amitriptyline Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856836,ConceptCodeName:Elavil 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856781,ConceptCodeName:Limbitrol 12.5/5 Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856796,ConceptCodeName:Limbitrol 25/10 mg Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:321988,ConceptCodeName:Escitalopram,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352741,ConceptCodeName:Lexapro,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349332,ConceptCodeName:Escitalopram 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351250,ConceptCodeName:Escitalopram 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351249,ConceptCodeName:Escitalopram 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351285,ConceptCodeName:Escitalopram 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404420,ConceptCodeName:Lexapro 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352272,ConceptCodeName:Lexapro 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352273,ConceptCodeName:Lexapro 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404408,ConceptCodeName:Lexapro 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2356,ConceptCodeName:chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:214220,ConceptCodeName:Amitriptyline / chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611854,ConceptCodeName:chlordiazePOXIDE / clidinium,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1007583,ConceptCodeName:chlordiazePOXIDE / Estrogens; Esterified (USP),CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:606640,ConceptCodeName:chlordiazePOXIDE / Methscopolamine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28697,ConceptCodeName:Librax,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3804,ConceptCodeName:Librium,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28727,ConceptCodeName:Limbitrol,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856769,ConceptCodeName:Amitriptyline Hydrochloride 12.5 MG / chlordiazePOXIDE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856792,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / chlordiazePOXIDE 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317077,ConceptCodeName:chlordiazePOXIDE 10 MG / Estrogens; Esterified (USP) 0.4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309177,ConceptCodeName:chlordiazePOXIDE 5 MG / Estrogens; Esterified (USP) 0.2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309178,ConceptCodeName:chlordiazePOXIDE 5 MG / Estrogens; Esterified (USP) 0.4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905369,ConceptCodeName:chlordiazePOXIDE Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905532,ConceptCodeName:chlordiazePOXIDE Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905495,ConceptCodeName:chlordiazePOXIDE Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905505,ConceptCodeName:chlordiazePOXIDE Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:889614,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG / Clidinium bromide 2.5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905509,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG / Methscopolamine 2.5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905516,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905525,ConceptCodeName:chlordiazePOXIDE Hydrochloride 50 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:889616,ConceptCodeName:Librax (chlordiazePOXIDE hydrochloride 5 MG / clidinium bromide 2.5 MG) Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905373,ConceptCodeName:Librium 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905497,ConceptCodeName:Librium 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905520,ConceptCodeName:Librium 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856781,ConceptCodeName:Limbitrol 12.5/5 Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856796,ConceptCodeName:Limbitrol 25/10 mg Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:6011,ConceptCodeName:Isocarboxazid,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152005,ConceptCodeName:Marplan,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104837,ConceptCodeName:Isocarboxazid 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:201708,ConceptCodeName:Marplan 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8123,ConceptCodeName:Phenelzine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:203799,ConceptCodeName:Nardil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312347,ConceptCodeName:Phenelzine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104836,ConceptCodeName:Nardil 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3247,ConceptCodeName:Desipramine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:203771,ConceptCodeName:Norpramin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8078,ConceptCodeName:Pertofrane,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309671,ConceptCodeName:Desipramine 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309672,ConceptCodeName:Desipramine 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099288,ConceptCodeName:Desipramine Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099292,ConceptCodeName:Desipramine Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099296,ConceptCodeName:Desipramine Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099300,ConceptCodeName:Desipramine Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099304,ConceptCodeName:Desipramine Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099316,ConceptCodeName:Desipramine Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099290,ConceptCodeName:Norpramin 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099294,ConceptCodeName:Norpramin 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099298,ConceptCodeName:Norpramin 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099302,ConceptCodeName:Norpramin 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099306,ConceptCodeName:Norpramin 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099318,ConceptCodeName:Norpramin 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099398,ConceptCodeName:Pertofrane 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10737,ConceptCodeName:traZODone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:204192,ConceptCodeName:Desyrel,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898698,ConceptCodeName:Oleptro,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856373,ConceptCodeName:traZODone Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898697,ConceptCodeName:24 HR traZODone Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856364,ConceptCodeName:traZODone Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898704,ConceptCodeName:24 HR traZODone Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856369,ConceptCodeName:traZODone Hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856377,ConceptCodeName:traZODone Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856379,ConceptCodeName:Desyrel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856366,ConceptCodeName:Desyrel Dividose 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898701,ConceptCodeName:Oleptro 150 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898706,ConceptCodeName:Oleptro 300 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:4493,ConceptCodeName:FLUoxetine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611247,ConceptCodeName:FLUoxetine / OLANZapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:58827,ConceptCodeName:PROzac,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:639464,ConceptCodeName:Sarafem,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:405343,ConceptCodeName:Symbyax,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1190110,ConceptCodeName:FLUoxetine 60 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313990,ConceptCodeName:FLUoxetine 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310384,ConceptCodeName:FLUoxetine 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:803293,ConceptCodeName:FLUoxetine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310385,ConceptCodeName:FLUoxetine 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:248642,ConceptCodeName:FLUoxetine 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310386,ConceptCodeName:FLUoxetine 4 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403970,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721787,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 3 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403969,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313989,ConceptCodeName:FLUoxetine 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403971,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403972,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313995,ConceptCodeName:FLUoxetine 90 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:205535,ConceptCodeName:PROzac 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104849,ConceptCodeName:PROzac 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104850,ConceptCodeName:PROzac 4 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261287,ConceptCodeName:PROzac 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:598032,ConceptCodeName:PROzac 90 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647325,ConceptCodeName:Sarafem 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647555,ConceptCodeName:Sarafem 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647556,ConceptCodeName:Sarafem 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725076,ConceptCodeName:Symbyax 12/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725068,ConceptCodeName:Symbyax 12/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725080,ConceptCodeName:Symbyax 3/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725064,ConceptCodeName:Symbyax 6/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725072,ConceptCodeName:Symbyax 6/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:734064,ConceptCodeName:Desvenlafaxine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435475,ConceptCodeName:Khedezla,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:711372,ConceptCodeName:Pristiq,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790264,ConceptCodeName:24 HR Desvenlafaxine 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790288,ConceptCodeName:24 HR Desvenlafaxine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435480,ConceptCodeName:24 HR Khedezla 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435483,ConceptCodeName:24 HR Khedezla 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790267,ConceptCodeName:24 HR Pristiq 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790290,ConceptCodeName:24 HR Pristiq 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:15996,ConceptCodeName:Mirtazapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:134774,ConceptCodeName:Remeron,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283406,ConceptCodeName:Mirtazapine 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:311725,ConceptCodeName:Mirtazapine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283407,ConceptCodeName:Mirtazapine 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314111,ConceptCodeName:Mirtazapine 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283485,ConceptCodeName:Mirtazapine 45 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:311726,ConceptCodeName:Mirtazapine 45 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476809,ConceptCodeName:Mirtazapine 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752869,ConceptCodeName:Remeron 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211322,ConceptCodeName:Remeron 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752870,ConceptCodeName:Remeron 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211323,ConceptCodeName:Remeron 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752871,ConceptCodeName:Remeron 45 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261135,ConceptCodeName:Remeron 45 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:51272,ConceptCodeName:QUEtiapine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:83553,ConceptCodeName:SEROquel,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312743,ConceptCodeName:QUEtiapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:389201,ConceptCodeName:QUEtiapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317174,ConceptCodeName:QUEtiapine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312744,ConceptCodeName:QUEtiapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312745,ConceptCodeName:QUEtiapine 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616483,ConceptCodeName:QUEtiapine 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616487,ConceptCodeName:QUEtiapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895670,ConceptCodeName:24 HR QUEtiapine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721791,ConceptCodeName:24 HR QUEtiapine 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721794,ConceptCodeName:24 HR QUEtiapine 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721796,ConceptCodeName:24 HR QUEtiapine 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853201,ConceptCodeName:24 HR QUEtiapine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895671,ConceptCodeName:24 HR SEROquel 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721793,ConceptCodeName:24 HR SEROquel 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721795,ConceptCodeName:24 HR SEROquel 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721797,ConceptCodeName:24 HR SEROquel 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853202,ConceptCodeName:24 HR SEROquel 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153639,ConceptCodeName:SEROquel 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153640,ConceptCodeName:SEROquel 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153638,ConceptCodeName:SEROquel 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284509,ConceptCodeName:SEROquel 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616485,ConceptCodeName:SEROquel 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616489,ConceptCodeName:SEROquel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:31565,ConceptCodeName:nefazodone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:151679,ConceptCodeName:Serzone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098649,ConceptCodeName:Nefazodone hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098666,ConceptCodeName:Nefazodone hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098670,ConceptCodeName:Nefazodone hydrochloride 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098674,ConceptCodeName:Nefazodone hydrochloride 250 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098710,ConceptCodeName:Nefazodone hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098678,ConceptCodeName:Nefazodone hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098651,ConceptCodeName:Serzone 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098668,ConceptCodeName:Serzone 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098672,ConceptCodeName:Serzone 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3638,ConceptCodeName:Doxepin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261625,ConceptCodeName:Prudoxin,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966788,ConceptCodeName:Silenor,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9801,ConceptCodeName:Zonalon,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966787,ConceptCodeName:Doxepin 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966793,ConceptCodeName:Doxepin 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000048,ConceptCodeName:Doxepin Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000054,ConceptCodeName:Doxepin Hydrochloride 10 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000058,ConceptCodeName:Doxepin Hydrochloride 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000064,ConceptCodeName:Doxepin Hydrochloride 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000070,ConceptCodeName:Doxepin Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000091,ConceptCodeName:Doxepin Hydrochloride 50 MG/ML Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000076,ConceptCodeName:Doxepin Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000097,ConceptCodeName:Doxepin Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000093,ConceptCodeName:Prudoxin 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966791,ConceptCodeName:Silenor 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966795,ConceptCodeName:Silenor 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000095,ConceptCodeName:Zonalon 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10834,ConceptCodeName:Trimipramine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:225029,ConceptCodeName:Surmontil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313496,ConceptCodeName:Trimipramine 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313497,ConceptCodeName:Trimipramine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313498,ConceptCodeName:Trimipramine 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199820,ConceptCodeName:Trimipramine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313499,ConceptCodeName:Trimipramine 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:245373,ConceptCodeName:Trimipramine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208645,ConceptCodeName:Surmontil 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208646,ConceptCodeName:Surmontil 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:106834,ConceptCodeName:Surmontil 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:5691,ConceptCodeName:Imipramine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:6716,ConceptCodeName:Tofranil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:220334,ConceptCodeName:Tofranil-PM,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835593,ConceptCodeName:Imipramine Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835582,ConceptCodeName:Imipramine Hydrochloride 12.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835564,ConceptCodeName:Imipramine Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835568,ConceptCodeName:Imipramine Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835591,ConceptCodeName:Imipramine pamoate 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835589,ConceptCodeName:Imipramine pamoate 125 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835577,ConceptCodeName:Imipramine pamoate 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835572,ConceptCodeName:Imipramine pamoate 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835596,ConceptCodeName:Tofranil 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835584,ConceptCodeName:Tofranil 12.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835566,ConceptCodeName:Tofranil 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835570,ConceptCodeName:Tofranil 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835598,ConceptCodeName:Tofranil-PM 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835600,ConceptCodeName:Tofranil-PM 125 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835579,ConceptCodeName:Tofranil-PM 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835574,ConceptCodeName:Tofranil-PM 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8076,ConceptCodeName:Perphenazine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198075,ConceptCodeName:Perphenazine 16 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198076,ConceptCodeName:Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198077,ConceptCodeName:Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:238104,ConceptCodeName:Perphenazine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312325,ConceptCodeName:Perphenazine 8 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198078,ConceptCodeName:Perphenazine 8 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086769,ConceptCodeName:vilazodone,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086773,ConceptCodeName:Viibryd,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086772,ConceptCodeName:vilazodone hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086778,ConceptCodeName:vilazodone hydrochloride 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086784,ConceptCodeName:vilazodone hydrochloride 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086789,ConceptCodeName:{7 (vilazodone hydrochloride 10 MG Oral Tablet) / 7 (vilazodone hydrochloride 20 MG Oral Tablet) / 16 (vilazodone hydrochloride 40 MG Oral Tablet) } Pack,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086776,ConceptCodeName:Viibryd 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086780,ConceptCodeName:Viibryd 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086786,ConceptCodeName:Viibryd 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086790,ConceptCodeName:Viibryd Patient Starter Kit,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8886,ConceptCodeName:Protriptyline,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:11270,ConceptCodeName:Vivactil,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905168,ConceptCodeName:Protriptyline Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905172,ConceptCodeName:Protriptyline Hydrochloride 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905170,ConceptCodeName:Vivactil 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905174,ConceptCodeName:Vivactil 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:36437,ConceptCodeName:Sertraline,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:82728,ConceptCodeName:Zoloft,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312938,ConceptCodeName:Sertraline 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:794947,ConceptCodeName:Sertraline 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:861064,ConceptCodeName:Sertraline 20 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:251200,ConceptCodeName:Sertraline 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312940,ConceptCodeName:Sertraline 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312941,ConceptCodeName:Sertraline 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208149,ConceptCodeName:Zoloft (as sertraline hydrochloride) 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:861066,ConceptCodeName:Zoloft 20 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:212233,ConceptCodeName:Zoloft 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208161,ConceptCodeName:Zoloft 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Substance Abuse Treatment Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2626,ConceptCodeName:cloZAPine,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:216102,ConceptCodeName:Clozaril,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542974,ConceptCodeName:Fazaclo,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369826,ConceptCodeName:Versacloz,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476177,ConceptCodeName:cloZAPine 100 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197535,ConceptCodeName:cloZAPine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721773,ConceptCodeName:cloZAPine 12.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1006801,ConceptCodeName:cloZAPine 150 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:996921,ConceptCodeName:cloZAPine 200 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309374,ConceptCodeName:cloZAPine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476179,ConceptCodeName:cloZAPine 25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197536,ConceptCodeName:cloZAPine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:429212,ConceptCodeName:cloZAPine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369825,ConceptCodeName:cloZAPine 50 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104776,ConceptCodeName:Clozaril 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104775,ConceptCodeName:Clozaril 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:542977,ConceptCodeName:Fazaclo 100 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721775,ConceptCodeName:Fazaclo 12.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1006803,ConceptCodeName:Fazaclo 150 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:996923,ConceptCodeName:Fazaclo 200 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:543013,ConceptCodeName:Fazaclo 25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1369831,ConceptCodeName:Versacloz 50 MG/ML Oral Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:35636,ConceptCodeName:risperiDONE,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152318,ConceptCodeName:RisperDAL,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:645037,ConceptCodeName:risperiDONE 0.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312828,ConceptCodeName:risperiDONE 0.25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403825,ConceptCodeName:risperiDONE 0.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312829,ConceptCodeName:risperiDONE 0.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:401953,ConceptCodeName:risperiDONE 1 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312830,ConceptCodeName:risperiDONE 1 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199387,ConceptCodeName:risperiDONE 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706822,ConceptCodeName:risperiDONE 6.25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:401954,ConceptCodeName:risperiDONE 2 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312831,ConceptCodeName:risperiDONE 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402010,ConceptCodeName:risperiDONE 12.5 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616698,ConceptCodeName:risperiDONE 3 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312832,ConceptCodeName:risperiDONE 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402011,ConceptCodeName:risperiDONE 18.8 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616705,ConceptCodeName:risperiDONE 4 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314211,ConceptCodeName:risperiDONE 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:249289,ConceptCodeName:risperiDONE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402012,ConceptCodeName:risperiDONE 25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:262077,ConceptCodeName:RisperDAL 0.25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806297,ConceptCodeName:RisperDAL 0.5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:262222,ConceptCodeName:RisperDAL 0.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806298,ConceptCodeName:RisperDAL 1 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104781,ConceptCodeName:RisperDAL 1 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211489,ConceptCodeName:RisperDAL 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706831,ConceptCodeName:RisperDAL 12.5 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706827,ConceptCodeName:RisperDAL 18.8 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:806299,ConceptCodeName:RisperDAL 2 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104782,ConceptCodeName:RisperDAL 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706829,ConceptCodeName:RisperDAL 25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:630890,ConceptCodeName:RisperDAL 3 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104783,ConceptCodeName:RisperDAL 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:630974,ConceptCodeName:RisperDAL 4 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104784,ConceptCodeName:RisperDAL 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:706825,ConceptCodeName:RisperDAL 6.25 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:89013,ConceptCodeName:ARIPiprazole,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352393,ConceptCodeName:Abilify,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:485496,ConceptCodeName:ARIPiprazole 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643019,ConceptCodeName:ARIPiprazole 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349545,ConceptCodeName:ARIPiprazole 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643022,ConceptCodeName:ARIPiprazole 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349490,ConceptCodeName:ARIPiprazole 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:602964,ConceptCodeName:ARIPiprazole 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643027,ConceptCodeName:ARIPiprazole 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349553,ConceptCodeName:ARIPiprazole 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643058,ConceptCodeName:ARIPiprazole 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349547,ConceptCodeName:ARIPiprazole 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1371191,ConceptCodeName:ARIPiprazole 200 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:402131,ConceptCodeName:ARIPiprazole 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:672356,ConceptCodeName:ARIPiprazole 7.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:544412,ConceptCodeName:Abilify 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352307,ConceptCodeName:Abilify 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352308,ConceptCodeName:Abilify 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:615172,ConceptCodeName:Abilify 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352309,ConceptCodeName:Abilify 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1371194,ConceptCodeName:Abilify 200 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352310,ConceptCodeName:Abilify 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404602,ConceptCodeName:Abilify 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:672540,ConceptCodeName:Abilify 7.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643021,ConceptCodeName:Abilify Discmelt 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643023,ConceptCodeName:Abilify Discmelt 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:61381,ConceptCodeName:OLANZapine,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611247,ConceptCodeName:FLUoxetine / OLANZapine,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:405343,ConceptCodeName:Symbyax,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:135423,ConceptCodeName:ZyPREXA,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403970,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721787,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 3 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403969,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403971,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403972,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312076,ConceptCodeName:OLANZapine 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314154,ConceptCodeName:OLANZapine 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351107,ConceptCodeName:OLANZapine 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312077,ConceptCodeName:OLANZapine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:885865,ConceptCodeName:OLANZapine 150 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:200034,ConceptCodeName:OLANZapine 2.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351108,ConceptCodeName:OLANZapine 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283639,ConceptCodeName:OLANZapine 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314155,ConceptCodeName:OLANZapine 5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312078,ConceptCodeName:OLANZapine 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:485968,ConceptCodeName:OLANZapine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312079,ConceptCodeName:OLANZapine 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725076,ConceptCodeName:Symbyax 12/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725068,ConceptCodeName:Symbyax 12/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725080,ConceptCodeName:Symbyax 3/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725064,ConceptCodeName:Symbyax 6/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725072,ConceptCodeName:Symbyax 6/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153048,ConceptCodeName:ZyPREXA 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261337,ConceptCodeName:ZyPREXA 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:885867,ConceptCodeName:ZyPREXA 150 MG/ML Injectable Suspension,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:212405,ConceptCodeName:ZyPREXA 2.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284514,ConceptCodeName:ZyPREXA 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754506,ConceptCodeName:ZyPREXA 5 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153046,ConceptCodeName:ZyPREXA 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:545353,ConceptCodeName:ZyPREXA 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153047,ConceptCodeName:ZyPREXA 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754503,ConceptCodeName:ZyPREXA Zydis 10 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754504,ConceptCodeName:ZyPREXA Zydis 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:754505,ConceptCodeName:ZyPREXA Zydis 20 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:51272,ConceptCodeName:QUEtiapine,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:83553,ConceptCodeName:SEROquel,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312743,ConceptCodeName:QUEtiapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:389201,ConceptCodeName:QUEtiapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317174,ConceptCodeName:QUEtiapine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312744,ConceptCodeName:QUEtiapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312745,ConceptCodeName:QUEtiapine 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616483,ConceptCodeName:QUEtiapine 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616487,ConceptCodeName:QUEtiapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895670,ConceptCodeName:24 HR QUEtiapine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721791,ConceptCodeName:24 HR QUEtiapine 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721794,ConceptCodeName:24 HR QUEtiapine 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721796,ConceptCodeName:24 HR QUEtiapine 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853201,ConceptCodeName:24 HR QUEtiapine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895671,ConceptCodeName:24 HR SEROquel 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721793,ConceptCodeName:24 HR SEROquel 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721795,ConceptCodeName:24 HR SEROquel 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721797,ConceptCodeName:24 HR SEROquel 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853202,ConceptCodeName:24 HR SEROquel 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153639,ConceptCodeName:SEROquel 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153640,ConceptCodeName:SEROquel 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153638,ConceptCodeName:SEROquel 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284509,ConceptCodeName:SEROquel 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616485,ConceptCodeName:SEROquel 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616489,ConceptCodeName:SEROquel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:115698,ConceptCodeName:ziprasidone,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:285064,ConceptCodeName:Geodon,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314286,ConceptCodeName:ziprasidone 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313776,ConceptCodeName:ziprasidone 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313777,ConceptCodeName:ziprasidone 60 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313778,ConceptCodeName:ziprasidone 80 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351223,ConceptCodeName:ziprasidone 20 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:285127,ConceptCodeName:Geodon 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352228,ConceptCodeName:Geodon 20 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284548,ConceptCodeName:Geodon 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284549,ConceptCodeName:Geodon 60 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284550,ConceptCodeName:Geodon 80 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:AntipsychoticValue Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3638,ConceptCodeName:Doxepin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261625,ConceptCodeName:Prudoxin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966788,ConceptCodeName:Silenor,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9801,ConceptCodeName:Zonalon,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966787,ConceptCodeName:Doxepin 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966793,ConceptCodeName:Doxepin 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000048,ConceptCodeName:Doxepin Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000054,ConceptCodeName:Doxepin Hydrochloride 10 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000058,ConceptCodeName:Doxepin Hydrochloride 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000064,ConceptCodeName:Doxepin Hydrochloride 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000070,ConceptCodeName:Doxepin Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000091,ConceptCodeName:Doxepin Hydrochloride 50 MG/ML Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000076,ConceptCodeName:Doxepin Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000097,ConceptCodeName:Doxepin Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000093,ConceptCodeName:Prudoxin 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966791,ConceptCodeName:Silenor 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966795,ConceptCodeName:Silenor 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000095,ConceptCodeName:Zonalon 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2597,ConceptCodeName:clomiPRAMINE,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:756,ConceptCodeName:Anafranil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857291,ConceptCodeName:clomiPRAMINE Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857297,ConceptCodeName:clomiPRAMINE Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857296,ConceptCodeName:clomiPRAMINE Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857301,ConceptCodeName:clomiPRAMINE Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857315,ConceptCodeName:clomiPRAMINE Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857305,ConceptCodeName:clomiPRAMINE Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857299,ConceptCodeName:Anafranil 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857303,ConceptCodeName:Anafranil 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:857307,ConceptCodeName:Anafranil 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42347,ConceptCodeName:buPROPion,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835486,ConceptCodeName:Aplenzin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:581646,ConceptCodeName:Budeprion,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:581650,ConceptCodeName:Buproban,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232586,ConceptCodeName:Forfivo,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42568,ConceptCodeName:Wellbutrin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:227948,ConceptCodeName:Zyban,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993550,ConceptCodeName:24 HR buPROPion hydrobromide 174 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993567,ConceptCodeName:24 HR buPROPion hydrobromide 348 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993681,ConceptCodeName:24 HR buPROPion hydrobromide 522 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993503,ConceptCodeName:12 HR buPROPion Hydrochloride 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993687,ConceptCodeName:buPROPion Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993518,ConceptCodeName:12 HR buPROPion Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993536,ConceptCodeName:12 HR buPROPion Hydrochloride 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232585,ConceptCodeName:24 HR buPROPion Hydrochloride 450 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993691,ConceptCodeName:buPROPion Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993541,ConceptCodeName:24 HR buPROPion Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993557,ConceptCodeName:24 HR buPROPion Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993505,ConceptCodeName:12 HR Budeprion 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993520,ConceptCodeName:12 HR Budeprion 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993524,ConceptCodeName:12 HR Buproban 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993511,ConceptCodeName:12 HR Wellbutrin 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993528,ConceptCodeName:12 HR Wellbutrin 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993537,ConceptCodeName:12 HR Wellbutrin 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993954,ConceptCodeName:12 HR Zyban 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993552,ConceptCodeName:24 HR Aplenzin 174 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993569,ConceptCodeName:24 HR Aplenzin 348 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993683,ConceptCodeName:24 HR Aplenzin 522 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993542,ConceptCodeName:24 HR Budeprion 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993559,ConceptCodeName:24 HR Budeprion 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1232591,ConceptCodeName:24 HR Forfivo 450 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993545,ConceptCodeName:24 HR Wellbutrin 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993564,ConceptCodeName:24 HR Wellbutrin 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993688,ConceptCodeName:Wellbutrin 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:993693,ConceptCodeName:Wellbutrin 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:722,ConceptCodeName:Amoxapine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:784649,ConceptCodeName:Asenapine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197363,ConceptCodeName:Amoxapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197364,ConceptCodeName:Amoxapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197365,ConceptCodeName:Amoxapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:197366,ConceptCodeName:Amoxapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859975,ConceptCodeName:Asenapine 10 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859981,ConceptCodeName:Asenapine 5 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859976,ConceptCodeName:Saphris,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859979,ConceptCodeName:Saphris 10 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859983,ConceptCodeName:Saphris 5 MG Sublingual Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:7531,ConceptCodeName:Nortriptyline,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:7866,ConceptCodeName:Pamelor,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198045,ConceptCodeName:Nortriptyline 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199283,ConceptCodeName:Nortriptyline 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312036,ConceptCodeName:Nortriptyline 2 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317136,ConceptCodeName:Nortriptyline 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198046,ConceptCodeName:Nortriptyline 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198047,ConceptCodeName:Nortriptyline 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209329,ConceptCodeName:Pamelor 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209339,ConceptCodeName:Pamelor 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209350,ConceptCodeName:Pamelor 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:209391,ConceptCodeName:Pamelor 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2556,ConceptCodeName:Citalopram,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:215928,ConceptCodeName:CeleXA,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283672,ConceptCodeName:Citalopram 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730440,ConceptCodeName:Citalopram 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309313,ConceptCodeName:Citalopram 2 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:200371,ConceptCodeName:Citalopram 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730441,ConceptCodeName:Citalopram 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309314,ConceptCodeName:Citalopram 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:730442,ConceptCodeName:Citalopram 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284591,ConceptCodeName:CeleXA 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:213344,ConceptCodeName:CeleXA 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:213345,ConceptCodeName:CeleXA 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:72625,ConceptCodeName:DULoxetine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:482574,ConceptCodeName:Cymbalta,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596926,ConceptCodeName:DULoxetine 20 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596930,ConceptCodeName:DULoxetine 30 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596934,ConceptCodeName:DULoxetine 60 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596928,ConceptCodeName:Cymbalta 20 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:596932,ConceptCodeName:Cymbalta 30 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:615186,ConceptCodeName:Cymbalta 60 MG (DULoxetine hydrochloride 67.3 MG) Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10737,ConceptCodeName:traZODone,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:204192,ConceptCodeName:Desyrel,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898698,ConceptCodeName:Oleptro,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856373,ConceptCodeName:traZODone Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898697,ConceptCodeName:24 HR traZODone Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856364,ConceptCodeName:traZODone Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898704,ConceptCodeName:24 HR traZODone Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856369,ConceptCodeName:traZODone Hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856377,ConceptCodeName:traZODone Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856379,ConceptCodeName:Desyrel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856366,ConceptCodeName:Desyrel Dividose 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898701,ConceptCodeName:Oleptro 150 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898706,ConceptCodeName:Oleptro 300 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:39786,ConceptCodeName:venlafaxine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:151692,ConceptCodeName:Effexor,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313581,ConceptCodeName:24 HR venlafaxine 150 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313583,ConceptCodeName:24 HR venlafaxine 37.5 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313585,ConceptCodeName:24 HR venlafaxine 75 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313580,ConceptCodeName:venlafaxine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808744,ConceptCodeName:24 HR venlafaxine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808748,ConceptCodeName:24 HR venlafaxine 225 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313582,ConceptCodeName:venlafaxine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313584,ConceptCodeName:venlafaxine 37.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808751,ConceptCodeName:24 HR venlafaxine 37.5 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314277,ConceptCodeName:venlafaxine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313586,ConceptCodeName:venlafaxine 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:808753,ConceptCodeName:24 HR venlafaxine 75 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729931,ConceptCodeName:24 HR Effexor 150 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729932,ConceptCodeName:24 HR Effexor 37.5 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:729929,ConceptCodeName:24 HR Effexor 75 MG Extended Release Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208848,ConceptCodeName:Effexor 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208849,ConceptCodeName:Effexor 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208850,ConceptCodeName:Effexor 37.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208851,ConceptCodeName:Effexor 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208853,ConceptCodeName:Effexor 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9639,ConceptCodeName:Selegiline,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:92571,ConceptCodeName:Eldepryl,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:617716,ConceptCodeName:Emsam,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:643054,ConceptCodeName:Zelapar,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865214,ConceptCodeName:24 HR selegiline hydrochloride 0.5 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859190,ConceptCodeName:selegiline hydrochloride 1.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859186,ConceptCodeName:selegiline hydrochloride 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859193,ConceptCodeName:selegiline hydrochloride 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865206,ConceptCodeName:24 HR selegiline hydrochloride 0.25 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865210,ConceptCodeName:24 HR selegiline hydrochloride 0.375 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865216,ConceptCodeName:24 HR Emsam 0.5 MG/HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859188,ConceptCodeName:Eldepryl 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865217,ConceptCodeName:Eldepryl 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865208,ConceptCodeName:Emsam 6 MG per 24 HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:865212,ConceptCodeName:Emsam 9 MG per 24 HR Transdermal Patch,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:859192,ConceptCodeName:Zelapar 1.25 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8076,ConceptCodeName:Perphenazine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198075,ConceptCodeName:Perphenazine 16 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198076,ConceptCodeName:Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198077,ConceptCodeName:Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:238104,ConceptCodeName:Perphenazine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312325,ConceptCodeName:Perphenazine 8 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198078,ConceptCodeName:Perphenazine 8 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:704,ConceptCodeName:Amitriptyline,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:214220,ConceptCodeName:Amitriptyline / chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:42940,ConceptCodeName:Elavil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28727,ConceptCodeName:Limbitrol,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856783,ConceptCodeName:Amitriptyline Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856762,ConceptCodeName:Amitriptyline Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856769,ConceptCodeName:Amitriptyline Hydrochloride 12.5 MG / chlordiazePOXIDE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856773,ConceptCodeName:Amitriptyline Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856792,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / chlordiazePOXIDE 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856834,ConceptCodeName:Amitriptyline Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856845,ConceptCodeName:Amitriptyline Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856853,ConceptCodeName:Amitriptyline Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856836,ConceptCodeName:Elavil 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856781,ConceptCodeName:Limbitrol 12.5/5 Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856796,ConceptCodeName:Limbitrol 25/10 mg Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:321988,ConceptCodeName:Escitalopram,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352741,ConceptCodeName:Lexapro,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:349332,ConceptCodeName:Escitalopram 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351250,ConceptCodeName:Escitalopram 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351249,ConceptCodeName:Escitalopram 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:351285,ConceptCodeName:Escitalopram 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404420,ConceptCodeName:Lexapro 1 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352272,ConceptCodeName:Lexapro 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:352273,ConceptCodeName:Lexapro 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:404408,ConceptCodeName:Lexapro 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:2356,ConceptCodeName:chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:214220,ConceptCodeName:Amitriptyline / chlordiazePOXIDE,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611854,ConceptCodeName:chlordiazePOXIDE / clidinium,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1007583,ConceptCodeName:chlordiazePOXIDE / Estrogens; Esterified (USP),CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:606640,ConceptCodeName:chlordiazePOXIDE / Methscopolamine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28697,ConceptCodeName:Librax,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3804,ConceptCodeName:Librium,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:28727,ConceptCodeName:Limbitrol,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856769,ConceptCodeName:Amitriptyline Hydrochloride 12.5 MG / chlordiazePOXIDE 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856792,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / chlordiazePOXIDE 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317077,ConceptCodeName:chlordiazePOXIDE 10 MG / Estrogens; Esterified (USP) 0.4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309177,ConceptCodeName:chlordiazePOXIDE 5 MG / Estrogens; Esterified (USP) 0.2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309178,ConceptCodeName:chlordiazePOXIDE 5 MG / Estrogens; Esterified (USP) 0.4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905369,ConceptCodeName:chlordiazePOXIDE Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905532,ConceptCodeName:chlordiazePOXIDE Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905495,ConceptCodeName:chlordiazePOXIDE Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905505,ConceptCodeName:chlordiazePOXIDE Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:889614,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG / Clidinium bromide 2.5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905509,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG / Methscopolamine 2.5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905516,ConceptCodeName:chlordiazePOXIDE Hydrochloride 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905525,ConceptCodeName:chlordiazePOXIDE Hydrochloride 50 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:889616,ConceptCodeName:Librax (chlordiazePOXIDE hydrochloride 5 MG / clidinium bromide 2.5 MG) Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905373,ConceptCodeName:Librium 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905497,ConceptCodeName:Librium 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905520,ConceptCodeName:Librium 5 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856781,ConceptCodeName:Limbitrol 12.5/5 Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856796,ConceptCodeName:Limbitrol 25/10 mg Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:6011,ConceptCodeName:Isocarboxazid,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:152005,ConceptCodeName:Marplan,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104837,ConceptCodeName:Isocarboxazid 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:201708,ConceptCodeName:Marplan 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8123,ConceptCodeName:Phenelzine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:203799,ConceptCodeName:Nardil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312347,ConceptCodeName:Phenelzine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104836,ConceptCodeName:Nardil 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3247,ConceptCodeName:Desipramine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:203771,ConceptCodeName:Norpramin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8078,ConceptCodeName:Pertofrane,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309671,ConceptCodeName:Desipramine 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:309672,ConceptCodeName:Desipramine 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099288,ConceptCodeName:Desipramine Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099292,ConceptCodeName:Desipramine Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099296,ConceptCodeName:Desipramine Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099300,ConceptCodeName:Desipramine Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099304,ConceptCodeName:Desipramine Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099316,ConceptCodeName:Desipramine Hydrochloride 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099290,ConceptCodeName:Norpramin 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099294,ConceptCodeName:Norpramin 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099298,ConceptCodeName:Norpramin 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099302,ConceptCodeName:Norpramin 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099306,ConceptCodeName:Norpramin 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099318,ConceptCodeName:Norpramin 75 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1099398,ConceptCodeName:Pertofrane 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10737,ConceptCodeName:traZODone,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:204192,ConceptCodeName:Desyrel,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898698,ConceptCodeName:Oleptro,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856373,ConceptCodeName:traZODone Hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898697,ConceptCodeName:24 HR traZODone Hydrochloride 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856364,ConceptCodeName:traZODone Hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898704,ConceptCodeName:24 HR traZODone Hydrochloride 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856369,ConceptCodeName:traZODone Hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856377,ConceptCodeName:traZODone Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856379,ConceptCodeName:Desyrel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856366,ConceptCodeName:Desyrel Dividose 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898701,ConceptCodeName:Oleptro 150 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:898706,ConceptCodeName:Oleptro 300 MG 24HR Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:4493,ConceptCodeName:FLUoxetine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:611247,ConceptCodeName:FLUoxetine / OLANZapine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:58827,ConceptCodeName:PROzac,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:639464,ConceptCodeName:Sarafem,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:405343,ConceptCodeName:Symbyax,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1190110,ConceptCodeName:FLUoxetine 60 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313990,ConceptCodeName:FLUoxetine 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310384,ConceptCodeName:FLUoxetine 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:803293,ConceptCodeName:FLUoxetine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310385,ConceptCodeName:FLUoxetine 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:248642,ConceptCodeName:FLUoxetine 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:310386,ConceptCodeName:FLUoxetine 4 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403970,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721787,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 3 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403969,ConceptCodeName:FLUoxetine 25 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313989,ConceptCodeName:FLUoxetine 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403971,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 12 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:403972,ConceptCodeName:FLUoxetine 50 MG / OLANZapine 6 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313995,ConceptCodeName:FLUoxetine 90 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:205535,ConceptCodeName:PROzac 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104849,ConceptCodeName:PROzac 20 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:104850,ConceptCodeName:PROzac 4 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261287,ConceptCodeName:PROzac 40 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:598032,ConceptCodeName:PROzac 90 MG Enteric Coated Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647325,ConceptCodeName:Sarafem 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647555,ConceptCodeName:Sarafem 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:647556,ConceptCodeName:Sarafem 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725076,ConceptCodeName:Symbyax 12/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725068,ConceptCodeName:Symbyax 12/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725080,ConceptCodeName:Symbyax 3/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725064,ConceptCodeName:Symbyax 6/25 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:725072,ConceptCodeName:Symbyax 6/50 Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:734064,ConceptCodeName:Desvenlafaxine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435475,ConceptCodeName:Khedezla,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:711372,ConceptCodeName:Pristiq,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790264,ConceptCodeName:24 HR Desvenlafaxine 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790288,ConceptCodeName:24 HR Desvenlafaxine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435480,ConceptCodeName:24 HR Khedezla 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1435483,ConceptCodeName:24 HR Khedezla 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790267,ConceptCodeName:24 HR Pristiq 100 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:790290,ConceptCodeName:24 HR Pristiq 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:15996,ConceptCodeName:Mirtazapine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:134774,ConceptCodeName:Remeron,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283406,ConceptCodeName:Mirtazapine 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:311725,ConceptCodeName:Mirtazapine 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283407,ConceptCodeName:Mirtazapine 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:314111,ConceptCodeName:Mirtazapine 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:283485,ConceptCodeName:Mirtazapine 45 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:311726,ConceptCodeName:Mirtazapine 45 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:476809,ConceptCodeName:Mirtazapine 7.5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752869,ConceptCodeName:Remeron 15 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211322,ConceptCodeName:Remeron 15 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752870,ConceptCodeName:Remeron 30 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:211323,ConceptCodeName:Remeron 30 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:752871,ConceptCodeName:Remeron 45 MG Disintegrating Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261135,ConceptCodeName:Remeron 45 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:51272,ConceptCodeName:QUEtiapine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:83553,ConceptCodeName:SEROquel,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312743,ConceptCodeName:QUEtiapine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:389201,ConceptCodeName:QUEtiapine 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:317174,ConceptCodeName:QUEtiapine 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312744,ConceptCodeName:QUEtiapine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312745,ConceptCodeName:QUEtiapine 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616483,ConceptCodeName:QUEtiapine 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616487,ConceptCodeName:QUEtiapine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895670,ConceptCodeName:24 HR QUEtiapine 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721791,ConceptCodeName:24 HR QUEtiapine 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721794,ConceptCodeName:24 HR QUEtiapine 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721796,ConceptCodeName:24 HR QUEtiapine 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853201,ConceptCodeName:24 HR QUEtiapine 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:895671,ConceptCodeName:24 HR SEROquel 150 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721793,ConceptCodeName:24 HR SEROquel 200 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721795,ConceptCodeName:24 HR SEROquel 300 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:721797,ConceptCodeName:24 HR SEROquel 400 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:853202,ConceptCodeName:24 HR SEROquel 50 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153639,ConceptCodeName:SEROquel 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153640,ConceptCodeName:SEROquel 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:153638,ConceptCodeName:SEROquel 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:284509,ConceptCodeName:SEROquel 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616485,ConceptCodeName:SEROquel 400 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:616489,ConceptCodeName:SEROquel 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:31565,ConceptCodeName:nefazodone,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:151679,ConceptCodeName:Serzone,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098649,ConceptCodeName:Nefazodone hydrochloride 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098666,ConceptCodeName:Nefazodone hydrochloride 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098670,ConceptCodeName:Nefazodone hydrochloride 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098674,ConceptCodeName:Nefazodone hydrochloride 250 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098710,ConceptCodeName:Nefazodone hydrochloride 300 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098678,ConceptCodeName:Nefazodone hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098651,ConceptCodeName:Serzone 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098668,ConceptCodeName:Serzone 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1098672,ConceptCodeName:Serzone 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:3638,ConceptCodeName:Doxepin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:261625,ConceptCodeName:Prudoxin,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966788,ConceptCodeName:Silenor,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:9801,ConceptCodeName:Zonalon,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966787,ConceptCodeName:Doxepin 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966793,ConceptCodeName:Doxepin 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000048,ConceptCodeName:Doxepin Hydrochloride 10 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000054,ConceptCodeName:Doxepin Hydrochloride 10 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000058,ConceptCodeName:Doxepin Hydrochloride 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000064,ConceptCodeName:Doxepin Hydrochloride 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000070,ConceptCodeName:Doxepin Hydrochloride 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000091,ConceptCodeName:Doxepin Hydrochloride 50 MG/ML Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000076,ConceptCodeName:Doxepin Hydrochloride 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000097,ConceptCodeName:Doxepin Hydrochloride 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000093,ConceptCodeName:Prudoxin 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966791,ConceptCodeName:Silenor 3 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:966795,ConceptCodeName:Silenor 6 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1000095,ConceptCodeName:Zonalon 5 % Topical Cream,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:10834,ConceptCodeName:Trimipramine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:225029,ConceptCodeName:Surmontil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313496,ConceptCodeName:Trimipramine 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313497,ConceptCodeName:Trimipramine 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313498,ConceptCodeName:Trimipramine 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:199820,ConceptCodeName:Trimipramine 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:313499,ConceptCodeName:Trimipramine 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:245373,ConceptCodeName:Trimipramine 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208645,ConceptCodeName:Surmontil 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208646,ConceptCodeName:Surmontil 25 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:106834,ConceptCodeName:Surmontil 50 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:5691,ConceptCodeName:Imipramine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:6716,ConceptCodeName:Tofranil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:220334,ConceptCodeName:Tofranil-PM,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835593,ConceptCodeName:Imipramine Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835582,ConceptCodeName:Imipramine Hydrochloride 12.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835564,ConceptCodeName:Imipramine Hydrochloride 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835568,ConceptCodeName:Imipramine Hydrochloride 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835591,ConceptCodeName:Imipramine pamoate 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835589,ConceptCodeName:Imipramine pamoate 125 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835577,ConceptCodeName:Imipramine pamoate 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835572,ConceptCodeName:Imipramine pamoate 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835596,ConceptCodeName:Tofranil 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835584,ConceptCodeName:Tofranil 12.5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835566,ConceptCodeName:Tofranil 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835570,ConceptCodeName:Tofranil 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835598,ConceptCodeName:Tofranil-PM 100 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835600,ConceptCodeName:Tofranil-PM 125 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835579,ConceptCodeName:Tofranil-PM 150 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:835574,ConceptCodeName:Tofranil-PM 75 MG Oral Capsule,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8076,ConceptCodeName:Perphenazine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:282427,ConceptCodeName:Amitriptyline / Perphenazine,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856706,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856720,ConceptCodeName:Amitriptyline Hydrochloride 10 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856797,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856825,ConceptCodeName:Amitriptyline Hydrochloride 25 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:856840,ConceptCodeName:Amitriptyline Hydrochloride 50 MG / Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198075,ConceptCodeName:Perphenazine 16 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198076,ConceptCodeName:Perphenazine 2 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198077,ConceptCodeName:Perphenazine 4 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:238104,ConceptCodeName:Perphenazine 5 MG/ML Injectable Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312325,ConceptCodeName:Perphenazine 8 MG Extended Release Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:198078,ConceptCodeName:Perphenazine 8 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086769,ConceptCodeName:vilazodone,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086773,ConceptCodeName:Viibryd,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086772,ConceptCodeName:vilazodone hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086778,ConceptCodeName:vilazodone hydrochloride 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086784,ConceptCodeName:vilazodone hydrochloride 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086789,ConceptCodeName:{7 (vilazodone hydrochloride 10 MG Oral Tablet) / 7 (vilazodone hydrochloride 20 MG Oral Tablet) / 16 (vilazodone hydrochloride 40 MG Oral Tablet) } Pack,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086776,ConceptCodeName:Viibryd 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086780,ConceptCodeName:Viibryd 20 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086786,ConceptCodeName:Viibryd 40 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:1086790,ConceptCodeName:Viibryd Patient Starter Kit,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:8886,ConceptCodeName:Protriptyline,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:11270,ConceptCodeName:Vivactil,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905168,ConceptCodeName:Protriptyline Hydrochloride 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905172,ConceptCodeName:Protriptyline Hydrochloride 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905170,ConceptCodeName:Vivactil 10 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:905174,ConceptCodeName:Vivactil 5 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:36437,ConceptCodeName:Sertraline,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:82728,ConceptCodeName:Zoloft,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312938,ConceptCodeName:Sertraline 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:794947,ConceptCodeName:Sertraline 150 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:861064,ConceptCodeName:Sertraline 20 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:251200,ConceptCodeName:Sertraline 200 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312940,ConceptCodeName:Sertraline 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:312941,ConceptCodeName:Sertraline 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208149,ConceptCodeName:Zoloft (as sertraline hydrochloride) 100 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:861066,ConceptCodeName:Zoloft 20 MG/ML Oral Solution,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:212233,ConceptCodeName:Zoloft 25 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:208161,ConceptCodeName:Zoloft 50 MG Oral Tablet,CodeSystemName:RxCUI,ValueSet:Antidepressant Value Set,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.88
ConceptCode:LP50411-5,ConceptCodeName:Amphetamines | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51690-6,ConceptCodeName:Amphetamines [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8147-1,ConceptCodeName:Amphetamines [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3348-0,ConceptCodeName:Amphetamines [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8148-9,ConceptCodeName:Amphetamines [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8149-7,ConceptCodeName:Amphetamines [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54797-3,ConceptCodeName:Amphetamines | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8139-8,ConceptCodeName:Amphetamines [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8140-6,ConceptCodeName:Amphetamines [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8141-4,ConceptCodeName:Amphetamines [Presence] in Gastric fluid by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8142-2,ConceptCodeName:Amphetamines [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51948-5,ConceptCodeName:Amphetamines | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9352-6,ConceptCodeName:Amphetamines [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40529-0,ConceptCodeName:Amphetamines [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40798-1,ConceptCodeName:Amphetamines [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48532-3,ConceptCodeName:Amphetamines | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8143-0,ConceptCodeName:Amphetamines [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26895-3,ConceptCodeName:Amphetamines [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43934-9,ConceptCodeName:Amphetamines [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8144-8,ConceptCodeName:Amphetamines [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8145-5,ConceptCodeName:Amphetamines [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8146-3,ConceptCodeName:Amphetamines [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48645-3,ConceptCodeName:Amphetamines | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27105-6,ConceptCodeName:Amphetamines [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52053-3,ConceptCodeName:Amphetamines | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40799-9,ConceptCodeName:Amphetamines [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41899-3,ConceptCodeName:Amphetamines | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12350-5,ConceptCodeName:Amphetamines [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18431-7,ConceptCodeName:Amphetamines [Presence] in Stool by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54800-5,ConceptCodeName:Amphetamines | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8153-9,ConceptCodeName:Amphetamines [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8154-7,ConceptCodeName:Amphetamines [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8155-4,ConceptCodeName:Amphetamines [Presence] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8156-2,ConceptCodeName:Amphetamines [Presence] in Unknown substance by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43255-6,ConceptCodeName:Amphetamines | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8150-5,ConceptCodeName:Amphetamines [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20410-7,ConceptCodeName:Amphetamines [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70138-3,ConceptCodeName:Amphetamines [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3349-8,ConceptCodeName:Amphetamines [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16369-1,ConceptCodeName:Amphetamines [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14309-9,ConceptCodeName:Amphetamines [Presence] in Urine by Confirm method >200 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8151-3,ConceptCodeName:Amphetamines [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8152-1,ConceptCodeName:Amphetamines [Presence] in Urine by SAMSHA screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19261-7,ConceptCodeName:Amphetamines [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14308-1,ConceptCodeName:Amphetamines [Presence] in Urine by Screen method >1000 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43983-6,ConceptCodeName:Amphetamines [Presence] in Urine by Screen method >500 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19269-0,ConceptCodeName:Amphetamines confirm method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19059-5,ConceptCodeName:Amphetamines cutoff [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19267-4,ConceptCodeName:Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19266-6,ConceptCodeName:Amphetamines cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19268-2,ConceptCodeName:Amphetamines screen method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19263-3,ConceptCodeName:Amphetamines tested for in Urine by Screen method Narrative,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19262-5,ConceptCodeName:Amphetamines tested for in Urine by Screen method Nominal,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41464-9,ConceptCodeName:Amphetamines/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48689-1,ConceptCodeName:Amphetamines | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27263-3,ConceptCodeName:Amphetamines [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27205-4,ConceptCodeName:Amphetamines [Presence] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49114-9,ConceptCodeName:Amphetamines | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48939-3,ConceptCodeName:Amphetamines [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29530-3,ConceptCodeName:Amphetamines [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16035-5,ConceptCodeName:Amphetaminil,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50415-6,ConceptCodeName:Amphetaminil | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3352-2,ConceptCodeName:Amphetaminil [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3351-4,ConceptCodeName:Amphetaminil [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3350-6,ConceptCodeName:Amphetaminil [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP31526-4,ConceptCodeName:Amphetamine+Methamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69733-1,ConceptCodeName:Amphetamine+Methamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40421-0,ConceptCodeName:Amphetamine+Methamphetamine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69763-8,ConceptCodeName:Amphetamine+Methamphetamine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43860-6,ConceptCodeName:Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69685-3,ConceptCodeName:Amphetamine+Methamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:56120-9,ConceptCodeName:Amphetamine+Methamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33280-9,ConceptCodeName:Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40419-4,ConceptCodeName:Amphetamine+Methamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69732-3,ConceptCodeName:Amphetamine+Methamphetamine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40420-2,ConceptCodeName:Amphetamine+Methamphetamine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99793-9,ConceptCodeName:Benzylpiperazine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100108-2,ConceptCodeName:Benzylpiperazine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59285-7,ConceptCodeName:Benzylpiperazine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59286-5,ConceptCodeName:Benzylpiperazine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99852-3,ConceptCodeName:Benzylpiperazine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59287-3,ConceptCodeName:Benzylpiperazine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59135-4,ConceptCodeName:Benzylpiperazine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:64233-0,ConceptCodeName:Benzylpiperazine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP71389-8,ConceptCodeName:Chloroamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:53821-5,ConceptCodeName:Chloroamphetamine [Mass/volume] in Serum,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16081-9,ConceptCodeName:Clobenzorex,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50882-7,ConceptCodeName:Clobenzorex | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3489-2,ConceptCodeName:Clobenzorex [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3488-4,ConceptCodeName:Clobenzorex [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18019-7,ConceptCodeName:Dextroamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50128-5,ConceptCodeName:Dextroamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9814-5,ConceptCodeName:Dextroamphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32642-1,ConceptCodeName:Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42699-6,ConceptCodeName:Dextroamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15366-8,ConceptCodeName:Dextroamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20525-2,ConceptCodeName:Dextroamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19420-9,ConceptCodeName:Dextroamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19419-1,ConceptCodeName:Dextroamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19422-5,ConceptCodeName:Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19421-7,ConceptCodeName:Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31025-0,ConceptCodeName:Dextroamphetamine/Amphetamines.total in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13497-3,ConceptCodeName:Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP19426-3,ConceptCodeName:Dextromethamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50129-3,ConceptCodeName:Dextromethamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32643-9,ConceptCodeName:Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42022-1,ConceptCodeName:Dextromethamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12477-6,ConceptCodeName:Dextromethamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19425-8,ConceptCodeName:Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58925-9,ConceptCodeName:Dextromethamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19424-1,ConceptCodeName:Dextromethamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19423-3,ConceptCodeName:Dextromethamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19428-2,ConceptCodeName:Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19427-4,ConceptCodeName:Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31026-8,ConceptCodeName:Dextromethamphetamine/Amphetamines.total in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13498-1,ConceptCodeName:Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP46203-3,ConceptCodeName:Dimetamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3566-7,ConceptCodeName:Dimetamphetamine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3565-9,ConceptCodeName:Dimetamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20526-0,ConceptCodeName:Dimetamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3564-2,ConceptCodeName:Dimetamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19453-0,ConceptCodeName:Dimetamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19452-2,ConceptCodeName:Dimetamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19455-5,ConceptCodeName:Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19454-8,ConceptCodeName:Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44639-0,ConceptCodeName:Ethylamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19459-7,ConceptCodeName:Ethylamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19458-9,ConceptCodeName:Ethylamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16212-3,ConceptCodeName:Ethylamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19456-3,ConceptCodeName:Ethylamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19461-3,ConceptCodeName:Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19460-5,ConceptCodeName:Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16144-5,ConceptCodeName:Fenetylline,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51269-6,ConceptCodeName:Fenetylline | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3629-3,ConceptCodeName:Fenetylline [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3628-5,ConceptCodeName:Fenetylline [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3627-7,ConceptCodeName:Fenetylline [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16147-8,ConceptCodeName:Fenproporex,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51273-8,ConceptCodeName:Fenproporex | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3635-0,ConceptCodeName:Fenproporex [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3634-3,ConceptCodeName:Fenproporex [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3633-5,ConceptCodeName:Fenproporex [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16154-4,ConceptCodeName:Furfenorex,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51278-7,ConceptCodeName:Furfenorex | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3658-2,ConceptCodeName:Furfenorex [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3657-4,ConceptCodeName:Furfenorex [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3656-6,ConceptCodeName:Furfenorex [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49557-9,ConceptCodeName:Levoamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31016-9,ConceptCodeName:Levoamphetamine/Amphetamines.total in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42023-9,ConceptCodeName:Levomethamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12478-4,ConceptCodeName:Levomethamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19512-3,ConceptCodeName:Levomethamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19511-5,ConceptCodeName:Levomethamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19510-7,ConceptCodeName:Levomethamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19515-6,ConceptCodeName:Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19514-9,ConceptCodeName:Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15404-7,ConceptCodeName:Levomethamphetamine/Amphetamines.total in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP134010-0,ConceptCodeName:Mephedrone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72795-8,ConceptCodeName:Mephedrone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:67838-3,ConceptCodeName:Mephedrone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72796-6,ConceptCodeName:Mephedrone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16194-0,ConceptCodeName:Methamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45300-8,ConceptCodeName:Methamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3776-2,ConceptCodeName:Methamphetamine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3778-8,ConceptCodeName:Methamphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17260-1,ConceptCodeName:Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3777-0,ConceptCodeName:Methamphetamine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43676-3,ConceptCodeName:Methamphetamine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14834-6,ConceptCodeName:Methamphetamine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52011-1,ConceptCodeName:Methamphetamine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40652-0,ConceptCodeName:Methamphetamine [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40803-9,ConceptCodeName:Methamphetamine [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44051-8,ConceptCodeName:Methamphetamine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15405-4,ConceptCodeName:Methamphetamine [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27289-8,ConceptCodeName:Methamphetamine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69022-2,ConceptCodeName:Methamphetamine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29286-2,ConceptCodeName:Methamphetamine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48649-5,ConceptCodeName:Methamphetamine | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27116-3,ConceptCodeName:Methamphetamine [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52056-6,ConceptCodeName:Methamphetamine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72735-4,ConceptCodeName:Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40804-7,ConceptCodeName:Methamphetamine [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48462-3,ConceptCodeName:Methamphetamine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26734-4,ConceptCodeName:Methamphetamine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44655-6,ConceptCodeName:Methamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3780-4,ConceptCodeName:Methamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16235-4,ConceptCodeName:Methamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55587-0,ConceptCodeName:Methamphetamine [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3779-6,ConceptCodeName:Methamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19555-2,ConceptCodeName:Methamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:21386-8,ConceptCodeName:Methamphetamine [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19554-5,ConceptCodeName:Methamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19557-8,ConceptCodeName:Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19556-0,ConceptCodeName:Methamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58358-3,ConceptCodeName:Methamphetamine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48222-1,ConceptCodeName:Methamphetamine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27277-3,ConceptCodeName:Methamphetamine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51892-5,ConceptCodeName:Methamphetamine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40381-6,ConceptCodeName:Methamphetamine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP21172-9,ConceptCodeName:Methylenedioxyethylamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49154-5,ConceptCodeName:Methylenedioxyethylamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33016-7,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29599-8,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61047-7,ConceptCodeName:Methylenedioxyethylamphetamine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102273-2,ConceptCodeName:Methylenedioxyethylamphetamine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61082-4,ConceptCodeName:Methylenedioxyethylamphetamine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48632-1,ConceptCodeName:Methylenedioxyethylamphetamine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27080-1,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69024-8,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48625-5,ConceptCodeName:Methylenedioxyethylamphetamine | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27074-4,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48631-3,ConceptCodeName:Methylenedioxyethylamphetamine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27079-3,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48636-2,ConceptCodeName:Methylenedioxyethylamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27085-0,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:45143-5,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61048-5,ConceptCodeName:Methylenedioxyethylamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59844-1,ConceptCodeName:Methylenedioxyethylamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:64127-4,ConceptCodeName:Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48718-8,ConceptCodeName:Methylenedioxyethylamphetamine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27299-7,ConceptCodeName:Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102255-9,ConceptCodeName:Methylenedioxyethylamphetamine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61049-3,ConceptCodeName:Methylenedioxyethylamphetamine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18612-9,ConceptCodeName:Methylenedioxymethamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP19144-2,ConceptCodeName:Methylenedianiline,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51734-9,ConceptCodeName:Methylenedianiline | Air,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:38748-0,ConceptCodeName:Methylenedianiline [Mass/volume] in Air,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45310-7,ConceptCodeName:Methylenedianiline | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17272-6,ConceptCodeName:Methylenedianiline [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33646-1,ConceptCodeName:Methylenedianiline [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48761-8,ConceptCodeName:Methylenedianiline | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27409-2,ConceptCodeName:Methylenedianiline [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP19292-9,ConceptCodeName:Methylenedioxyamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45784-3,ConceptCodeName:Methylenedioxyamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18359-0,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59837-5,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29598-0,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55551-6,ConceptCodeName:Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61045-1,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51949-3,ConceptCodeName:Methylenedioxyamphetamine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40531-6,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48704-8,ConceptCodeName:Methylenedioxyamphetamine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27244-3,ConceptCodeName:Methylenedioxyamphetamine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69023-0,ConceptCodeName:Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48464-9,ConceptCodeName:Methylenedioxyamphetamine | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26742-7,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158103-4,ConceptCodeName:Methylenedioxyamphetamine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72736-2,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48484-7,ConceptCodeName:Methylenedioxyamphetamine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26792-2,ConceptCodeName:Methylenedioxyamphetamine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45781-9,ConceptCodeName:Methylenedioxyamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18355-8,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20545-0,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42253-5,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19566-9,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19565-1,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20546-8,ConceptCodeName:Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19567-7,ConceptCodeName:Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:64138-1,ConceptCodeName:Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48678-4,ConceptCodeName:Methylenedioxyamphetamine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27189-0,ConceptCodeName:Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102254-2,ConceptCodeName:Methylenedioxyamphetamine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61046-9,ConceptCodeName:Methylenedioxyamphetamine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45782-7,ConceptCodeName:Methylenedioxymethamphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18357-4,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18356-6,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29619-4,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40493-9,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102274-0,ConceptCodeName:Methylenedioxymethamphetamine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61083-2,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP135765-8,ConceptCodeName:Methylenedioxymethamphetamine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69025-5,ConceptCodeName:Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48485-4,ConceptCodeName:Methylenedioxymethamphetamine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26793-0,ConceptCodeName:Methylenedioxymethamphetamine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43225-9,ConceptCodeName:Methylenedioxymethamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19570-1,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18358-2,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14267-9,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19569-3,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19568-5,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19572-7,ConceptCodeName:Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19571-9,ConceptCodeName:Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:44424-0,ConceptCodeName:Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48677-6,ConceptCodeName:Methylenedioxymethamphetamine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27188-2,ConceptCodeName:Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51930-3,ConceptCodeName:Methylenedioxymethamphetamine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40481-4,ConceptCodeName:Methylenedioxymethamphetamine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163969-1,ConceptCodeName:Methylone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72793-3,ConceptCodeName:Methylone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72794-1,ConceptCodeName:Methylone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16202-1,ConceptCodeName:Methylphenidate,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP29634-0,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49898-7,ConceptCodeName:Alpha-phenyl-2-piperidine Acetate | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32153-9,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102280-7,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61090-7,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50416-4,ConceptCodeName:Alpha-phenyl-2-piperidine Acetate | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33507-5,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72790-9,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61058-4,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72791-7,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102260-9,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61059-2,ConceptCodeName:Alpha-Phenyl-2-Piperidine acetate [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51335-5,ConceptCodeName:Methylphenidate | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3807-5,ConceptCodeName:Methylphenidate [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55552-4,ConceptCodeName:Methylphenidate [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3806-7,ConceptCodeName:Methylphenidate [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102275-7,ConceptCodeName:Methylphenidate | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61084-0,ConceptCodeName:Methylphenidate [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP46215-7,ConceptCodeName:Methylphenidate | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3810-9,ConceptCodeName:Methylphenidate [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3809-1,ConceptCodeName:Methylphenidate [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20548-4,ConceptCodeName:Methylphenidate [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3808-3,ConceptCodeName:Methylphenidate [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19578-4,ConceptCodeName:Methylphenidate [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19577-6,ConceptCodeName:Methylphenidate [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19580-0,ConceptCodeName:Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19579-2,ConceptCodeName:Methylphenidate cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72792-5,ConceptCodeName:Methylphenidate/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102256-7,ConceptCodeName:Methylphenidate | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61050-1,ConceptCodeName:Methylphenidate [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16234-4,ConceptCodeName:Para hydroxyamphetamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP46221-5,ConceptCodeName:Para Hydroxyamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3903-2,ConceptCodeName:Para hydroxyamphetamine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3902-4,ConceptCodeName:Para hydroxyamphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20554-2,ConceptCodeName:Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3901-6,ConceptCodeName:Para hydroxyamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19652-7,ConceptCodeName:Para hydroxyamphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19651-9,ConceptCodeName:Para hydroxyamphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19654-3,ConceptCodeName:Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19653-5,ConceptCodeName:Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16245-0,ConceptCodeName:Phendimetrazine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49165-1,ConceptCodeName:Phendimetrazine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3938-8,ConceptCodeName:Phendimetrazine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29613-7,ConceptCodeName:Phendimetrazine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48445-8,ConceptCodeName:Phendimetrazine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26711-2,ConceptCodeName:Phendimetrazine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48644-6,ConceptCodeName:Phendimetrazine | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27102-3,ConceptCodeName:Phendimetrazine [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48722-0,ConceptCodeName:Phendimetrazine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27303-7,ConceptCodeName:Phendimetrazine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51821-4,ConceptCodeName:Phendimetrazine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3941-2,ConceptCodeName:Phendimetrazine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3940-4,ConceptCodeName:Phendimetrazine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3939-6,ConceptCodeName:Phendimetrazine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48672-7,ConceptCodeName:Phendimetrazine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27178-3,ConceptCodeName:Phendimetrazine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18064-3,ConceptCodeName:Phenethylamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP145348-1,ConceptCodeName:2;5-dimethoxy-4-bromoamphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69798-7,ConceptCodeName:2;5-dimethoxy-4-bromoamphetamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41878-7,ConceptCodeName:Phenethylamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12331-5,ConceptCodeName:Phenethylamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16254-2,ConceptCodeName:Pholedrine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51843-8,ConceptCodeName:Pholedrine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3970-1,ConceptCodeName:Pholedrine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49150-3,ConceptCodeName:Amphetamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42576-9,ConceptCodeName:Amphetamine [Mass/volume] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:30112-7,ConceptCodeName:Amphetamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29592-3,ConceptCodeName:Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:66127-2,ConceptCodeName:Amphetamine [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48573-7,ConceptCodeName:Amphetamine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26959-7,ConceptCodeName:Amphetamine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158117-4,ConceptCodeName:Amphetamine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72758-6,ConceptCodeName:Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48483-9,ConceptCodeName:Amphetamine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26791-4,ConceptCodeName:Amphetamine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44654-9,ConceptCodeName:Amphetamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19346-6,ConceptCodeName:Amphetamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16234-7,ConceptCodeName:Amphetamine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52957-8,ConceptCodeName:Amphetamine [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19344-1,ConceptCodeName:Amphetamine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19343-3,ConceptCodeName:Amphetamine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19348-2,ConceptCodeName:Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19347-4,ConceptCodeName:Amphetamine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58357-5,ConceptCodeName:Amphetamine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16058-7,ConceptCodeName:Cannabinoids,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP130276-1,ConceptCodeName:Cannabinoids synthetic,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157951-7,ConceptCodeName:AM-2201 4-hydroxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72817-0,ConceptCodeName:AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72463-3,ConceptCodeName:AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72818-8,ConceptCodeName:AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157948-3,ConceptCodeName:JWH-018 4/5-hydroxypenty metabolites | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72459-1,ConceptCodeName:JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163973-3,ConceptCodeName:JWH-018 carboxylated metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72808-9,ConceptCodeName:JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72809-7,ConceptCodeName:JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157950-9,ConceptCodeName:JWH-018 pentanoate metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72782-6,ConceptCodeName:JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72461-7,ConceptCodeName:JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72783-4,ConceptCodeName:JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163968-3,ConceptCodeName:JWH-018 pentanol metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72780-0,ConceptCodeName:JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72781-8,ConceptCodeName:JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157949-1,ConceptCodeName:JWH-073 3-hydroxybutyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72460-9,ConceptCodeName:JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157952-5,ConceptCodeName:JWH-073 4-hydroxybutyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72464-1,ConceptCodeName:JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157953-3,ConceptCodeName:JWH-073 butanoate metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72778-4,ConceptCodeName:JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72465-8,ConceptCodeName:JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72779-2,ConceptCodeName:JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163972-5,ConceptCodeName:JWH-073 carboxylated metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72806-3,ConceptCodeName:JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72807-1,ConceptCodeName:JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157962-4,ConceptCodeName:JWH-122 5-hydroxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72474-0,ConceptCodeName:JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157644-8,ConceptCodeName:JWH-200 4-Hydroxyindole metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72462-5,ConceptCodeName:JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163971-7,ConceptCodeName:JWH-210 5-carboxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72804-8,ConceptCodeName:JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72805-5,ConceptCodeName:JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157955-8,ConceptCodeName:JWH-250 5-carboxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72802-2,ConceptCodeName:JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72467-4,ConceptCodeName:JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72803-0,ConceptCodeName:JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157954-1,ConceptCodeName:JWH-250 5-hydroxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72466-6,ConceptCodeName:JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157961-6,ConceptCodeName:JWH-398 5 hydroxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72473-2,ConceptCodeName:JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157958-2,ConceptCodeName:MAM-2201 pentanoate metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72470-8,ConceptCodeName:MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157957-4,ConceptCodeName:RCS-4 5-carboxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72469-0,ConceptCodeName:RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157956-6,ConceptCodeName:RCS-4 5-hydroxypentyl metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72468-2,ConceptCodeName:RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157959-0,ConceptCodeName:UR-144 4/5-hydroxypentyl metabolites | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72471-6,ConceptCodeName:UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157960-8,ConceptCodeName:UR-144 pentanoate metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72472-4,ConceptCodeName:UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP130325-6,ConceptCodeName:Cannabinoids synthetic | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:67126-3,ConceptCodeName:Cannabinoids synthetic [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157591-1,ConceptCodeName:Cannabinoids synthetic | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72379-1,ConceptCodeName:Cannabinoids synthetic [Presence] in Unspecified specimen by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16059-5,ConceptCodeName:Tetrahydrocannabinol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14468-0,ConceptCodeName:Carboxy tetrahydrocannabinol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44610-1,ConceptCodeName:Carboxy Tetrahydrocannabinol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26995-1,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42492-9,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16150-5,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47386-8,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26743-5,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49746-1,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49063-8,ConceptCodeName:Carboxy Tetrahydrocannabinol | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29326-6,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61062-6,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49616-3,ConceptCodeName:Carboxy Tetrahydrocannabinol | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31136-5,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69007-3,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57924-3,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158121-6,ConceptCodeName:Carboxy tetrahydrocannabinol | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72764-4,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48461-5,ConceptCodeName:Carboxy Tetrahydrocannabinol | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26732-8,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP46058-1,ConceptCodeName:Carboxy Tetrahydrocannabinol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3436-3,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20521-1,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3435-5,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19382-1,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19381-3,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19384-7,ConceptCodeName:Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19383-9,ConceptCodeName:Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19055-3,ConceptCodeName:Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48694-1,ConceptCodeName:Carboxy Tetrahydrocannabinol | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27213-8,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63561-2,ConceptCodeName:Carboxy Tetrahydrocannabinol | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48944-3,ConceptCodeName:Carboxy tetrahydrocannabinol [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61063-4,ConceptCodeName:Carboxy tetrahydrocannabinol [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP35627-6,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52078-0,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70178-9,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40864-1,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63556-2,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48934-4,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48935-1,ConceptCodeName:11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52978-1,ConceptCodeName:Tetrahydrocannabinol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58047-2,ConceptCodeName:Tetrahydrocannabinol [Presence] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3528-7,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:44049-5,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51791-2,ConceptCodeName:Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54803-9,ConceptCodeName:Tetrahydrocannabinol | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8162-0,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8163-8,ConceptCodeName:Tetrahydrocannabinol [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8164-6,ConceptCodeName:Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8165-3,ConceptCodeName:Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54804-7,ConceptCodeName:Tetrahydrocannabinol | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8166-1,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26893-8,ConceptCodeName:Tetrahydrocannabinol [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8167-9,ConceptCodeName:Tetrahydrocannabinol [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8168-7,ConceptCodeName:Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8169-5,ConceptCodeName:Tetrahydrocannabinol [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41902-5,ConceptCodeName:Tetrahydrocannabinol | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26731-0,ConceptCodeName:Tetrahydrocannabinol [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12351-3,ConceptCodeName:Tetrahydrocannabinol [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18432-5,ConceptCodeName:Tetrahydrocannabinol [Presence] in Stool by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42683-0,ConceptCodeName:Tetrahydrocannabinol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3530-3,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14313-1,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3426-4,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19416-7,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17872-3,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8174-5,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8175-2,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by SAMSHA screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19415-9,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:21557-4,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:21556-6,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14312-3,ConceptCodeName:Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19418-3,ConceptCodeName:Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19417-5,ConceptCodeName:Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13478-3,ConceptCodeName:Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63097-7,ConceptCodeName:Tetrahydrocannabinol | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27193-2,ConceptCodeName:Tetrahydrocannabinol [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52872-6,ConceptCodeName:Tetrahydrocannabinol | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43834-1,ConceptCodeName:Tetrahydrocannabinol [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44656-4,ConceptCodeName:Cannabinoids | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16243-8,ConceptCodeName:Cannabinoids [Mass/volume] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42630-4,ConceptCodeName:Cannabinoids [Presence] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42491-1,ConceptCodeName:Cannabinoids [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8170-3,ConceptCodeName:Cannabinoids [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16542-3,ConceptCodeName:Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3425-6,ConceptCodeName:Cannabinoids [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8171-1,ConceptCodeName:Cannabinoids [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8172-9,ConceptCodeName:Cannabinoids [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP65459-7,ConceptCodeName:Cannabinoids | Dialysis fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50338-3,ConceptCodeName:Cannabinoids [Mass/volume] in Dialysis fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50443-8,ConceptCodeName:Cannabinoids | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33561-2,ConceptCodeName:Cannabinoids [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59573-6,ConceptCodeName:Cannabinoids [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48468-0,ConceptCodeName:Cannabinoids | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59160-2,ConceptCodeName:Cannabinoids [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26764-1,ConceptCodeName:Cannabinoids [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40800-5,ConceptCodeName:Cannabinoids [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48601-6,ConceptCodeName:Cannabinoids | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27024-9,ConceptCodeName:Cannabinoids [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33282-5,ConceptCodeName:Cannabinoids [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50406-8,ConceptCodeName:Cannabinoids [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31080-5,ConceptCodeName:Cannabinoids [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52054-1,ConceptCodeName:Cannabinoids | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40801-3,ConceptCodeName:Cannabinoids [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48512-5,ConceptCodeName:Cannabinoids | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26856-5,ConceptCodeName:Cannabinoids [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44794-3,ConceptCodeName:Cannabinoids | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8176-0,ConceptCodeName:Cannabinoids [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16543-1,ConceptCodeName:Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8177-8,ConceptCodeName:Cannabinoids [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8178-6,ConceptCodeName:Cannabinoids [Presence] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8179-4,ConceptCodeName:Cannabinoids [Presence] in Unknown substance by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45738-9,ConceptCodeName:Cannabinoids | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42860-7,ConceptCodeName:Cannabinoids [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20413-1,ConceptCodeName:Cannabinoids [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70143-3,ConceptCodeName:Cannabinoids [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52954-5,ConceptCodeName:Cannabinoids [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3427-2,ConceptCodeName:Cannabinoids [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19289-8,ConceptCodeName:Cannabinoids [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18282-4,ConceptCodeName:Cannabinoids [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70144-1,ConceptCodeName:Cannabinoids [Presence] in Urine by Screen method >20 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70145-8,ConceptCodeName:Cannabinoids [Presence] in Urine by Screen method >50 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19294-8,ConceptCodeName:Cannabinoids confirm method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19073-6,ConceptCodeName:Cannabinoids cutoff [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19292-2,ConceptCodeName:Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19291-4,ConceptCodeName:Cannabinoids cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19293-0,ConceptCodeName:Cannabinoids screen method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19288-0,ConceptCodeName:Cannabinoids tested for in Urine by Screen method Narrative,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19287-2,ConceptCodeName:Cannabinoids tested for in Urine by Screen method Nominal,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26747-6,ConceptCodeName:Cannabinoids/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48637-0,ConceptCodeName:Cannabinoids | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27086-8,ConceptCodeName:Cannabinoids [Presence] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63560-4,ConceptCodeName:Cannabinoids | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48942-7,ConceptCodeName:Cannabinoids [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48943-5,ConceptCodeName:Cannabinoids [Presence] in Unspecified specimen by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16048-8,ConceptCodeName:Cocaine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16047-0,ConceptCodeName:Benzoylecgonine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44747-1,ConceptCodeName:Benzoylecgonine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42856-5,ConceptCodeName:Benzoylecgonine [Mass/volume] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72407-0,ConceptCodeName:Benzoylecgonine [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3392-8,ConceptCodeName:Benzoylecgonine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59616-3,ConceptCodeName:Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55525-0,ConceptCodeName:Benzoylecgonine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3391-0,ConceptCodeName:Benzoylecgonine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16446-7,ConceptCodeName:Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54809-6,ConceptCodeName:Benzoylecgonine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8182-8,ConceptCodeName:Benzoylecgonine [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8183-6,ConceptCodeName:Benzoylecgonine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8184-4,ConceptCodeName:Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8185-1,ConceptCodeName:Benzoylecgonine [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54219-8,ConceptCodeName:Benzoylecgonine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5936-0,ConceptCodeName:Benzoylecgonine [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5938-6,ConceptCodeName:Benzoylecgonine [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48603-2,ConceptCodeName:Benzoylecgonine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8186-9,ConceptCodeName:Benzoylecgonine [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27026-4,ConceptCodeName:Benzoylecgonine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69010-7,ConceptCodeName:Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8187-7,ConceptCodeName:Benzoylecgonine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8188-5,ConceptCodeName:Benzoylecgonine [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8189-3,ConceptCodeName:Benzoylecgonine [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP97407-8,ConceptCodeName:Benzoylecgonine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57301-4,ConceptCodeName:Benzoylecgonine [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41903-3,ConceptCodeName:Benzoylecgonine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27248-4,ConceptCodeName:Benzoylecgonine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12352-1,ConceptCodeName:Benzoylecgonine [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42684-8,ConceptCodeName:Benzoylecgonine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3394-4,ConceptCodeName:Benzoylecgonine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16226-3,ConceptCodeName:Benzoylecgonine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70146-6,ConceptCodeName:Benzoylecgonine [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3393-6,ConceptCodeName:Benzoylecgonine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14315-6,ConceptCodeName:Benzoylecgonine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8192-7,ConceptCodeName:Benzoylecgonine [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8193-5,ConceptCodeName:Benzoylecgonine [Presence] in Urine by SAMSHA screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14314-9,ConceptCodeName:Benzoylecgonine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43984-4,ConceptCodeName:Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43985-1,ConceptCodeName:Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19065-2,ConceptCodeName:Benzoylecgonine cutoff [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19358-1,ConceptCodeName:Benzoylecgonine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19357-3,ConceptCodeName:Benzoylecgonine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13479-1,ConceptCodeName:Benzoylecgonine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48746-9,ConceptCodeName:Benzoylecgonine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27358-1,ConceptCodeName:Benzoylecgonine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51996-4,ConceptCodeName:Benzoylecgonine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43230-2,ConceptCodeName:Benzoylecgonine [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40609-0,ConceptCodeName:Benzoylecgonine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP36028-6,ConceptCodeName:Cocaine+Benzoylecgonine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP64836-7,ConceptCodeName:Cocaine+benzoylecgonine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49747-9,ConceptCodeName:Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52391-7,ConceptCodeName:Cocaine+benzoylecgonine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47400-7,ConceptCodeName:Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42241-0,ConceptCodeName:Cocaine+Benzoylecgonine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18505-5,ConceptCodeName:Cocaethylene,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49615-5,ConceptCodeName:Cocaethylene | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31135-7,ConceptCodeName:Cocaethylene [Mass/volume] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42742-4,ConceptCodeName:Cocaethylene | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27226-0,ConceptCodeName:Cocaethylene [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59643-7,ConceptCodeName:Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55530-0,ConceptCodeName:Cocaethylene [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13553-3,ConceptCodeName:Cocaethylene [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49061-2,ConceptCodeName:Cocaethylene | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29324-1,ConceptCodeName:Cocaethylene [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44612-7,ConceptCodeName:Cocaethylene | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16171-1,ConceptCodeName:Cocaethylene [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49072-2,ConceptCodeName:Cocaethylene [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48489-6,ConceptCodeName:Cocaethylene | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26815-1,ConceptCodeName:Cocaethylene [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69011-5,ConceptCodeName:Cocaethylene [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57945-8,ConceptCodeName:Cocaethylene [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48717-0,ConceptCodeName:Cocaethylene | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27295-5,ConceptCodeName:Cocaethylene [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44845-3,ConceptCodeName:Cocaethylene | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19408-4,ConceptCodeName:Cocaethylene [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16632-2,ConceptCodeName:Cocaethylene [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19406-8,ConceptCodeName:Cocaethylene [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19405-0,ConceptCodeName:Cocaethylene [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19410-0,ConceptCodeName:Cocaethylene cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19409-2,ConceptCodeName:Cocaethylene cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49062-0,ConceptCodeName:Cocaethylene | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29325-8,ConceptCodeName:Cocaethylene [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63563-8,ConceptCodeName:Cocaethylene | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48946-8,ConceptCodeName:Cocaethylene [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP35633-4,ConceptCodeName:3-Hydroxybenzoylecgonine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP65614-7,ConceptCodeName:3-hydroxybenzoylecgonine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50593-3,ConceptCodeName:3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52102-8,ConceptCodeName:3-hydroxybenzoylecgonine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40901-1,ConceptCodeName:3-Hydroxybenzoylecgonine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69012-3,ConceptCodeName:3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP65615-4,ConceptCodeName:3-hydroxybenzoylecgonine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50594-1,ConceptCodeName:3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP28530-1,ConceptCodeName:Ecgonine methyl ester,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49342-6,ConceptCodeName:Ecgonine Methyl Ester | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:30107-7,ConceptCodeName:Ecgonine methyl ester [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:45320-9,ConceptCodeName:Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49344-2,ConceptCodeName:Ecgonine Methyl Ester | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:30109-3,ConceptCodeName:Ecgonine methyl ester [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49343-4,ConceptCodeName:Ecgonine Methyl Ester | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:30108-5,ConceptCodeName:Ecgonine methyl ester [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP65613-9,ConceptCodeName:Ecgonine Methyl Ester | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50592-5,ConceptCodeName:Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49345-9,ConceptCodeName:Ecgonine Methyl Ester | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:30110-1,ConceptCodeName:Ecgonine methyl ester [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP71280-9,ConceptCodeName:Cocaine metabolites.other | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:53743-1,ConceptCodeName:Cocaine metabolites.other [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49617-1,ConceptCodeName:Cocaine | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31137-3,ConceptCodeName:Cocaine [Mass/volume] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44748-9,ConceptCodeName:Cocaine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72405-4,ConceptCodeName:Cocaine [Mass/volume] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16633-0,ConceptCodeName:Cocaine [Presence] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41036-5,ConceptCodeName:Cocaine [Presence] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3396-9,ConceptCodeName:Cocaine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59644-5,ConceptCodeName:Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3395-1,ConceptCodeName:Cocaine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8190-1,ConceptCodeName:Cocaine [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8191-9,ConceptCodeName:Cocaine [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49060-4,ConceptCodeName:Cocaine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29323-3,ConceptCodeName:Cocaine [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:38384-4,ConceptCodeName:Cocaine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48647-9,ConceptCodeName:Cocaine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27114-8,ConceptCodeName:Cocaine [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41021-7,ConceptCodeName:Cocaine [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34715-3,ConceptCodeName:Cocaine [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48571-1,ConceptCodeName:Cocaine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26956-3,ConceptCodeName:Cocaine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69009-9,ConceptCodeName:Cocaine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40527-4,ConceptCodeName:Cocaine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41037-3,ConceptCodeName:Cocaine [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52055-8,ConceptCodeName:Cocaine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72737-0,ConceptCodeName:Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40802-1,ConceptCodeName:Cocaine [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48467-2,ConceptCodeName:Cocaine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26758-3,ConceptCodeName:Cocaine [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54539-9,ConceptCodeName:Cocaine | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8194-3,ConceptCodeName:Cocaine [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8195-0,ConceptCodeName:Cocaine [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8196-8,ConceptCodeName:Cocaine [Presence] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8197-6,ConceptCodeName:Cocaine [Presence] in Unknown substance by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44749-7,ConceptCodeName:Cocaine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3398-5,ConceptCodeName:Cocaine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20519-5,ConceptCodeName:Cocaine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52953-7,ConceptCodeName:Cocaine [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3397-7,ConceptCodeName:Cocaine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19360-7,ConceptCodeName:Cocaine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19359-9,ConceptCodeName:Cocaine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19363-1,ConceptCodeName:Cocaine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19362-3,ConceptCodeName:Cocaine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48688-3,ConceptCodeName:Cocaine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27204-7,ConceptCodeName:Cocaine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45686-0,ConceptCodeName:Cocaine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18208-9,ConceptCodeName:Cocaine [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57898-9,ConceptCodeName:Cocaine [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40625-6,ConceptCodeName:Cocaine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48947-6,ConceptCodeName:Cocaine [Presence] in Unspecified specimen by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18049-4,ConceptCodeName:Hallucinogens,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16809-3,ConceptCodeName:Bufotenine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41988-4,ConceptCodeName:Bufotenine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12433-9,ConceptCodeName:Bufotenine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43534-4,ConceptCodeName:Bufotenine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5608-5,ConceptCodeName:Bufotenine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16115-5,ConceptCodeName:Dimethyltryptamine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51161-5,ConceptCodeName:Dimethyltryptamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3567-5,ConceptCodeName:Dimethyltryptamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41836-5,ConceptCodeName:Dimethyltryptamine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3568-3,ConceptCodeName:Dimethyltryptamine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12292-9,ConceptCodeName:Dimethyltryptamine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16179-1,ConceptCodeName:Lysergate diethylamide,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP53326-2,ConceptCodeName:2-oxo-3-hydroxy-lysergate diethylamide | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:45185-6,ConceptCodeName:2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51310-8,ConceptCodeName:Lysergate Diethylamide | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3731-7,ConceptCodeName:Lysergate diethylamide [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5678-8,ConceptCodeName:Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3730-9,ConceptCodeName:Lysergate diethylamide [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102283-1,ConceptCodeName:Lysergate diethylamide | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61094-9,ConceptCodeName:Lysergate diethylamide [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44641-6,ConceptCodeName:Lysergate Diethylamide | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5679-6,ConceptCodeName:Lysergate diethylamide [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20542-7,ConceptCodeName:Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33350-0,ConceptCodeName:Lysergate diethylamide [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3732-5,ConceptCodeName:Lysergate diethylamide [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16214-9,ConceptCodeName:Lysergate diethylamide [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19528-9,ConceptCodeName:Lysergate diethylamide [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19531-3,ConceptCodeName:Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19530-5,ConceptCodeName:Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102261-7,ConceptCodeName:Lysergate diethylamide | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61065-9,ConceptCodeName:Lysergate diethylamide [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP17987-6,ConceptCodeName:Mescaline,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44608-5,ConceptCodeName:Mescaline | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16145-5,ConceptCodeName:Mescaline [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41841-5,ConceptCodeName:Mescaline | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9726-1,ConceptCodeName:Mescaline [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20543-5,ConceptCodeName:Mescaline [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12296-0,ConceptCodeName:Mescaline [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19543-8,ConceptCodeName:Mescaline [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19542-0,ConceptCodeName:Mescaline [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19545-3,ConceptCodeName:Mescaline cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19544-6,ConceptCodeName:Mescaline cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18864-6,ConceptCodeName:Psilocin,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44609-3,ConceptCodeName:Psilocin | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16146-3,ConceptCodeName:Psilocin [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45825-4,ConceptCodeName:Psilocin | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18415-0,ConceptCodeName:Psilocin [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20558-3,ConceptCodeName:Psilocin [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18414-3,ConceptCodeName:Psilocin [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19683-2,ConceptCodeName:Psilocin [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19682-4,ConceptCodeName:Psilocin [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19685-7,ConceptCodeName:Psilocin cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19684-0,ConceptCodeName:Psilocin cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP17245-9,ConceptCodeName:Psilocybin,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45438-6,ConceptCodeName:Psilocybin | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17505-9,ConceptCodeName:Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45437-8,ConceptCodeName:Psilocybin | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:6930-2,ConceptCodeName:Psilocybin [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19688-1,ConceptCodeName:Psilocybin [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17504-2,ConceptCodeName:Psilocybin [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19687-3,ConceptCodeName:Psilocybin [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19686-5,ConceptCodeName:Psilocybin [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19691-5,ConceptCodeName:Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19690-7,ConceptCodeName:Psilocybin cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100049-8,ConceptCodeName:Salvinorin A,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100136-3,ConceptCodeName:Salvinorin A | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59324-4,ConceptCodeName:Salvinorin A [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59326-9,ConceptCodeName:Salvinorin A [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100138-9,ConceptCodeName:Salvinorin A | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59328-5,ConceptCodeName:Salvinorin A [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100050-6,ConceptCodeName:Salvinorin B,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100137-1,ConceptCodeName:Salvinorin B | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59325-1,ConceptCodeName:Salvinorin B [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59327-7,ConceptCodeName:Salvinorin B [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100139-7,ConceptCodeName:Salvinorin B | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59329-3,ConceptCodeName:Salvinorin B [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45559-9,ConceptCodeName:Tryptamine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17751-9,ConceptCodeName:Tryptamine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41840-7,ConceptCodeName:Hallucinogens | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12295-2,ConceptCodeName:Hallucinogens [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15016-6,ConceptCodeName:Methaqualone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50663-1,ConceptCodeName:Methaqualone Metabolite | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34182-6,ConceptCodeName:Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69752-1,ConceptCodeName:Methaqualone+metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42252-7,ConceptCodeName:Methaqualone+Metabolite [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49591-8,ConceptCodeName:Methaqualone | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31085-4,ConceptCodeName:Methaqualone [Mass/volume] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48177-7,ConceptCodeName:Methaqualone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3785-3,ConceptCodeName:Methaqualone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35619-6,ConceptCodeName:Methaqualone [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:25475-5,ConceptCodeName:Methaqualone [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3784-6,ConceptCodeName:Methaqualone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP65106-4,ConceptCodeName:Methaqualone | Body Fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50005-8,ConceptCodeName:Methaqualone [Presence] in Body fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49091-9,ConceptCodeName:Methaqualone | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29388-6,ConceptCodeName:Methaqualone [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59929-0,ConceptCodeName:Methaqualone [Moles/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40382-4,ConceptCodeName:Methaqualone [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42797-8,ConceptCodeName:Methaqualone | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13646-5,ConceptCodeName:Methaqualone [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41267-3,ConceptCodeName:Methaqualone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11026-2,ConceptCodeName:Methaqualone [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27262-5,ConceptCodeName:Methaqualone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41904-1,ConceptCodeName:Methaqualone | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12353-9,ConceptCodeName:Methaqualone [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44657-2,ConceptCodeName:Methaqualone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3787-9,ConceptCodeName:Methaqualone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16244-6,ConceptCodeName:Methaqualone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59928-2,ConceptCodeName:Methaqualone [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3786-1,ConceptCodeName:Methaqualone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18389-7,ConceptCodeName:Methaqualone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19558-6,ConceptCodeName:Methaqualone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19560-2,ConceptCodeName:Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19559-4,ConceptCodeName:Methaqualone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48743-6,ConceptCodeName:Methaqualone | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27347-4,ConceptCodeName:Methaqualone [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49861-5,ConceptCodeName:Methaqualone | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60316-7,ConceptCodeName:Methaqualone [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32096-0,ConceptCodeName:Methaqualone [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18149-2,ConceptCodeName:Narcotics and opioids,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14980-4,ConceptCodeName:6-Monoacetylmorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP28812-3,ConceptCodeName:6-monoacetylmorphine free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44659-8,ConceptCodeName:6-monoacetylmorphine Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49749-5,ConceptCodeName:6-monoacetylmorphine free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16248-7,ConceptCodeName:6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46263-0,ConceptCodeName:6-monoacetylmorphine free [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP57465-4,ConceptCodeName:6-monoacetylmorphine Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51740-9,ConceptCodeName:6-monoacetylmorphine free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47004-7,ConceptCodeName:6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63009-2,ConceptCodeName:Morphine-3-glucuronide | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48364-4,ConceptCodeName:Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP62452-5,ConceptCodeName:Morphine-6-glucuronide | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48363-6,ConceptCodeName:Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42174-0,ConceptCodeName:6-monoacetylmorphine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12788-6,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14844-5,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43184-1,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18343-4,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43682-1,ConceptCodeName:6-monoacetylmorphine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14843-7,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48453-2,ConceptCodeName:6-monoacetylmorphine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26721-1,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49075-2,ConceptCodeName:6-monoacetylmorphine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29345-6,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP97406-0,ConceptCodeName:6-Monoacetylmorphine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57300-6,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72763-6,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41228-5,ConceptCodeName:6-monoacetylmorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10975-1,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19593-3,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55520-1,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70197-9,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10976-9,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19322-7,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19321-9,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19324-3,ConceptCodeName:6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19323-5,ConceptCodeName:6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58384-9,ConceptCodeName:6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49863-1,ConceptCodeName:6-monoacetylmorphine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32099-4,ConceptCodeName:6-Monoacetylmorphine (6-MAM) [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16021-5,ConceptCodeName:Alfentanil,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50286-1,ConceptCodeName:Alfentanil | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3307-6,ConceptCodeName:Alfentanil [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44701-8,ConceptCodeName:Alfentanil | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16334-5,ConceptCodeName:Alfentanil [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18383-0,ConceptCodeName:Alfentanil [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16022-3,ConceptCodeName:Alphaprodine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50287-9,ConceptCodeName:Alphaprodine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3308-4,ConceptCodeName:Alphaprodine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49728-6,ConceptCodeName:Alphaprodine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3311-8,ConceptCodeName:Alphaprodine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3310-0,ConceptCodeName:Alphaprodine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3309-2,ConceptCodeName:Alphaprodine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16036-3,ConceptCodeName:Anileridine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50444-6,ConceptCodeName:Anileridine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3356-3,ConceptCodeName:Anileridine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55523-5,ConceptCodeName:Anileridine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50446-1,ConceptCodeName:Anileridine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3359-7,ConceptCodeName:Anileridine [Moles/volume] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3357-1,ConceptCodeName:Anileridine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16054-6,ConceptCodeName:Buprenorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69721-6,ConceptCodeName:Buprenorphine+Norbuprenorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:38373-7,ConceptCodeName:Buprenorphine+Norbuprenorphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58359-1,ConceptCodeName:Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44778-6,ConceptCodeName:Buprenorphine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3413-2,ConceptCodeName:Buprenorphine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:53846-2,ConceptCodeName:Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158120-8,ConceptCodeName:Buprenorphine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72762-8,ConceptCodeName:Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44636-6,ConceptCodeName:Buprenorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3416-5,ConceptCodeName:Buprenorphine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3415-7,ConceptCodeName:Buprenorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49752-9,ConceptCodeName:Buprenorphine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3414-0,ConceptCodeName:Buprenorphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16208-1,ConceptCodeName:Buprenorphine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58360-9,ConceptCodeName:Buprenorphine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP17844-9,ConceptCodeName:Butorphanol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41946-2,ConceptCodeName:Butorphanol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12394-3,ConceptCodeName:Butorphanol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54970-6,ConceptCodeName:Butorphanol | Body Fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9313-8,ConceptCodeName:Butorphanol [Mass/volume] in Body fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41880-3,ConceptCodeName:Butorphanol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12395-0,ConceptCodeName:Butorphanol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16499-6,ConceptCodeName:Butorphanol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12333-1,ConceptCodeName:Butorphanol [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19378-9,ConceptCodeName:Butorphanol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19377-1,ConceptCodeName:Butorphanol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19380-5,ConceptCodeName:Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19379-7,ConceptCodeName:Butorphanol cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16093-4,ConceptCodeName:Codeine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP29031-9,ConceptCodeName:Codeine Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42170-8,ConceptCodeName:Codeine Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12784-5,ConceptCodeName:Codeine Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16644-7,ConceptCodeName:Codeine Free [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46262-2,ConceptCodeName:Codeine Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48727-9,ConceptCodeName:Codeine Free | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27311-0,ConceptCodeName:Codeine Free [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP66670-8,ConceptCodeName:Codeine Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51739-1,ConceptCodeName:Codeine Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP64857-3,ConceptCodeName:Norcodeine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP64884-7,ConceptCodeName:Norcodeine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49830-3,ConceptCodeName:Norcodeine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP64883-9,ConceptCodeName:Norcodeine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49829-5,ConceptCodeName:Norcodeine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP101457-2,ConceptCodeName:6-Acetylcodeine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60514-7,ConceptCodeName:6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43864-5,ConceptCodeName:Codeine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41038-1,ConceptCodeName:Codeine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3506-3,ConceptCodeName:Codeine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15102-7,ConceptCodeName:Codeine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3505-5,ConceptCodeName:Codeine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41770-6,ConceptCodeName:Codeine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29372-0,ConceptCodeName:Codeine [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14261-2,ConceptCodeName:Codeine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48452-4,ConceptCodeName:Codeine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26720-3,ConceptCodeName:Codeine [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44031-0,ConceptCodeName:Codeine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15364-3,ConceptCodeName:Codeine [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26865-6,ConceptCodeName:Codeine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:68542-0,ConceptCodeName:Codeine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29278-9,ConceptCodeName:Codeine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP97410-2,ConceptCodeName:Codeine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57304-8,ConceptCodeName:Codeine [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72759-4,ConceptCodeName:Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42793-7,ConceptCodeName:Codeine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3508-9,ConceptCodeName:Codeine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16250-3,ConceptCodeName:Codeine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70206-8,ConceptCodeName:Codeine [Moles/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3507-1,ConceptCodeName:Codeine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16197-6,ConceptCodeName:Codeine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13641-6,ConceptCodeName:Codeine [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19411-8,ConceptCodeName:Codeine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19414-2,ConceptCodeName:Codeine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19413-4,ConceptCodeName:Codeine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58391-4,ConceptCodeName:Codeine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52006-1,ConceptCodeName:Codeine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40626-4,ConceptCodeName:Codeine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16106-4,ConceptCodeName:Dextromoramide,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44902-2,ConceptCodeName:Dextromoramide | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16747-8,ConceptCodeName:Dextromoramide [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51027-8,ConceptCodeName:Dextromoramide | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3541-0,ConceptCodeName:Dextromoramide [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3540-2,ConceptCodeName:Dextromoramide [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16107-2,ConceptCodeName:Diamorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44907-1,ConceptCodeName:Diamorphine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18387-1,ConceptCodeName:Diamorphine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16756-9,ConceptCodeName:Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41872-0,ConceptCodeName:Diamorphine | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16754-4,ConceptCodeName:Diamorphine [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12326-5,ConceptCodeName:Diamorphine [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44630-9,ConceptCodeName:Diamorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3547-7,ConceptCodeName:Diamorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16755-1,ConceptCodeName:Diamorphine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3546-9,ConceptCodeName:Diamorphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16198-4,ConceptCodeName:Diamorphine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19439-9,ConceptCodeName:Diamorphine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19442-3,ConceptCodeName:Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19441-5,ConceptCodeName:Diamorphine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18183-1,ConceptCodeName:Dihydrocodeine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP21164-6,ConceptCodeName:Dihydrocodeine+Hydrocodeinone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69611-9,ConceptCodeName:Dihydrocodeine+hydrocodeinone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27035-5,ConceptCodeName:Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69618-4,ConceptCodeName:Dihydrocodeine+hydrocodeinone | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:28072-7,ConceptCodeName:Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42171-6,ConceptCodeName:Dihydrocodeine Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12785-2,ConceptCodeName:Dihydrocodeine Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16775-9,ConceptCodeName:Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40336-7,ConceptCodeName:Dihydrocodeine+Hydrocodol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP53507-7,ConceptCodeName:Dihydrocodeine+hydrocodol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51765-6,ConceptCodeName:Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46257-2,ConceptCodeName:Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP66372-1,ConceptCodeName:Dihydrocodeine+hydrocodol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51448-9,ConceptCodeName:Dihydrocodeine+Hydrocodol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40489-4,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69790-1,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49750-3,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46704-3,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46703-5,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69828-9,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51955-3,ConceptCodeName:Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43093-1,ConceptCodeName:Dihydrocodeine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14067-3,ConceptCodeName:Dihydrocodeine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42901-9,ConceptCodeName:Dihydrocodeine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43092-3,ConceptCodeName:Dihydrocodeine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19449-8,ConceptCodeName:Dihydrocodeine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19448-0,ConceptCodeName:Dihydrocodeine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14066-5,ConceptCodeName:Dihydrocodeine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16211-5,ConceptCodeName:Dihydrocodeine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19446-4,ConceptCodeName:Dihydrocodeine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19451-4,ConceptCodeName:Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19450-6,ConceptCodeName:Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:64131-6,ConceptCodeName:Dihydrocodeine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16117-1,ConceptCodeName:Dipipanone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51204-3,ConceptCodeName:Dipipanone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3575-8,ConceptCodeName:Dipipanone [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3574-1,ConceptCodeName:Dipipanone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3573-3,ConceptCodeName:Dipipanone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16139-5,ConceptCodeName:Ethylmorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45007-9,ConceptCodeName:Ethylmorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3619-4,ConceptCodeName:Ethylmorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20527-8,ConceptCodeName:Ethylmorphine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3618-6,ConceptCodeName:Ethylmorphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19463-9,ConceptCodeName:Ethylmorphine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19462-1,ConceptCodeName:Ethylmorphine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19465-4,ConceptCodeName:Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19464-7,ConceptCodeName:Ethylmorphine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15167-7,ConceptCodeName:Fentanyl,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99216-1,ConceptCodeName:Fentanyl+Norfentanyl,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP124893-1,ConceptCodeName:Fentanyl+Norfentanyl | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:66130-6,ConceptCodeName:Fentanyl+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99226-0,ConceptCodeName:Fentanyl+Norfentanyl | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:66129-8,ConceptCodeName:Fentanyl+Norfentanyl [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58379-9,ConceptCodeName:Fentanyl+Norfentanyl [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15048-9,ConceptCodeName:Norfentanyl,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41319-2,ConceptCodeName:Norfentanyl | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11074-2,ConceptCodeName:Norfentanyl [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61052-7,ConceptCodeName:Norfentanyl [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102276-5,ConceptCodeName:Norfentanyl | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61086-5,ConceptCodeName:Norfentanyl [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158109-1,ConceptCodeName:Norfentanyl | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72745-3,ConceptCodeName:Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41320-0,ConceptCodeName:Norfentanyl | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11075-9,ConceptCodeName:Norfentanyl [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58383-1,ConceptCodeName:Norfentanyl [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43199-9,ConceptCodeName:Norfentanyl [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43200-5,ConceptCodeName:Norfentanyl [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58382-3,ConceptCodeName:Norfentanyl/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102257-5,ConceptCodeName:Norfentanyl | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61053-5,ConceptCodeName:Norfentanyl [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15047-1,ConceptCodeName:Despropionylfentanyl,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41317-6,ConceptCodeName:Despropionylfentanyl | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11072-6,ConceptCodeName:Despropionylfentanyl [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41318-4,ConceptCodeName:Despropionylfentanyl | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11073-4,ConceptCodeName:Despropionylfentanyl [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49079-4,ConceptCodeName:Fentanyl | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3636-8,ConceptCodeName:Fentanyl [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55537-5,ConceptCodeName:Fentanyl [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29356-3,ConceptCodeName:Fentanyl [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44928-7,ConceptCodeName:Fentanyl | Body Fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16858-3,ConceptCodeName:Fentanyl [Mass/volume] in Body fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102269-0,ConceptCodeName:Fentanyl | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61077-4,ConceptCodeName:Fentanyl [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158118-2,ConceptCodeName:Fentanyl | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72760-2,ConceptCodeName:Fentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41482-8,ConceptCodeName:Fentanyl | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3637-6,ConceptCodeName:Fentanyl [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58381-5,ConceptCodeName:Fentanyl [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11235-9,ConceptCodeName:Fentanyl [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40839-3,ConceptCodeName:Fentanyl [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59673-4,ConceptCodeName:Fentanyl [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58380-7,ConceptCodeName:Fentanyl/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102252-6,ConceptCodeName:Fentanyl | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61042-8,ConceptCodeName:Fentanyl [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16161-9,ConceptCodeName:Hydrocodone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP29064-0,ConceptCodeName:Hydrocodone Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42172-4,ConceptCodeName:Hydrocodone Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12786-0,ConceptCodeName:Hydrocodone Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46261-4,ConceptCodeName:Hydrocodone Free [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48728-7,ConceptCodeName:Hydrocodone Free | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27312-8,ConceptCodeName:Hydrocodone Free [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP66669-0,ConceptCodeName:Hydrocodone Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51738-3,ConceptCodeName:Hydrocodone Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48745-1,ConceptCodeName:Hydrocodone Free | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27357-3,ConceptCodeName:Hydrocodone Free [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102596-6,ConceptCodeName:Norhydrocodone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158108-3,ConceptCodeName:Norhydrocodone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72744-6,ConceptCodeName:Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102617-0,ConceptCodeName:Norhydrocodone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61422-2,ConceptCodeName:Norhydrocodone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61421-4,ConceptCodeName:Norhydrocodone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61420-6,ConceptCodeName:Norhydrocodone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51286-0,ConceptCodeName:Hydrocodone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3680-6,ConceptCodeName:Hydrocodone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3679-8,ConceptCodeName:Hydrocodone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52008-7,ConceptCodeName:Hydrocodone | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40634-8,ConceptCodeName:Hydrocodone [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48451-6,ConceptCodeName:Hydrocodone | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26719-5,ConceptCodeName:Hydrocodone [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48515-8,ConceptCodeName:Hydrocodone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26863-1,ConceptCodeName:Hydrocodone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:68544-6,ConceptCodeName:Hydrocodone [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57981-3,ConceptCodeName:Hydrocodone [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158115-8,ConceptCodeName:Hydrocodone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72753-7,ConceptCodeName:Hydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41855-5,ConceptCodeName:Hydrocodone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3681-4,ConceptCodeName:Hydrocodone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16252-9,ConceptCodeName:Hydrocodone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12308-3,ConceptCodeName:Hydrocodone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19483-7,ConceptCodeName:Hydrocodone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19482-9,ConceptCodeName:Hydrocodone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19485-2,ConceptCodeName:Hydrocodone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19484-5,ConceptCodeName:Hydrocodone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58393-0,ConceptCodeName:Hydrocodone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49848-2,ConceptCodeName:Hydrocodone | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57861-7,ConceptCodeName:Hydrocodone [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32080-4,ConceptCodeName:Hydrocodone [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16162-7,ConceptCodeName:Hydromorphone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP29067-3,ConceptCodeName:Hydromorphone Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42173-2,ConceptCodeName:Hydromorphone Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12787-8,ConceptCodeName:Hydromorphone Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46260-6,ConceptCodeName:Hydromorphone Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48729-5,ConceptCodeName:Hydromorphone Free | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27314-4,ConceptCodeName:Hydromorphone Free [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP57118-9,ConceptCodeName:Hydromorphone Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51737-5,ConceptCodeName:Hydromorphone Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46971-8,ConceptCodeName:Hydromorphone Free [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48685-9,ConceptCodeName:Hydromorphone Free | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27196-5,ConceptCodeName:Hydromorphone Free [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51287-8,ConceptCodeName:Hydromorphone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3683-0,ConceptCodeName:Hydromorphone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3682-2,ConceptCodeName:Hydromorphone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51891-7,ConceptCodeName:Hydromorphone | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40369-1,ConceptCodeName:Hydromorphone [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48450-8,ConceptCodeName:Hydromorphone | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26718-7,ConceptCodeName:Hydromorphone [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48514-1,ConceptCodeName:Hydromorphone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26862-3,ConceptCodeName:Hydromorphone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:68541-2,ConceptCodeName:Hydromorphone [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57982-1,ConceptCodeName:Hydromorphone [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158102-6,ConceptCodeName:Hydromorphone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72733-9,ConceptCodeName:Hydromorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45076-4,ConceptCodeName:Hydromorphone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9835-0,ConceptCodeName:Hydromorphone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16998-7,ConceptCodeName:Hydromorphone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9834-3,ConceptCodeName:Hydromorphone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18473-9,ConceptCodeName:Hydromorphone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19486-0,ConceptCodeName:Hydromorphone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19488-6,ConceptCodeName:Hydromorphone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19487-8,ConceptCodeName:Hydromorphone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58394-8,ConceptCodeName:Hydromorphone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49849-0,ConceptCodeName:Hydromorphone | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57863-3,ConceptCodeName:Hydromorphone [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32081-2,ConceptCodeName:Hydromorphone [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16173-4,ConceptCodeName:Levorphanol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51307-4,ConceptCodeName:Levorphanol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3710-1,ConceptCodeName:Levorphanol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44640-8,ConceptCodeName:Levorphanol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3713-5,ConceptCodeName:Levorphanol [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3712-7,ConceptCodeName:Levorphanol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20540-1,ConceptCodeName:Levorphanol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3711-9,ConceptCodeName:Levorphanol [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16213-1,ConceptCodeName:Levorphanol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19516-4,ConceptCodeName:Levorphanol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19519-8,ConceptCodeName:Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19518-0,ConceptCodeName:Levorphanol cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16184-1,ConceptCodeName:Meperidine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP66955-3,ConceptCodeName:Meperidine+Normeperidine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP67150-0,ConceptCodeName:Meperidine+Normeperidine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51984-3,ConceptCodeName:Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99227-8,ConceptCodeName:Meperidine+Normeperidine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72384-1,ConceptCodeName:Meperidine+Normeperidine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58385-6,ConceptCodeName:Meperidine+Normeperidine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14726-1,ConceptCodeName:Normeperidine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40868-9,ConceptCodeName:Normeperidine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10996-7,ConceptCodeName:Normeperidine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35625-3,ConceptCodeName:Normeperidine [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59944-9,ConceptCodeName:Normeperidine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10544-5,ConceptCodeName:Normeperidine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102277-3,ConceptCodeName:Normeperidine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61087-3,ConceptCodeName:Normeperidine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158107-5,ConceptCodeName:Normeperidine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72743-8,ConceptCodeName:Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48819-4,ConceptCodeName:Normeperidine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3869-5,ConceptCodeName:Normeperidine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58389-8,ConceptCodeName:Normeperidine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27920-8,ConceptCodeName:Normeperidine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58388-0,ConceptCodeName:Normeperidine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58387-2,ConceptCodeName:Normeperidine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102258-3,ConceptCodeName:Normeperidine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61054-3,ConceptCodeName:Normeperidine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51145-8,ConceptCodeName:Meperidine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3745-7,ConceptCodeName:Meperidine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35617-0,ConceptCodeName:Meperidine [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59924-1,ConceptCodeName:Meperidine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3744-0,ConceptCodeName:Meperidine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43671-4,ConceptCodeName:Meperidine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29400-9,ConceptCodeName:Meperidine [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14826-2,ConceptCodeName:Meperidine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158113-3,ConceptCodeName:Meperidine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72749-5,ConceptCodeName:Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43525-2,ConceptCodeName:Meperidine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3748-1,ConceptCodeName:Meperidine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3747-3,ConceptCodeName:Meperidine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16253-7,ConceptCodeName:Meperidine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3746-5,ConceptCodeName:Meperidine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16207-3,ConceptCodeName:Meperidine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19532-1,ConceptCodeName:Meperidine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19535-4,ConceptCodeName:Meperidine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19534-7,ConceptCodeName:Meperidine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58386-4,ConceptCodeName:Meperidine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49856-5,ConceptCodeName:Meperidine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57864-1,ConceptCodeName:Meperidine [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32088-7,ConceptCodeName:Meperidine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15015-8,ConceptCodeName:Methadone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP19141-8,ConceptCodeName:Methadone.long acting metabolite,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45299-2,ConceptCodeName:Methadone.long Acting Metabolite | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17259-3,ConceptCodeName:Methadone.long acting metabolite [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50429-7,ConceptCodeName:Methadone.long Acting Metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:33527-3,ConceptCodeName:Methadone.long acting metabolite [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50718-3,ConceptCodeName:Methadone.R | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34427-5,ConceptCodeName:Methadone.R [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48365-1,ConceptCodeName:Methadone.R [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP36029-4,ConceptCodeName:Methadone+Metabolite,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69785-1,ConceptCodeName:Methadone+metabolite | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48403-0,ConceptCodeName:Methadone+Metabolite [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:45022-1,ConceptCodeName:Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157661-2,ConceptCodeName:Methadone+Metabolite | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72475-7,ConceptCodeName:Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69751-3,ConceptCodeName:Methadone+metabolite | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42251-9,ConceptCodeName:Methadone+Metabolite [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP35885-0,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52339-6,ConceptCodeName:2-ethylidene-1;5-dimethyl-3;3-diphenylpyrrolidine (EDDP) | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60071-8,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41860-8,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102268-2,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61076-6,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP172593-8,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:73562-1,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157594-5,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72385-8,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72386-6,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52337-0,ConceptCodeName:2-ethylidene-1;5-dimethyl-3;3-diphenylpyrrolidine (EDDP) | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50542-0,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58429-2,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41858-2,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58428-4,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58390-6,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52338-8,ConceptCodeName:2-ethylidene-1;5-dimethyl-3;3-diphenylpyrrolidine (EDDP) | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41859-0,ConceptCodeName:2-Ethylidene-1;5-Dimethyl-3;3-Diphenylpyrrolidine (EDDP) [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49590-0,ConceptCodeName:Methadone | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31084-7,ConceptCodeName:Methadone [Mass/volume] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43867-8,ConceptCodeName:Methadone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72400-5,ConceptCodeName:Methadone [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3772-1,ConceptCodeName:Methadone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35618-8,ConceptCodeName:Methadone [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15108-4,ConceptCodeName:Methadone [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3771-3,ConceptCodeName:Methadone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47411-4,ConceptCodeName:Methadone [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59705-4,ConceptCodeName:Methadone [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49053-9,ConceptCodeName:Methadone | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29294-6,ConceptCodeName:Methadone [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29285-4,ConceptCodeName:Methadone [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41491-9,ConceptCodeName:Methadone | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11243-3,ConceptCodeName:Methadone [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41266-5,ConceptCodeName:Methadone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11025-4,ConceptCodeName:Methadone [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29159-1,ConceptCodeName:Methadone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43595-8,ConceptCodeName:Methadone [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48616-4,ConceptCodeName:Methadone | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27052-0,ConceptCodeName:Methadone [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157595-2,ConceptCodeName:Methadone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72388-2,ConceptCodeName:Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72734-7,ConceptCodeName:Methadone [Mass/volume] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72387-4,ConceptCodeName:Methadone [Presence] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72626-5,ConceptCodeName:Methadone [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41907-4,ConceptCodeName:Methadone | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27283-1,ConceptCodeName:Methadone [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12356-2,ConceptCodeName:Methadone [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44631-7,ConceptCodeName:Methadone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3775-4,ConceptCodeName:Methadone [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3774-7,ConceptCodeName:Methadone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16246-1,ConceptCodeName:Methadone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70147-4,ConceptCodeName:Methadone [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52958-6,ConceptCodeName:Methadone [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3773-9,ConceptCodeName:Methadone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16199-2,ConceptCodeName:Methadone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19550-3,ConceptCodeName:Methadone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70148-2,ConceptCodeName:Methadone [Presence] in Urine by Screen method >150 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70149-0,ConceptCodeName:Methadone [Presence] in Urine by Screen method >300 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19553-7,ConceptCodeName:Methadone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19552-9,ConceptCodeName:Methadone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41466-4,ConceptCodeName:Methadone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48691-7,ConceptCodeName:Methadone | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27207-0,ConceptCodeName:Methadone [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49116-4,ConceptCodeName:Methadone | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48957-5,ConceptCodeName:Methadone [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48956-7,ConceptCodeName:Methadone [Mass/volume] in Unspecified specimen by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32093-7,ConceptCodeName:Methadone [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45312-3,ConceptCodeName:Methylfentanyl | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17275-9,ConceptCodeName:Methylfentanyl [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157686-9,ConceptCodeName:Mitragynine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163962-6,ConceptCodeName:7-Hydroxymitragynine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72731-3,ConceptCodeName:7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72729-7,ConceptCodeName:7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP163963-4,ConceptCodeName:Mitragynine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72732-1,ConceptCodeName:Mitragynine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72730-5,ConceptCodeName:Mitragynine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15174-3,ConceptCodeName:Morphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP28863-6,ConceptCodeName:Morphine Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49592-6,ConceptCodeName:Morphine Free | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31086-2,ConceptCodeName:Morphine Free [Mass/volume] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41492-7,ConceptCodeName:Morphine Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11244-1,ConceptCodeName:Morphine Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46259-8,ConceptCodeName:Morphine Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48618-0,ConceptCodeName:Morphine Free | Cerebral spinal fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27054-6,ConceptCodeName:Morphine Free [Mass/volume] in Cerebral spinal fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49069-5,ConceptCodeName:Morphine Free | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29337-3,ConceptCodeName:Morphine Free [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48439-1,ConceptCodeName:Morphine Free | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26696-5,ConceptCodeName:Morphine Free [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP46219-9,ConceptCodeName:Morphine Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3829-9,ConceptCodeName:Morphine Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20550-0,ConceptCodeName:Morphine Free [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3828-1,ConceptCodeName:Morphine Free [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19602-2,ConceptCodeName:Morphine Free [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19601-4,ConceptCodeName:Morphine Free [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19604-8,ConceptCodeName:Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19603-0,ConceptCodeName:Morphine Free cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48690-9,ConceptCodeName:Morphine Free | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27206-2,ConceptCodeName:Morphine Free [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP64885-4,ConceptCodeName:Normorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:49831-1,ConceptCodeName:Normorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43870-2,ConceptCodeName:Morphine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3827-3,ConceptCodeName:Morphine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15110-0,ConceptCodeName:Morphine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3826-5,ConceptCodeName:Morphine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17290-8,ConceptCodeName:Morphine [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48617-2,ConceptCodeName:Morphine | Cerebral spinal fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27053-8,ConceptCodeName:Morphine [Mass/volume] in Cerebral spinal fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP55021-7,ConceptCodeName:Morphine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9438-3,ConceptCodeName:Morphine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51894-1,ConceptCodeName:Morphine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40384-0,ConceptCodeName:Morphine [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44033-6,ConceptCodeName:Morphine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15370-0,ConceptCodeName:Morphine [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26860-7,ConceptCodeName:Morphine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69027-1,ConceptCodeName:Morphine [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29287-0,ConceptCodeName:Morphine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158114-1,ConceptCodeName:Morphine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72752-9,ConceptCodeName:Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42798-6,ConceptCodeName:Morphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3832-3,ConceptCodeName:Morphine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3831-5,ConceptCodeName:Morphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16251-1,ConceptCodeName:Morphine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70210-0,ConceptCodeName:Morphine [Moles/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3830-7,ConceptCodeName:Morphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16196-8,ConceptCodeName:Morphine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13648-1,ConceptCodeName:Morphine [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19597-4,ConceptCodeName:Morphine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19600-6,ConceptCodeName:Morphine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19599-0,ConceptCodeName:Morphine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58392-2,ConceptCodeName:Morphine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49865-6,ConceptCodeName:Morphine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32100-0,ConceptCodeName:Morphine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16212-0,ConceptCodeName:Nalbuphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44947-7,ConceptCodeName:Nalbuphine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17318-7,ConceptCodeName:Nalbuphine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44645-7,ConceptCodeName:Nalbuphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3841-4,ConceptCodeName:Nalbuphine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3840-6,ConceptCodeName:Nalbuphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20551-8,ConceptCodeName:Nalbuphine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3839-8,ConceptCodeName:Nalbuphine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16218-0,ConceptCodeName:Nalbuphine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19605-5,ConceptCodeName:Nalbuphine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19608-9,ConceptCodeName:Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19607-1,ConceptCodeName:Nalbuphine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP55150-4,ConceptCodeName:Nalbuphine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9777-4,ConceptCodeName:Nalbuphine [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP31478-8,ConceptCodeName:Narcotic antagonists,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16213-8,ConceptCodeName:Nalorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51491-6,ConceptCodeName:Nalorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3842-2,ConceptCodeName:Nalorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP28525-1,ConceptCodeName:Naloxone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48885-5,ConceptCodeName:Naloxone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:28061-0,ConceptCodeName:Naloxone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52507-8,ConceptCodeName:Naloxone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42618-9,ConceptCodeName:Naloxone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15000-0,ConceptCodeName:Naltrexone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18094-0,ConceptCodeName:6-Beta naltrexone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41958-7,ConceptCodeName:6-beta naltrexone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12407-3,ConceptCodeName:6-Beta naltrexone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158126-5,ConceptCodeName:6-Beta naltrexone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72787-5,ConceptCodeName:6-Beta naltrexone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72788-3,ConceptCodeName:6-Beta naltrexone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41240-0,ConceptCodeName:Naltrexone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10994-2,ConceptCodeName:Naltrexone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41856-3,ConceptCodeName:Naltrexone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19611-3,ConceptCodeName:Naltrexone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19610-5,ConceptCodeName:Naltrexone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12309-1,ConceptCodeName:Naltrexone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18334-3,ConceptCodeName:Naltrexone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19609-7,ConceptCodeName:Naltrexone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19613-9,ConceptCodeName:Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19612-1,ConceptCodeName:Naltrexone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72789-1,ConceptCodeName:Naltrexone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16217-9,ConceptCodeName:Nicomorphine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51526-9,ConceptCodeName:Nicomorphine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3851-3,ConceptCodeName:Nicomorphine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14565-3,ConceptCodeName:Opiates,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51750-5,ConceptCodeName:Opiates | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51691-4,ConceptCodeName:Opiates [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8217-2,ConceptCodeName:Opiates [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3878-6,ConceptCodeName:Opiates [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8218-0,ConceptCodeName:Opiates [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8219-8,ConceptCodeName:Opiates [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54818-7,ConceptCodeName:Opiates | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8209-9,ConceptCodeName:Opiates [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8210-7,ConceptCodeName:Opiates [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8211-5,ConceptCodeName:Opiates [Presence] in Gastric fluid by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8212-3,ConceptCodeName:Opiates [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40657-6,ConceptCodeName:Opiates | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10369-7,ConceptCodeName:Opiates [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40528-2,ConceptCodeName:Opiates [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40805-4,ConceptCodeName:Opiates [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48465-6,ConceptCodeName:Opiates | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8213-1,ConceptCodeName:Opiates [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29158-3,ConceptCodeName:Opiates [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26744-3,ConceptCodeName:Opiates [Mass/mass] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8214-9,ConceptCodeName:Opiates [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8215-6,ConceptCodeName:Opiates [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8216-4,ConceptCodeName:Opiates [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50620-4,ConceptCodeName:Opiates cutoff [Mass/mass] in Meconium for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48730-3,ConceptCodeName:Opiates | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27321-9,ConceptCodeName:Opiates [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52057-4,ConceptCodeName:Opiates | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40806-2,ConceptCodeName:Opiates [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41905-8,ConceptCodeName:Opiates | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27064-5,ConceptCodeName:Opiates [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12354-7,ConceptCodeName:Opiates [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54821-1,ConceptCodeName:Opiates | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8223-0,ConceptCodeName:Opiates [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8224-8,ConceptCodeName:Opiates [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8225-5,ConceptCodeName:Opiates [Presence] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8226-3,ConceptCodeName:Opiates [Presence] in Unknown substance by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45379-2,ConceptCodeName:Opiates | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8220-6,ConceptCodeName:Opiates [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17384-9,ConceptCodeName:Opiates [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70150-8,ConceptCodeName:Opiates [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5706-7,ConceptCodeName:Opiates [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52952-9,ConceptCodeName:Opiates [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3879-4,ConceptCodeName:Opiates [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18390-5,ConceptCodeName:Opiates [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8221-4,ConceptCodeName:Opiates [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8222-2,ConceptCodeName:Opiates [Presence] in Urine by SAMSHA screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19295-5,ConceptCodeName:Opiates [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:21431-2,ConceptCodeName:Opiates [Presence] in Urine by Screen method >2000 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70151-6,ConceptCodeName:Opiates [Presence] in Urine by Screen method >300 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19302-9,ConceptCodeName:Opiates confirm method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19138-7,ConceptCodeName:Opiates cutoff [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19300-3,ConceptCodeName:Opiates cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19299-7,ConceptCodeName:Opiates cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19301-1,ConceptCodeName:Opiates screen method [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19297-1,ConceptCodeName:Opiates tested for in Urine by Screen method Narrative,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19296-3,ConceptCodeName:Opiates tested for in Urine by Screen method Nominal,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:41465-6,ConceptCodeName:Opiates/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48654-5,ConceptCodeName:Opiates | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27136-1,ConceptCodeName:Opiates [Presence] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50660-7,ConceptCodeName:Opiates | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48961-7,ConceptCodeName:Opiates [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34177-6,ConceptCodeName:Opiates [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15003-4,ConceptCodeName:Oxycodone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP29091-3,ConceptCodeName:Oxycodone Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42175-7,ConceptCodeName:Oxycodone Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12789-4,ConceptCodeName:Oxycodone Free [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46256-4,ConceptCodeName:Oxycodone Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48716-2,ConceptCodeName:Oxycodone Free | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27293-0,ConceptCodeName:Oxycodone Free [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP57119-7,ConceptCodeName:Oxycodone Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51954-6,ConceptCodeName:Oxycodone Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46973-4,ConceptCodeName:Oxycodone Free [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99251-8,ConceptCodeName:Oxycodone+Oxymorphone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP149566-4,ConceptCodeName:Oxycodone+Oxymorphone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:71430-3,ConceptCodeName:Oxycodone+Oxymorphone [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99257-5,ConceptCodeName:Oxycodone+Oxymorphone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61197-0,ConceptCodeName:Oxycodone+Oxymorphone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58430-0,ConceptCodeName:Oxycodone+Oxymorphone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60276-3,ConceptCodeName:Oxycodone+Oxymorphone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102595-8,ConceptCodeName:Noroxycodone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158106-7,ConceptCodeName:Noroxycodone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72742-0,ConceptCodeName:Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP102616-2,ConceptCodeName:Noroxycodone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61425-5,ConceptCodeName:Noroxycodone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61424-8,ConceptCodeName:Noroxycodone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61423-0,ConceptCodeName:Noroxycodone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41752-4,ConceptCodeName:Oxycodone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72402-1,ConceptCodeName:Oxycodone [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3893-5,ConceptCodeName:Oxycodone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:13576-4,ConceptCodeName:Oxycodone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50021-5,ConceptCodeName:Oxycodone [Mass/volume] in Serum; Plasma or Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43695-3,ConceptCodeName:Oxycodone | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14863-5,ConceptCodeName:Oxycodone [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48454-0,ConceptCodeName:Oxycodone | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26722-9,ConceptCodeName:Oxycodone [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48517-4,ConceptCodeName:Oxycodone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26869-8,ConceptCodeName:Oxycodone [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:68543-8,ConceptCodeName:Oxycodone [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP136076-9,ConceptCodeName:Oxycodone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72750-3,ConceptCodeName:Oxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72751-1,ConceptCodeName:Oxycodone [Mass/volume] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69356-4,ConceptCodeName:Oxycodone [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41242-6,ConceptCodeName:Oxycodone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11246-6,ConceptCodeName:Oxycodone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16249-5,ConceptCodeName:Oxycodone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:70215-9,ConceptCodeName:Oxycodone [Moles/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10998-3,ConceptCodeName:Oxycodone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19643-6,ConceptCodeName:Oxycodone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19642-8,ConceptCodeName:Oxycodone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19645-1,ConceptCodeName:Oxycodone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19644-4,ConceptCodeName:Oxycodone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58395-5,ConceptCodeName:Oxycodone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49866-4,ConceptCodeName:Oxycodone | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57865-8,ConceptCodeName:Oxycodone [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32101-8,ConceptCodeName:Oxycodone [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15176-8,ConceptCodeName:Oxymorphone,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40335-9,ConceptCodeName:Oxymorphone Free,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP53508-5,ConceptCodeName:Oxymorphone Free | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46974-2,ConceptCodeName:Oxymorphone Free [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46258-0,ConceptCodeName:Oxymorphone Free [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP57120-5,ConceptCodeName:Oxymorphone Free | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51736-7,ConceptCodeName:Oxymorphone Free [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46975-9,ConceptCodeName:Oxymorphone Free [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41890-2,ConceptCodeName:Oxymorphone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60467-8,ConceptCodeName:Oxymorphone [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12342-2,ConceptCodeName:Oxymorphone [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP135764-1,ConceptCodeName:Oxymorphone | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:69028-9,ConceptCodeName:Oxymorphone [Mass/mass] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP158122-4,ConceptCodeName:Oxymorphone | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72766-9,ConceptCodeName:Oxymorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41494-3,ConceptCodeName:Oxymorphone | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19648-5,ConceptCodeName:Oxymorphone [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17395-5,ConceptCodeName:Oxymorphone [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11247-4,ConceptCodeName:Oxymorphone [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18325-1,ConceptCodeName:Oxymorphone [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19646-9,ConceptCodeName:Oxymorphone [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19650-1,ConceptCodeName:Oxymorphone cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19649-3,ConceptCodeName:Oxymorphone cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58396-3,ConceptCodeName:Oxymorphone/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP18145-0,ConceptCodeName:Papaverine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42078-3,ConceptCodeName:Papaverine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60125-2,ConceptCodeName:Papaverine [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12550-0,ConceptCodeName:Papaverine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP101086-9,ConceptCodeName:Papaverine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60126-0,ConceptCodeName:Papaverine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP15017-4,ConceptCodeName:Propoxyphene,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14549-7,ConceptCodeName:Norpropoxyphene,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40628-7,ConceptCodeName:Norpropoxyphene | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10341-6,ConceptCodeName:Norpropoxyphene [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35626-1,ConceptCodeName:Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55559-9,ConceptCodeName:Norpropoxyphene [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3870-3,ConceptCodeName:Norpropoxyphene [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49090-1,ConceptCodeName:Norpropoxyphene | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29387-8,ConceptCodeName:Norpropoxyphene [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48693-3,ConceptCodeName:Norpropoxyphene | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27211-2,ConceptCodeName:Norpropoxyphene [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48604-0,ConceptCodeName:Norpropoxyphene | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27029-8,ConceptCodeName:Norpropoxyphene [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157972-3,ConceptCodeName:Norpropoxyphene | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72619-0,ConceptCodeName:Norpropoxyphene [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72620-8,ConceptCodeName:Norpropoxyphene [Presence] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48611-5,ConceptCodeName:Norpropoxyphene | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27041-3,ConceptCodeName:Norpropoxyphene [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45375-0,ConceptCodeName:Norpropoxyphene | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19635-2,ConceptCodeName:Norpropoxyphene [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17377-3,ConceptCodeName:Norpropoxyphene [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3871-1,ConceptCodeName:Norpropoxyphene [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:17376-5,ConceptCodeName:Norpropoxyphene [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19632-9,ConceptCodeName:Norpropoxyphene [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19637-8,ConceptCodeName:Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19636-0,ConceptCodeName:Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58399-7,ConceptCodeName:Norpropoxyphene/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP63572-9,ConceptCodeName:Norpropoxyphene | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48960-9,ConceptCodeName:Norpropoxyphene [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP69363-7,ConceptCodeName:Propoxyphene+acetaminophen | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10533-8,ConceptCodeName:Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP17947-0,ConceptCodeName:Propoxyphene + Norpropoxyphene,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157938-4,ConceptCodeName:Propoxyphene + Norpropoxyphene | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9626-3,ConceptCodeName:Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47415-5,ConceptCodeName:Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55574-8,ConceptCodeName:Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157971-5,ConceptCodeName:Propoxyphene + Norpropoxyphene | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72618-2,ConceptCodeName:Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157928-5,ConceptCodeName:Propoxyphene + Norpropoxyphene | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19436-5,ConceptCodeName:Propoxyphene + Norpropoxyphene [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19435-7,ConceptCodeName:Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19434-0,ConceptCodeName:Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19433-2,ConceptCodeName:Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19438-1,ConceptCodeName:Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19437-3,ConceptCodeName:Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44903-0,ConceptCodeName:Propoxyphene | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72401-3,ConceptCodeName:Propoxyphene [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3543-6,ConceptCodeName:Propoxyphene [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35649-3,ConceptCodeName:Propoxyphene [Mass/volume] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32125-7,ConceptCodeName:Propoxyphene [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3542-8,ConceptCodeName:Propoxyphene [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16748-6,ConceptCodeName:Propoxyphene [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59734-4,ConceptCodeName:Propoxyphene [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP55136-3,ConceptCodeName:Propoxyphene | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9737-8,ConceptCodeName:Propoxyphene [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59961-3,ConceptCodeName:Propoxyphene [Moles/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9809-5,ConceptCodeName:Propoxyphene [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41481-0,ConceptCodeName:Propoxyphene | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11234-2,ConceptCodeName:Propoxyphene [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41268-1,ConceptCodeName:Propoxyphene | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:11027-0,ConceptCodeName:Propoxyphene [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27067-8,ConceptCodeName:Propoxyphene [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:73567-0,ConceptCodeName:Propoxyphene [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP157970-7,ConceptCodeName:Propoxyphene | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72621-6,ConceptCodeName:Propoxyphene [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72622-4,ConceptCodeName:Propoxyphene [Presence] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72617-4,ConceptCodeName:Propoxyphene [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41908-2,ConceptCodeName:Propoxyphene | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27281-5,ConceptCodeName:Propoxyphene [Mass/mass] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12357-0,ConceptCodeName:Propoxyphene [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44632-5,ConceptCodeName:Propoxyphene | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3545-1,ConceptCodeName:Propoxyphene [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16242-0,ConceptCodeName:Propoxyphene [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59960-5,ConceptCodeName:Propoxyphene [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19141-1,ConceptCodeName:Propoxyphene [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16200-8,ConceptCodeName:Propoxyphene [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19429-0,ConceptCodeName:Propoxyphene [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19432-4,ConceptCodeName:Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19431-6,ConceptCodeName:Propoxyphene cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58398-9,ConceptCodeName:Propoxyphene/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48679-2,ConceptCodeName:Propoxyphene | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27190-8,ConceptCodeName:Propoxyphene [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52861-9,ConceptCodeName:Propoxyphene | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48964-1,ConceptCodeName:Propoxyphene [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48963-3,ConceptCodeName:Propoxyphene [Mass/volume] in Unspecified specimen by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:60330-8,ConceptCodeName:Propoxyphene [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:43811-9,ConceptCodeName:Propoxyphene [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP17874-6,ConceptCodeName:Sufentanil,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54999-5,ConceptCodeName:Sufentanil | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9395-5,ConceptCodeName:Sufentanil [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45844-5,ConceptCodeName:Sufentanil | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9396-3,ConceptCodeName:Sufentanil [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18435-8,ConceptCodeName:Sufentanil [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99218-7,ConceptCodeName:Tapentadol,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP121247-3,ConceptCodeName:Nortapentadol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:65808-8,ConceptCodeName:Nortapentadol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100153-8,ConceptCodeName:Tapentadol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59352-5,ConceptCodeName:Tapentadol [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59354-1,ConceptCodeName:Tapentadol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP100154-6,ConceptCodeName:Tapentadol | Body fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59353-3,ConceptCodeName:Tapentadol [Mass/volume] in Body fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP133002-8,ConceptCodeName:Tapentadol | Tissue and Smears,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59355-8,ConceptCodeName:Tapentadol [Mass/volume] in Tissue,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP99229-4,ConceptCodeName:Tapentadol | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:65807-0,ConceptCodeName:Tapentadol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58402-9,ConceptCodeName:Tapentadol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58401-1,ConceptCodeName:Tapentadol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72485-6,ConceptCodeName:Tapentadol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61429-7,ConceptCodeName:Tapentadol/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16300-3,ConceptCodeName:Trimeperidine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52038-4,ConceptCodeName:Trimeperidine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:4077-4,ConceptCodeName:Trimeperidine [Mass/time] in 24 hour Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:4076-6,ConceptCodeName:Trimeperidine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:4075-8,ConceptCodeName:Trimeperidine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49594-2,ConceptCodeName:Narcotics and opioids | Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:31088-8,ConceptCodeName:Narcotics and opioids [Identifier] in Bile fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49083-6,ConceptCodeName:Narcotics and opioids | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29376-1,ConceptCodeName:Narcotics and opioids [Identifier] in Blood,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49084-4,ConceptCodeName:Narcotics and opioids | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:29377-9,ConceptCodeName:Narcotics and opioids [Identifier] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42082-5,ConceptCodeName:Narcotics and opioids | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12554-2,ConceptCodeName:Narcotics and opioids [Identifier] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14566-1,ConceptCodeName:Phencyclidine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51815-6,ConceptCodeName:Phencyclidine | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58042-3,ConceptCodeName:Phencyclidine [Presence] in Blood by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:51692-2,ConceptCodeName:Phencyclidine [Presence] in Blood by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3934-7,ConceptCodeName:Phencyclidine [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:59956-3,ConceptCodeName:Phencyclidine [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3935-4,ConceptCodeName:Phencyclidine [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8235-4,ConceptCodeName:Phencyclidine [Presence] in Serum or Plasma by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8236-2,ConceptCodeName:Phencyclidine [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54824-5,ConceptCodeName:Phencyclidine | Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8227-1,ConceptCodeName:Phencyclidine [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8228-9,ConceptCodeName:Phencyclidine [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8229-7,ConceptCodeName:Phencyclidine [Presence] in Gastric fluid by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8230-5,ConceptCodeName:Phencyclidine [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40658-4,ConceptCodeName:Phencyclidine | Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10370-5,ConceptCodeName:Phencyclidine [Mass/mass] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40394-9,ConceptCodeName:Phencyclidine [Presence] in Hair,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40807-0,ConceptCodeName:Phencyclidine [Presence] in Hair by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48494-6,ConceptCodeName:Phencyclidine | Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8231-3,ConceptCodeName:Phencyclidine [Mass/volume] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26859-9,ConceptCodeName:Phencyclidine [Mass/mass] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26829-2,ConceptCodeName:Phencyclidine [Mass/mass] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8232-1,ConceptCodeName:Phencyclidine [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8233-9,ConceptCodeName:Phencyclidine [Presence] in Meconium by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8234-7,ConceptCodeName:Phencyclidine [Presence] in Meconium by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48588-5,ConceptCodeName:Phencyclidine | Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:26994-4,ConceptCodeName:Phencyclidine [Mass/volume] in Milk,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP52058-2,ConceptCodeName:Phencyclidine | Saliva,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72765-1,ConceptCodeName:Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40808-8,ConceptCodeName:Phencyclidine [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41906-6,ConceptCodeName:Phencyclidine | Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12355-4,ConceptCodeName:Phencyclidine [Presence] in Stool,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54826-0,ConceptCodeName:Phencyclidine | Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8239-6,ConceptCodeName:Phencyclidine [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8240-4,ConceptCodeName:Phencyclidine [Presence] in Unknown substance,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8241-2,ConceptCodeName:Phencyclidine [Presence] in Unknown substance by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8242-0,ConceptCodeName:Phencyclidine [Presence] in Unknown substance by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43256-4,ConceptCodeName:Phencyclidine | Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3937-0,ConceptCodeName:Phencyclidine [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16254-5,ConceptCodeName:Phencyclidine [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:72825-3,ConceptCodeName:Phencyclidine [Mass/volume] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:52951-1,ConceptCodeName:Phencyclidine [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3936-2,ConceptCodeName:Phencyclidine [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:18392-1,ConceptCodeName:Phencyclidine [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14311-5,ConceptCodeName:Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8237-0,ConceptCodeName:Phencyclidine [Presence] in Urine by SAMHSA confirm method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:8238-8,ConceptCodeName:Phencyclidine [Presence] in Urine by SAMSHA screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19659-2,ConceptCodeName:Phencyclidine [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14310-7,ConceptCodeName:Phencyclidine [Presence] in Urine by Screen method >25 ng/mL,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19661-8,ConceptCodeName:Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:19660-0,ConceptCodeName:Phencyclidine cutoff [Mass/volume] in Urine for Screen method,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58397-1,ConceptCodeName:Phencyclidine/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP48652-9,ConceptCodeName:Phencyclidine | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27356-5,ConceptCodeName:Phencyclidine [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:27131-2,ConceptCodeName:Phencyclidine [Presence] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP41163-4,ConceptCodeName:Phencyclidine | XXX,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10915-7,ConceptCodeName:Phencyclidine [Mass/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:57869-0,ConceptCodeName:Phencyclidine [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32107-5,ConceptCodeName:Phencyclidine [Presence] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Toxicology Drug Testing  Value Set,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP14348-4,ConceptCodeName:Ethanol,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP16119-7,ConceptCodeName:Disulfiram,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP51222-5,ConceptCodeName:Disulfiram | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:3577-4,ConceptCodeName:Disulfiram [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44964-2,ConceptCodeName:Disulfiram | Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:9357-5,ConceptCodeName:Disulfiram [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16781-7,ConceptCodeName:Disulfiram [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP53374-2,ConceptCodeName:Ethyl glucuronide | Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:45324-1,ConceptCodeName:Ethyl glucuronide [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58378-1,ConceptCodeName:Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:55349-5,ConceptCodeName:Ethyl glucuronide [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58377-3,ConceptCodeName:Ethyl glucuronide [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58375-7,ConceptCodeName:Ethyl glucuronide [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58376-5,ConceptCodeName:Ethyl glucuronide/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP43273-9,ConceptCodeName:Ethanol | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5640-8,ConceptCodeName:Ethanol [Mass/volume] in Blood,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:56478-1,ConceptCodeName:Ethanol [Mass/volume] in Blood by Gas chromatography,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15120-9,ConceptCodeName:Ethanol [Moles/volume] in Blood,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5639-0,ConceptCodeName:Ethanol [Presence] in Blood,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5643-2,ConceptCodeName:Ethanol [Mass/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14336-2,ConceptCodeName:Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:14719-9,ConceptCodeName:Ethanol [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5642-4,ConceptCodeName:Ethanol [Presence] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:20470-1,ConceptCodeName:Ethanol [Presence] in Serum or Plasma by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45002-0,ConceptCodeName:Ethanol | Body Fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16843-5,ConceptCodeName:Ethanol [Mass/volume] in Body fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP54131-5,ConceptCodeName:Ethanol | Exhaled gas,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5641-6,ConceptCodeName:Ethanol [Mass/volume] in Exhaled gas,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP40656-8,ConceptCodeName:Ethanol | Gastric fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:10367-1,ConceptCodeName:Ethanol [Mass/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:47107-8,ConceptCodeName:Ethanol [Moles/volume] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:40530-8,ConceptCodeName:Ethanol [Presence] in Gastric fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61095-6,ConceptCodeName:Ethanol [Presence] in Gastric fluid by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP44049-2,ConceptCodeName:Ethanol | Meconium,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:15402-1,ConceptCodeName:Ethanol [Presence] in Meconium,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP50880-1,ConceptCodeName:Ethanol | Saliva,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34882-1,ConceptCodeName:Ethanol [Mass/volume] in Saliva (oral fluid),CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50343-3,ConceptCodeName:Ethanol [Presence] in Saliva (oral fluid) by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP131065-7,ConceptCodeName:Ethanol | Tissue and Smears,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:23861-8,ConceptCodeName:Ethanol [Mass/mass] in Tissue,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP45001-2,ConceptCodeName:Ethanol | Unknown substance,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:16842-7,ConceptCodeName:Ethanol [Mass/volume] in Unknown substance,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP47217-2,ConceptCodeName:Ethanol | Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5645-7,ConceptCodeName:Ethanol [Mass/volume] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:46983-3,ConceptCodeName:Ethanol [Mass/volume] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:22745-4,ConceptCodeName:Ethanol [Moles/volume] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:5644-0,ConceptCodeName:Ethanol [Presence] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:34180-0,ConceptCodeName:Ethanol [Presence] in Urine by Confirmatory method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:42242-8,ConceptCodeName:Ethanol [Presence] in Urine by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:35664-2,ConceptCodeName:Ethanol [Mass/volume] in unspecified time Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:58356-7,ConceptCodeName:Ethanol/Creatinine [Mass Ratio] in Urine,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP42011-4,ConceptCodeName:Ethanol | Vitreous fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:12465-1,ConceptCodeName:Ethanol [Mass/volume] in Vitreous fluid,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP49842-5,ConceptCodeName:Ethanol | XXX,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:32070-5,ConceptCodeName:Ethanol [Moles/volume] in Unspecified specimen,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:61066-7,ConceptCodeName:Ethanol [Presence] in Unspecified specimen by Screen method,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:LP172697-7,ConceptCodeName:Ethanol+Methanol+Isopropyl alchohol+Acetone | Bld-Ser-Plas,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:48342-0,ConceptCodeName:Ethanol+Methanol+Isopropyl alchohol+Acetone [Moles/volume] in Serum or Plasma,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:50022-3,ConceptCodeName:Ethanol+Methanol+Isopropyl alchohol+Acetone [Presence] in Serum; Plasma or Blood,CodeSystemName:LOINC,ValueSet:Ethanol Testing Testing  Value Set,ValueSetCategory:Alcohol Abuse,CodeSystem:2.16.840.1.113883.6.1
ConceptCode:111880001,ConceptCodeName:Acute HIV,CodeSystemName:SNOMED-CT,ValueSet:HIV,ValueSetCategory:HIV,CodeSystem:2.16.840.1.113883.6.96
ConceptCode:413307004,ConceptCodeName:Mental health problem,CodeSystemName:SNOMED-CT,ValueSet:Mental health problem,ValueSetCategory:Psychiatric Information,CodeSystem:2.16.840.1.113883.6.96
ConceptCode:26416006,ConceptCodeName:Drug abuse,CodeSystemName:SNOMED-CT,ValueSet:Substance abuse,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.96
ConceptCode:66214007,ConceptCodeName:Substance abuse,CodeSystemName:SNOMED-CT,ValueSet:Substance abuse,ValueSetCategory:Drug Abuse,CodeSystem:2.16.840.1.113883.6.96
